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ABSTRACT
The zebrafish is an ideal model organism for the genetic study of vertebrate
development because it combines rapid early development which is amenable to
direct observation and manipulation, the ability to house a large number of genetically
distinct lines, large numbers of progeny from a single mating, and a relatively short
generation time. Chemical mutagenesis screens have identified at least half of the
estimated 2,400 genes required for the proper embryonic development of this animal.
However, the cloning of these genes is likely to be impeded by the large size of the
zebrafish genome and the relatively sparse genetic map. Insertional mutagenesis is
an alternative method for isolating mutations in which integrated DNA of known
sequence is used as the mutagen; this DNA also serves as a molecular tag to facilitate
the cloning of the disrupted gene. A pseudotyped retrovirus, containing the envelope
protein of the pantropic vesicular stomatitis virus and a retroviral vector genome, was
developed for use as an insertional mutagen in zebrafish.
High titer concentrated stocks of pseudotyped retrovirus were injected into blastula
stage embryos, which resulted in the integration of proviral DNA into the chromosomes
of many of the cells of the developing embryos, including the presumptive germ cells.
On average, a dozen different insertions could be inherited through the germ-lines of
these mosaic founder fish, each in an average of 3% of their offspring; these offspring
were non-mosaic and thus transmitted the transgenes to 50% of their progeny. This
strategy of transgenesis was used to generate hundreds of transgenic lines, which
were inbred and screened for mutations in genes affecting embryonic development.
In a pilot screen of 217 inbred lines, three mutations were found which were
shown to be caused by the proviral insertions, suggesting that 1-2% of proviral
insertions will cause recessive embryonic lethal mutations. The genes disrupted in
two of these mutants were rapidly cloned. Four more insertional mutants were found
as the screen continued, and the genes affected by each of these mutations were
cloned as well. These results suggest that it should be possible to screen tens of
thousands of proviral insertions by this method and thus isolate readily clonable
alleles of hundreds of genes required for the embryonic development of this model
vertebrate organism.
Thesis Supervisor: Nancy Hopkins
Title: Professor of Biology
ACKNOWLEDGMENTS
There are many people whom I must thank, without whose help and support this
work could not have been completed. I thank Drs. Robert Grafstrom, Kenneth Zaret,
and Rudolf Grosschedl, each of whom helped to push me towards pursuing an
advanced degree in biology and to prepare me for the experience. I thank Drs. Hazel
Sive and Rudolf Jaenisch for helpful comments and advice during my graduate school
tenure. I thank all members of the Hopkins lab, past and present, especially Nick
Gaiano, Shuo Lin, Miguel Allende, Koichi Kawakami, Tom Becker, Shawn Burgess,
and Dean Thompson, both for scientific collaboration and for being a joy to work with
every day. I thank Lucinda Stratton for her love, support, and patience.
I thank my advisor, Nancy Hopkins, not just for valuable advice and training, but
for always having faith in me, even when it was undeserved.
Above all, I thank my family, especially my mother, without whom I could never
have accomplished any of this.
TABLE OF CONTENTS
Abstract 2
Acknowledgments 3
Chapter 1: Introduction: Reasons for developing an
insertional mutagenesis strategy in the zebrafish 6
Zebrafish as a model organism for the genetic study of development 7
Large-scale chemical mutagenesis in zebrafish 9
Prospects for cloning genes from the chemical mutagenesis screens 12
Transposon tagging in flies and worms 14
Insertional mutagenesis in mice 16
Requirements for insertional mutagenesis in zebrafish 21
Transgenesis in zebrafish 22
The use of MoMLV/VSV retroviral vectors to generate transgenic zebrafish 25
Towards insertional mutagenesis 26
References 27
Chapter 2: The Aequorea victoria green fluorescent protein can
be used as a reporter in live zebrafish embryos 43
Abstract 44
Introduction 45
Results 47
Expression of Xex-GFP in injected embryos 47
Germ-line transmission of GFP transgenes 47
Expression of GFP in transgenic lines 50
Maintenance of transgene expression in subsequent generations 53
Transgene copy number in fluorescent and non-fluorescent
GFP transgenic fish 54
Microinjection of recombinant GFP 57
Discussion 61
Materials and Methods 64
References 66
Preface to Chapters 3 and 4 69
Chapter 3: Highly efficient germ-line transmission
of proviral insertions in zebrafish 71
Abstract 72
Introduction 72
Results 73
High frequency germ-line transmission of proviral integrations 73
Germ-line mosaicism of founders 75
SFG founders transmit an average of 11 proviral insertions to
their F1 progeny 76
Analysis of SFG proviral genome structures 78
Discussion 81
Materials and Methods 83
References 86
Chapter 4: Insertional Mutagenesis and rapid cloning
of essential genes in zebrafish 88
Abstract 89
Results and Discussion 89
Retroviral insertional mutagenesis in zebrafish 89
The no arches phenotype and gene 95
Summary 102
Materials and Methods 102
References 103
Preface to Chapters 5 and 6 105
Chapter 5: Insertional mutagenesis in zebrafish identifies two novel genes,
pescadillo and dead eye, essential for embryonic development 107
Abstract 108
Introduction 109
Results 110
Evidence that dye is an insertional mutant and preliminary
characterization of the mutant phenotype 111
Isolation of the dye gene and demonstration that its
expression is disrupted in mutants 116
The pes gene encodes a highly conserved novel protein 125
Expression of the pes gene is developmentally regulated 128
The pes mutation affects the development of a subset of embryonic
primordia which correlate with sites of strong pes expression 134
Discussion 139
Ease of molecular cloning of genes disrupted by proviral insertion 140
Relationship of insertional mutants to previously
identified zebrafish mutants 143
Understanding the pes and dye mutant phenotypes 144
Feasibility of genetic screens 145
Materials and Methods 146
References 149
Chapter 6: Large scale insertional mutagenesis screen in zebrafish 154
General applicability of retroviral insertional mutagenesis in zebrafish 155
Protocol for a large scale screen 159
Alternative screening protocols 165
Areas for improvement in the technology 166
Cloning the genes 171
Implications for vertebrate biology 172
References 174
Appendix 1: List of Publications 179
Appendix 2: Production of transgenic zebrafish 180
Appendix 3: Green fluorescent protein: uses in transgenic vertebrates 195
Appendix 4: Retrovirus-mediated insertional mutagenesis in zebrafish and
identification of a molecular marker for embryonic germ cells 220
CHAPTER 1
INTRODUCTION: REASONS FOR DEVELOPING AN INSERTIONAL MUTAGENESIS
STRATEGY IN THE ZEBRAFISH
(Most of this chapter (along with Chapter 6) will be published as part of a book chapter:
Amsterdam, A. and Hopkins, N. (1998) Insertional mutagenesis in zebrafish, in
Development: Genetics, epigenetics, and environmental regulation, eds. Russo, E.,
Cove, D., Edgar, L., Jaenisch, R., and Salamini, F. (Springer-Verlag: Berlin).)
Zebrafish as a model organism for the genetic study of vertebrate development
One of the fundamental goals of modern biology is to understand the molecular
mechanisms governing the development of multicellular organisms. Several
approaches have contributed to our understanding of the gene products involved in
these mechanisms and their interactions with each other. One such approach
examines the result of the ectopic expression of genes during development or the
addition of gene products to in vitro situations that represent individual developmental
processes, such as the ability of a given gene's expression to affect digit identity in a
chick limb bud (1) or the inductive properties of certain secreted factors upon frog
ectoderm (2, 3). This approach has been very powerful in assessing the potential role
of many gene products in development; however, while such experiments can
demonstrate the ability of a certain gene product to perform a certain role, they do not
necessarily show that the factor normally performs this role in the course of
development. Conversely, one can examine the results of the absence of these gene
products. One way to do this is the use of inhibitors of these gene products or the
expression of dominant negative alleles (4, 5), though one must be careful to prove
that the gene of interest is the only one being inhibited. Similarly, in mice, one can use
homologous recombination in embryonic stem (ES) cells to create a null allele (or
"knock-out") any cloned gene, thus discovering the effect of its absence (6). The
inhibition or elimination of cloned genes to examine the effects of their absence can be
considered "reverse genetics"; in contrast, one can use a classical "forward" genetic
approach whereby mutations are isolated based upon their phenotype, and the gene
is subsequently cloned.
One clear distinction between the reverse genetics approaches and the forward
genetics approach is that in the former, the gene products must be identified prior to
the assessment of their role in the developmental program, while in the latter it is their
essential role in the developmental program which identifies them. The source of
genes to test by reverse genetics can include those which appear to be of interest
based upon biochemical activity, expression pattern, even homology to genes
identified genetically in invertebrates (see below). However, in vitro activity and
expression pattern have often failed to be a good predictor of the phenotype that
results when these genes are disrupted (7, 8). If one's interest is to define the role of a
certain transcription factor, a specific signaling pathway, or a certain gene whose
human homolog is implicated in some disease, then the reverse genetics approaches
are ideal. However, if one's primary interest is a developmental process, and not the
role of genes identified by some other means, the most straightforward way to identify
the essential genes is to perform a forward genetic screen.
The organisms in which the molecular mechanisms of development are most fully
understood are the fruit fly, Drosophila melanogaster and the nematode Caenhabditis
elegans, and the bulk of this understanding has come from the application of the
forward genetic approach. The ability to perform saturation mutagenesis in these
organisms has allowed the identification of all, or nearly all, of the genetic loci required
for any given developmental process (9-13). Such genetic screens and the
subsequent cloning of the affected genes has led to a tremendous advance in
understanding the developmental programs of these two organisms, as the genetic
pathways were supplemented by the ability to detect, manipulate, and define
biochemical functions for the individual gene products. Furthermore, because many of
these genes proved to have homologs throughout the animal kingdom, their
identification has led to the isolation of many genes involved in the development of
vertebrates (14-19).
While the fly and worm have been ideal for forward genetic analysis, it is clear
that many developmental processes will be very different between either of these
invertebrates and vertebrate organisms. However, the traditionally studied vertebrate
organisms are not well suited for the forward genetics approach, which is why they
have mostly been studied using either ectopic expression or reverse genetics
approaches. The chicken and frog have long generation times, and mice develop in
utero, which makes forward screening for developmental defects difficult if not
impossible. Furthermore, while a limited forward genetic screen might be possible in
mice through the use of gene traps and ES cells (see below) the raising and housing
of the number of independent genetic lines required for a large scale screen is
impractical. Can a forward genetic screen be performed in a vertebrate?
In the past decade, the zebrafish has become a popular model organism for
developmental biology exactly because it is amenable to forward genetic analysis (20-
22). The zebrafish combines rapid early development, an embryo which is accessible
to direct observation and manipulation, large numbers of progeny from single matings,
a relatively short generation time (about three months), and relatively small space
requirements such that a single lab could raise and maintain thousands of
independent lines. Many of the embryological analyses that have been done in the
frog have been repeated in the fish, including the development of fate maps and the
establishment of specification assays on the embryo and induction assays in cultured
explants (23-26).
Additionally, parthenogenetic embryos can be generated by variety of methods,
which can allow the identification of mutants without the requirement for inbreeding
genetic lesions, the creation of essentially inbred strains, and certain mapping
procedures (see below). One can create gynogenetic diploids by one of two methods,
each of which utilizes oocytes activated by UV-irradiated sperm which provide no
genetic information (27). One method produces true homozygotes at every loci by
suppressing the embryo's first mitotic cleavage division. The other prevents the
completion of the second meiotic division, allowing the consequences of crossing over
to be observed in the resultant "half-tetrad" diploids (28). Screens utilizing
parthenogenetic diploids have isolated mutations affecting early development (29, 30),
neuronal survival (31), and migration and differentiation of neural crest (32).
Alternatively, one can generate haploid embryos, which develop somewhat normally
for the first two days of development (27). Haploid screens have identified mutants
abnormal in motility (33, 34), notochord development (35), and patterning of the
central nervous system(36). However, both of these methods produce abnormal
embryos as well as normal ones, which can complicate the identification of mutants.
Thus while several important mutations affecting early development have been found
by these different parthenogenetic screens, it seemed that the real promise lay in the
ability to do a large-scale near-saturation diploid screen, whereby mutants could be
isolated in every developmental process, from early pattern formation to
organogenesis.
Large-scale chemical mutagenesis in zebrafish
Two laboratories, that of Nusslein-Volhard in Tubingen, Germany and that of
Fishman and Driever in Boston, Massachusetts, carried out large scale chemical
mutagenesis screens (37, 38). Their goal was to reach saturation , that is, to mutate
and identify every gene required for normal embryogenesis. Pilot screens were first
conducted to determine single hit rates at specific loci (39, 40). This is done by
mutagenizing founders with N-ethyl-N-nitrosourea (ENU) and crossing them to tester
fish which were heterozygous for one (or more) of four pigment mutations. The
percentage of noncomplementers was determined for each locus. In one study, this
varied from 0.13% to 0.33% per locus, that is from about 1 to 3 hits per 1,000 haploid
genomes screened. Thus the goal was to screen 3,000 haploid genomes in the
Tubingen screen, which was expected to reach at least 95% saturation, and 1,600
haploid genomes in the Boston screen, which was expected to reach at least 85%
saturation.
Both screens were carried out similarly (see Fig. 1). ENU-treated founder fish
were outcrossed to produce F1 fish, each of which should have carried unique genetic
lesions. F1 fish were crossed to each other such that F2 families were enriched for
mutations, and multiple sib-crosses were screened from every F2 family. Since any
mutation carried by a heterozygous F1 will be present in half of the fish in the F2
family, one quarter of the crosses should produce the mutant phenotype. An average
of four to five successful crosses were in fact analyzed, thus about 70% of the
mutagenized genomes were actually screened. Based on these estimates, the
Tubingen group screened 3857 mutagenized genomes while the Boston group
screened 2337 genomes. Thus both groups appeared to exceed their goals.
However, further analysis suggests that they did not achieve saturation. The final
results suggest that perhaps the average locus hit rate estimates were too high, and
that only about 50% saturation was reached in Tubingen, and less than this in Boston.
This is based on the average allele frequency for the mutants obtained and the size of
the single allele class. The estimated screen requirements may have been low either
because the loci used in the single loci tests might have had higher than average
mutagenic frequencies, or because weak alleles would probably give an easily
scorable phenotype in trans to the strong tester alleles, while in the real screen, some
weak alleles might be missed when homozygous.
In each screen, about 70% of the mutations were discarded as "non-specific" (this
included general degeneration, central nervous system necrosis followed by general
degeneration, and general retardation); consequently they could not be placed in
complementation groups. The other 30% of the mutations recovered were considered
"specific", and about 70% have been placed in complementation groups. Thus the
Tubingen group kept at least 372 genes, of which as many as 25% are represented by
a single allele, while the Boston group reported at least 220 specific defect genes, with
an even higher single allele rate. Assuming that the allele frequency for the "non-
specific" mutations was the same as for the mutations which were kept, a rough
estimate predicts about 2,400 loci which would mutate to embryonic lethality or visible
phenotype (37). Of these, 700-800 could be expected to have "specific" defects in
patterning or organogenesis.
The mutants kept by these groups fall into a diverse array of phenotypic classes.
About 10% display early phenotypes which either arrest during epiboly, affect
gastrulation, or appear to dorsalize or ventralize the embryo (41-45). Another 7%
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Figure 1: Breeding scheme for large-scale chemical mutagenesis F3 screen
affect mesodermal derivatives, the notochord and muscle (46-48), 15% affect the
central nervous system (not including the degeneration mutants) (49-52), and 5%
affect head cartilage (53-55). Nearly 25% of the mutants affect pigmentation (56),
while another 25% affect specific organs such as the eye, ear, heart, blood, liver, gut,
or, kidney (57-64). Finally, about 13% had motility defects, both with and without
visible muscle fiber defects (65), and 3% had defects in the correct spatial projection of
axons from the retina to the tectum, which was detected in a parallel screen in which
the retinas were injected with lipophilic dye and the axons were traced (66).
Prospects for cloning genes from the chemical mutagenesis screens
While the phenotypic consequence of these various mutants can and will be
studied in great detail, a true molecular understanding of both the mutations and the
processes that they perturb will require the cloning of the mutated genes. As ENU
produces predominantly point mutations, the cloning of the chemically mutated genes
will require positional cloning strategies. This in turn will require a good genetic map
and strategies for cloning the genes based upon genetic position. The zebrafish
genome is estimated to be about 1.6 X 109 bp, and occupies twenty-five
chromosomes. Two separate linkage maps have been made, one based on random
amplified polymorphic DNAs (RAPD markers, 67), and the other on simple sequence
length polymorphisms (SSLPs, 68). Through the use of bulked segregant analysis,
whereby DNA from pools of mutants or wild type embryos from a cross are tested for
prevalence of a marker from the mutation-carrying parent, mutations can be quickly
placed roughly on the map, allowing fine mapping (requiring individual embryos) to
follow with only the markers in that region. In some cases, one can even short-cut this
rough mapping step. Because of the ability to make "half-tetrad diploids", markers and
mutations can also be mapped to centromere markers (69), allowing quick assignment
to one of the twenty-five linkage groups, assuming that the heterozygous fish is
polymorphic for all of the markers.
The RAPD map currently includes 652 markers mapped from the haploid progeny
of a single fish heterozygous for two laboratory strains (69). RAPD markers are
generally dominant (a fragment of given size is amplified by a pair of decamer primers
or it is not), thus this analysis is only easily performed upon haploids. Furthermore, the
RAPD markers mapped are only appropriate for the two strains used to make the map,
thus if the mutations are not in one of these strains (the Tubingen mutants are not),
many of these markers may not be usable. The SSLP map contains 450 markers,
which are currently being mapped on a reference cross of over 500 progeny of a
single cross (68, 70). This number of meioses gives a theoretical resolution of 0.1 cM
(estimated to be about 60 kb); however, the markers are only at an average density of
one per 9 cM, so most mutations will be 2-4 cm from a marker (1.3-2.5 Mb). Even
when the RAPD and SSLP maps are integrated with each other and any other
polymorphisms (polymorphic markers from over one hundred genes are currently
mapped to either the RAPD or SSLP map), the average intermarker distance will be
2.5 cM (70). Furthermore, as fish strains are not truly inbred, only some proportion of
these markers will be polymorphic for any given cross.
From there, two options exist. One is pure positional cloning. Large-insert
genomic libraries in YAC, BAC, and PAC vectors have been made, thus it should be
possible to go from a linked marker to contigs which cover the 400-800 kbp locus in
which a gene should reside. One can then attempt to use the same techniques used
in the positional cloning of human and mouse genes, such as cDNA selection and
exon trapping, to identify transcripts in the region. However, deciding which of these
transcripts represents the mutated gene will still represent a significant challenge, and
to date only one zebrafish mutant gene has been cloned purely on the basis of map
position (J. Zhang, W.S. Talbot, and A.F. Schier, pers. comm).
The other option is the use of a positional candidate gene approach, an approach
gaining popularity in other systems (notably human) where genome sizes are large
but there are fairly dense transcript maps (71). Mutations are mapped to the resolution
possible, and then one surveys the transcript map in this region to look for attractive
candidates. At best this works for genes with known biochemical properties which
logically connect to the mutation. For example, the gene for Marfan's syndrome was
cloned when the gene for an extracellular matrix protein whose synthesis was known
to be affected in the disorder mapped to the same locus; after finding this coincidence,
the gene was sequenced from affected patients and found to be mutated (72, 73).
Similarly, a proto-oncogene was found to be responsible for multiple endocrine
neoplasia type 2 (74) and a number of DNA mismatch repair enzymes mutated in
hereditary non-polyposis colon cancer (75-77). As the transcript map becomes
denser, predominantly with the addition of expressed sequence tags (ESTs) without
known functions, the number of "candidate transcripts" in a region may increase, but
the ability to make such educated guesses may be limited to the expression pattems of
these genes as determined by in situ hybridization.
The positional candidate approach will surely result in the cloning of many of the
newly isolated zebrafish mutants; in fact several successes have already been
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reported, in each case with a gene well known to developmental biologists (e.g., 78-
80). Continued success of this approach will rely first upon mapping a large number of
cloned zebrafish genes. Over 100 genes have been mapped, and this number is
certainly increasing (70). However, as with the use of this approach in human
genetics, logical candidates will only emerge from the population of known genes;
thus while this approach will be able to assign these genes their proper essential role,
it is less helpful for cloning unknown genes. The successful application of the
candidate gene approach in the zebrafish could be enhanced by an EST project
whereby ESTs are both mapped and their expression pattern determined by in situ
hybridization, thus providing a much larger pool of candidates. The undertaking of
such a project on a sufficient scale to aid in the cloning of many genes would be
worthwhile, but would take several years.
Thus it is likely that the majority of the chemically induced mutations will be
difficult to clone for at least the next two or three years. Due to the level of effort each
will require, only a small subset of those which are not found by the candidate gene
approach will probably be attempted. If the power of zebrafish genetics is to be
brought to its full potential, what is required is a method which allows the rapid cloning
of mutated genes, both novel and known. A tool that has helped realize this goal in
other organisms is insertional mutagenesis, whereby DNA of known sequence is used
as both the mutagen and a molecular tag to aid in the cloning of the disrupted gene.
The animals in which this has been most successful are C. elegans, Drosophila, and
mice.
Transposon tagging in flies and worms
In both C. elegans and Drosophila, insertional mutagenesis by the use of
transposons has been of great use in the cloning of mutated genes, though generally
only in the cloning of loci already identified by chemical mutagenesis. In both cases it
was realized that certain spontaneous mutations were caused by transposable
elements, and these transposable elements were harnessed for the use of controlled
insertional mutagenesis.
In C. elegans, the transposon used is Tcl, a mobile element which is present in
all strains, though it varies in its copy number from 30 to 300 copies per strain (81).
Furthermore, the mobility of these elements also varies between strains, such that
insertional mutants are found at a higher frequency in mobility promoting mutator
strains. The situation is not ideal, because there are no strains which lack
endogenous Tcl elements; thus the insertion causing the mutation must be uniquely
identified. This can be done through successive generations of backcrosses to a
strain with fewer and less mobile Tcl elements, until the mutation-causing insertion
can be identified as the only extra one. This method has generally been used to clone
genes of already isolated mutations either as reversions of dominant gain-of-function
mutations (82) or as a straight-forward mutagenesis screen, selecting for phenotype,
then testing for non-complementation with previously identified alleles (83, 84).
In Drosophila, the P element is a transposon which was identified as the
causative agent in a phenomenon known as P-M hybrid dysgenesis. When males of
certain strains, known as P strains, were crossed to females of other strains known as
M strains, mutations occurred. The cause of these mutations was discovered to be a
mobile element, which while normally repressed in its ability to transpose, was
released from this repression in the germ line of zygotes derived from M strain females
(85). As P elements transpose with a cut-and-paste mechanism, old insertion sites are
left vacant upon transposition, allowing for the isolation of insertion-less revertants,
which can help prove that the mutation was in fact caused by the insertion (86). P
element vectors, containing marker genes in place of the transposase gene, were later
designed and shown to integrate when microinjected into developing embryos (87).
Furthermore, these P element vectors were shown to be capable of disrupting genes,
creating insertional mutations (88). Later a strategy was devised using crosses
instead of injection to generate a large number of independent lines, each with single,
unique insertions (89). The ability to generate and inbreed so many lines
demonstrated that about 15% of these insertions resulted in the mutation of genes that
were required either for viability or fertility (89). However, it was estimated that only
30-50% of the genes that could be mutated by EMS could be mutated by P elements
(90, 91), suggesting the possibility of insertion site preferences. Analysis of the
insertion sites of 56 mutagenic P element integrations shows a marked preference for
the 5' ends of genes, further suggesting that target selection is not random (91). It was
also discovered that a disproportionate number of P element transposition events
occur locally (92).
These discoveries have led to the development of two alternative strategies to
use P elements to help clone genes. In one, P elements are used to clone the genes
defined by previously identified mutations; a P element which maps near a mutation of
interest is mobilized, and insertions which cause loss-of-function of the gene are
recovered either as revertants of dominant gain-of function alleles (93, 94), or as
noncomplementers to recessive alleles (95, 96). In the other, the isolation of non-local
hops would be achieved by selecting males who received a P element inherited from
the X chromosome of their father. Their P element-containing progeny would then be
inbred and screened for mutations in any developmental process (89 ,97). This
method also allows the creation of a "library" of insertions, representing both genetic
markers for mapping, and a catalog of thousands of tagged mutations, which can be
used to test for non-complementation with chemically induced mutations found in other
screens. Currently, this library contains insertions in over 700 loci, about 20% of the
genes which can be mutated to scorable phenotype in the fly (91).
One other way of tagging genes with P elements is the use of "enhancer-traps".
These are P element vectors which contain the 13-galactosidase gene driven by a very
weak promoter, so that the expression of this reporter will be affected by the
chromosomal location into which it inserts (98-100). Diverse expression patterns are
found amongst different insertion sites, and it is thought that the expression of the
reporter is affected by the cis-acting elements of a nearby gene (101). As with
mutagenic insertions, these P elements can facilitate the cloning of this nearby gene.
About two-thirds of the insertions with enhancer-traps activate the reporter gene;
however, only 15% of these are embryonic lethals in the homozygous state, about the
same proportion as with unselected insertions (99). Thus while this method has
generated thousands of lines with useful staining patterns, and can be used to tag and
clone genes with interesting expression patterns, it does not enrich for insertional
mutations.
Insertional mutaaenesis in mice
Two different sources of DNA have been used to create insertional mutants in
mice, plasmid DNA and retroviruses. Each has been delivered in several ways,
plasmid by pronuclear injection of fertilized eggs or electroporation of ES cells, and
retrovirus either by infection of embryos or infection of ES cells. Because the method
of delivery of the exogenous DNA can affect both the site of the insertions and the state
of the locus after the insertion, these different methods have varied in their levels of
success.
The generation of transgenic mice by pronuclear microinjection has been a
popular method for studying gene action during mammalian development (102, 103).
However, it was also found that many transgenes became mutagenic in the
homozygous state. 8-10% of insertions made by pronuclear microinjection lead to
embryonic lethal mutations (103). However, these integration events often result in
deletions and rearrangements at the chromosomal site of the insertion, which has
frequently made the cloning of the affected gene very difficult (104). Deletions of 2-50
kb were generally detected at the site of the insertion (105, 106); the presence of 2-20
kb of mouse genomic DNA from elsewhere in the genome was often also observed
(107, 108). In a few of these cases, it was possible to clone the DNA corresponding to
the wild type locus and find the affected gene (108-111), but in most cases the genes
have remained elusive, often because the chromosomal disruptions were so severe.
Retroviral infection leads to the integration of proviral DNA without causing any
greater chromosomal damage than short (4-6 base pair) duplications on either side of
the insertion site; thus the genes disrupted by retrovirally induced insertional mutations
should prove easier to clone. It was first found that retroviruses could be used as
insertional mutagens in tissue culture cells, where the src oncogene in a transformed
cell line was disrupted by a proviral insertion following infection with Moloney murine
leukemia virus (MoMLV), causing reversion of the transformed phenotype in this cell
(112). Furthermore, back-revertants (transformed again) were isolated in which most
of the MoMLV provirus was deleted, demonstrating that the provirus was the cause of
gene disruption.
Subsequently, it was found that an allele of the dilute mutation (a coat color
mutation often associated with neurological disorders as well in other alleles) was
caused by the presence of an endogenous retrovirus (113). The provirus segregated
with the mutation; furthermore, reversion of the mutation was associated with deletion
of most of the provirus, similar to the situation with the oncogene disruption above. As
the locus was now tagged with proviral DNA of known sequence, it was now possible
to clone the gene responsible for the dilute mutation (114).
Meanwhile, several methods were being developed to generate new proviral
insertions into the germ lines of mice. One method involved the infection of embryos at
various stages, from 4-cell premorula to midgestation (115). Many of these animals
became germ-line mosaics, transmitting proviral insertions to a fraction of their
progeny. The transgenic progeny however were fully heterozygous, and in
subsequent generations, these insertions segregated as individual Mendelian loci.
Another method utilized the observation that certain hybrid strains of mice
spontaneously acquired new germ line proviral insertions (116). In some ways this
was analogous to Drosophila P-M hybrid dysgenesis, because in the hybrid one strain
provided the endogenous proviruses while the other provided (dominant) genetic
susceptibility, allowing virus production, thus spread and infection of oocytes. Using
this method, many transgenic lines could be produced in the absence of the
manipulations required for exogenous infection (117). Still another method for
generating new proviral insertions into the mouse germ-line was the use of ES cells.
ES cells could be infected in culture and used to make chimeric embryos, in which the
ES cell-derived portion of the germ-line would contain the new insertions. This
method allows infection at high multiplicities of infection, such that many proviruses
could be transmitted at once, potentially increasing the efficiency of conducting
insertional mutagenesis (118). It also allows for selection of specific integration events
in culture before making chimeras, a feature essential for the gene trap strategy (see
below).
By breeding these new proviral insertions to homozygosity, it was found that
about 5% cause recessive mutations (104). Most of these are embryonic lethal, and in
fact the embryos are reabsorbed by the uterine wall; the mutations had to initially be
detected by the absence of homozygotes amongst the live born pups. Probes from the
DNA flanking the insertion sites were used to clone the genes affected in several of
these mutations, as well as the dilute locus (the mutation caused by the endogenous
provirus). All but two of these genes have turned out to be novel; the exceptions were
the first gene cloned by this approach, the al (I) collagen gene (119), and a mutation in
a ubiquitin-conjugating enzyme (120). Amongst the new genes, several with no
obvious motifs to indicate function were found (121, 122), while some had sequences
that immediately suggested their function; the gene mutated in the dilute mutation
encodes a novel myosin heavy chain (114), while the gene disrupted in the 413.d
mutant, in which formation of the primitive streak and thus gastrulation does not occur,
is a member of the TGF-B family of signaling molecules, termed nodal (123, 124).
The proviral insertion sites in these genes may have had a great impact upon
how the expression of these genes was altered, and thus upon their phenotype. None
of the proviruses in the above cases inserted into exons. Studies of retroviral
insertions in tissue culture cells already suggested a number of ways in which a
retrovirus could cause loss-of-function mutations when inserted into introns.
Sometimes the provirus caused premature polyadenylation, creating a truncated
protein (125). Other times, strong expression from the provirus in the opposite
orientation to that of the gene prevented normal transcription of the gene, a promoter
interference model (126). In most of the retrovirally induced insertional mutants, the
steady state amount of transcript of the wild type gene is clearly reduced considerably,
if not entirely (120, 122, 124, 127, 128). The one case in which this has been looked
into most carefully is the mutation of the al (I) collagen gene. In this case, an insertion
in the first intron of the gene prevents the initiation of transcription, as well as the
formation of a DNAse I hypersensitive site in the promoter (129, 130). As the provirus
is not transcriptionally active during embryonic development this cannot be explained
by promoter interference. It had also been suggested that transcription could be
suppressed by provirus-induced methylation at the locus (131). However, neither
demethylation of locus with 5-azacytidine nor introduction of a plasmid representing
the unmethylated locus allow for transcription of the gene (132, 133). It is currently
thought that the insertion displaces necessary cis-acting sequences in the intron,
preventing their contribution to the formation of a transcription complex (133).
Interestingly, this occurs in a tissue specific manner; in teeth primordia, the insertion-
bearing allele is active, demonstrating the use of different cis-acting sequences in this
tissue (134). Similarly, in the dilute mutation, it is known that the coat color-affecting
insertional allele is not as strong as some other alleles which have neurological, and
sometimes lethal phenotypes as well. The provirus in this case is in the third intron,
and has tissue-specific effects upon the alternative splicing of this gene (135). In other
mutations, expression is reduced or eliminated by proviral insertions into promoter
regions or the first intron (120, 121, 123).
While insertional mutagenesis in mice by retroviral infection does lead to
relatively easily clonable genes, it does not seem practical to generate a very large
number of mutations at a frequency of one in twenty insertions. Given both the cost of
generating and maintaining so many lines of mice and the fact that the in utero
development of the embryo precludes the ability to screen for developmental defects
directly, requiring the molecular genotyping of live births, it is unlikely that any
laboratory could generate very many mutants by this method. This has led to the
desire to preselect for insertions likely to be mutagenic, and if possible, likely to be
mutagenic in specific developmental pathways. One possible way of achieving this is
the use of gene trap vectors in ES cells (136-139). Gene traps are somewhat similar
to the enhancer traps used in Drosophila, but require insertion within a gene, not just
near one, to be activated. Gene traps contain a reporter gene without their own
promoter. Some are designed with splice acceptors preceding the reporter so that if
they integrate into an intron, a fusion transcript should be produced containing the
reporter gene in place of the rest of the endogenous gene (138). Others, referred to
as promoter traps, contain only an initiation codon as well as an in-frame stop codon
upstream of it (140); these must integrate in a 5' untranslated region to generate
reporter activity, and thus should surely prevent wild type gene product from being
produced. Gene trap vectors can be either recombinant retroviruses or plasmid DNA,
which can be electroporated into ES cells, presumably resulting in integration events
that are not as disruptive as those caused when DNA is microinjected into the nucleus.
When electroporated, splicing traps appeared to be activated in 2% (when the reporter
lacked an initiation codon and thus must have been part of a fusion protein) or 5%
(when the reporter contained an initiation codon) of the insertion events (136, 137).
When retroviral vectors were used, splice traps were activated 12% of the time, while
promoter traps were activated in only 0.04 - 0.6% of the insertions, depending upon
the reporter used (137, 140, 141). When ES cells containing activated insertions were
used to generate chimeric mice, a variety of patterns of expression of the reporter gene
were seen, demonstrating that these insertions had occurred in genes with different
developmentally regulated patterns of expression. Furthermore, after passage
through the germ-line, roughly half of these insertions proved mutagenic when bred to
homozygosity, an enrichment of ten-fold over unselected retroviral integrations (137-
139). Additionally, one can use this methodology to be even more selective about
which insertions to inbreed. One can use the expression pattern in chimeric embryos
obtained by injection of ES cells into mouse blastocysts to determine which insertions
are in genes which are developmentally regulated, or expressed in tissues of interest
to the investigator. Furthermore, one can use changes in expression in the ES cells in
vitro in response to differentiation factors to select for developmentally regulated
genes before making chimeras (142, 143). Very selective traps have even been
constructed to capture certain types of molecules. For example, one such trap is
utilizes an alteration of the reporter gene such that activity is only seen if the insertion
is in a gene with a secretion signal sequence (144).
Gene trap approaches have generated a number of insertional mutants in mice,
but still suffer from the inability to maintain sufficient numbers of transgenic lines to
inbreed and screen; it might be possible to generate a saturating number of gene trap
events in ES cells, but only a limited number can feasibly be used to produce chimeric
embryos and inbreed their offspring (145). In order to enrich for the mutation of
developmentally interesting genes, one can use other aspects of preselection, such as
expression pattern or response of the reporter to growth and differentiation factors in
vitro, to decide which to inbreed. However, the experience of targeted knock-outs
suggests that selecting genes based on expression pattern sometimes provides little
predictive value to the phenotype when they are mutated. This may be in part due to
functional redundancy, that is, the ability of other gene products to partially or fully fulfill
the function of the disrupted gene (146, 147). Additionally, the activation of a gene
trap is not a guarantee that the gene has been disrupted, as some proportion of the
transcripts may splice around the provirus to produce wild type product (148). Thus
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while the gene trap approach does increase the frequency of producing insertional
mutations, and can allow one to preselect for those in genes that are developmentally
regulated, this effort, applied to the mouse, is unlikely to lead to the identification of a
significant proportion of the genes required in embryonic development.
Requirements for insertional mutagenesis in zebrafish
The efficiency of an insertional mutagen will depend on four factors: the degree to
which integration is random, the effective target size for disruption of a gene, the size
of the genome, and the number of genes which can mutate to a scorable phenotype.
The experiences with insertional mutagenesis in both flies and mice are very
instructive in determining the requirements for insertional mutagenesis in zebrafish.
Drosophila contain about 5,000 genes which mutate to scorable phenotype, 3,500 of
these residing on the second and third chromosome. Of 3,000 mutagenic P element
insertions residing in these two chromosomes, which were selected for phenotype
from about 20,000 insertions, about one third of these genes will be disrupted (91).
This should represent nearly two thirds of the number that can be mutated by P
elements, contributing to the estimate that only about half of the genes in Drosophila
are mutable by P element insertion. It also suggests, if P element insertion were
completely random, that the effective target size per gene is about 3 kb. While P
element insertion and/or gene disruption is clearly not random, as evidenced both by
the fact that only half of the genes appear to be mutable and that most mutagenic
mutations appear in the 5' end of genes, it provides a rough sense of scale of what is
required of an insertional mutagen.
In the mouse, 5% of retroviral insertions have been mutagenic. It is an unresolved
issue whether retroviral insertion is random or has a preference for transcribed
regions. Studies which looked at a small number of insertions found a
disproportionate number of them to be in transcribed regions or near sites of open
chromatin conformation as determined by DNAse I hypersensitivity (149-151). Studies
which are able to look at very large numbers of integration events show that
integration appears roughly random and widespread over the genome (152-153), but
were not performed in a way which could distinguish slight preferences for a large
number of kilobase-size regions, which is what one might expect if there were a
preference for transcribed regions. If one were to assume that about 5,000 to 10,000
genes can mutate to phenotype in the mouse, then an assumption of randomness
would make the effective target size of mutagenic insertions about 15-30 kb, which is
about the size of the average mammalian gene. Thus, in so far as any integration
preference exists, it must be canceled out by an equal change in effective target size.
In other words, while transcribed regions may be preferred sites for integration, it is
possible that not all integrative events throughout the coding and non-coding portions
of a gene will be disruptive, and these opposing forces may be roughly equal in
magnitude.
These factors must be considered in planning an insertional mutagenesis
strategy in fish. Flies and mice provide examples of insertional mutagenic frequencies
of 15% and 5%, but the factors of randomness and target size which are at play in
these systems may not be the same as for the fish. Thus, while assuming randomness
of the insertional mutagen, an average mutagenic target of 10 kb, and 2,400 mutable
loci, one could expect just under 2% of insertions to be mutagenic. This number will
rise and fall with the true randomness and effective target size of the mutagen.
However, if one accepts that a frequency of 2% is possible, then it would take over
100,000 insertions to equal the smaller of the chemical screens. Achieving 10%
saturation, which would provide about 75 "specific" mutations and 165 "non-specific"
mutations, would require breeding nearly 15,000 insertions to homozygosity. Thus
when setting out to develop an insertional mutagenesis strategy for the fish, one must
start with a method for transgenesis which is capable of generating and identifying
tens of thousands of insertions.
Transgenesis in zebrafish
Germ-line transmission of exogenous DNA in zebrafish was first reported by
Stuart, et al. (154); these transgenic fish were made by the microinjection of plasmid
DNA into the cytoplasm of one-cell stage embryos. Unlike pronuclear injection of
mouse embryos, integration of DNA seems to take place many cell cycles later, such
that embryos are highly mosaic with respect to integrated DNA. Typically 5-10% of
injected embryos transmit the foreign DNA to their progeny, although higher
frequencies have been observed (155). The germ-line of founder fish is mosaic such
that anywhere from 2-50% of the F1 generation is transgenic. Founder fish usually
only transmit a single transgenic locus, though occasional founders have been found
which transmit two or more loci. F1 fish are not mosaic and thus transmit the
transgenes in a Mendelian fashion. The inherited transgenes can vary from single
copy inserts to arrays of over one hundred copies, which can include head-to-tail,
head-to-head and tail-to-tail multimers of the plasmid DNA; partial deletions of the
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plasmid have also been observed. Due to both the low frequency of transgenesis and
the lack of predictability of the integrated transgene, it did not seem feasible to use this
method for insertional mutagenesis. However, it seemed possible that improvements
could be made that might increase the frequency and make for more predictable
structures of the integrants. Furthermore, according to the thinking about five years
ago, if methods for detecting transgenic fish could be improved over the requirement
for DNA analysis on tail biopsies, such as the presence of a dominant visible marker,
the efficiency of this otherwise rate-limiting step could be vastly increased.
Several potential improvements to transgenesis have been attempted to try to
make the generation of transgenic fish more efficient. For example, both
electroporation of embryos and particle bombardment have been tried in efforts to
create conditions whereby many more embryos could be targeted; each of these
methods resulted in some gene expression from the exogenous DNA, but no evidence
has been shown to demonstrate integration (156, 157). Following microinjection some
injected DNA can remain in embryos in an extrachromosomal state, thus reporter gene
expression in injected fish cannot be used as a measure of integration. Another
approach has been to coinject DNA with factors which might increase the rate of
integration. For example, it has been investigated whether coinjecting the DNA with
either restriction enzymes (restriction-enzyme mediated integration, as has been used
in Neurospora and decondensed Xenopus sperm nuclei) might both facilitate the
integration of the exogenous DNA into the chromosome and guide the DNA to
integrate in a predictable structure by defining the termini of the insertion and
preventing concatemerization. While slight increases in expression from the injected
DNA were observed, improvements in transgenic frequency were not (C. Konig and
J.A. Campos-Ortega, pers. comm.); increases in gene expression may reflect
increased stability of extrachromosomal DNA rather than an increase in the amount of
integration. .Similarly, some groups have tried to use a retroviral integrase enzyme to
mediate the integration of linear DNA molecules flanked with the integrase's
recognition sequences (INRS). While again gene expression from the injected DNA
seemed higher with the enzyme than without, and there was evidence the total amount
of integrated DNA was increased in the presence of integrase, it was not shown that
the frequency of germ-line transmission was affected (158).
Another approach for increasing the integration rate of injected DNA was to
coinject a peptide corresponding to a nuclear localization signal (NLS). It was shown
that at low DNA concentrations, use of such a peptide increased nuclear uptake of the
injected DNA as well as levels of gene expression (159). Preliminary results have
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indicated an increase in germ-line transmission (P. Collas, pers. comm.). It is also
being tested whether a combination of this NLS peptide with integrase protein and
INRS-flanked DNA can be even more efficient.
Yet another approach that could prove very promising in the generation of a very
large number of insertions is the development of a transposon system that could act in
a manner similar to that of P elements in Drosophila. A Tcl related sequence, named
Tdrl, has been found to be present at about one thousand copies in the zebrafish
genome (160). Other fish species also contain many copies of Tcl-related sequences
(161, 162). Tdr sequences appear to be mutated transposons in which a portion of the
transposase gene was deleted; this truncated transposon appears to have been
amplified and mobilized throughout the zebrafish genome, while the active-
transposase-containing transposons were lost. However, Ivics et al. (163)
reconstructed a functional transposon from a consensus sequence derived from Tcl-
like sequences from several species, thus presumably removing the independent
accumulated mutations. The transposase in this reconstructed transposon was shown
to be able to mediate the integration of a DNA vector containing the transposon's
terminal inverted repeats (cis-sequences required for transposition) in both fish and
mammalian cells. While the efficiency of this process and its efficacy in the germ-line
have yet to be investigated, it is possible that this synthetic transposon could become
an effective means for generating the many independent transgenic lines required to
conduct an insertional mutagenesis screen.
If the rate of integration of injected DNA, and thus the transgenic frequency, could
be significantly raised, then the use of a visible expression marker would be very
useful for identifying the transgenic fish. Transgenic F1 fish made by microinjection
have been shown to be capable of expressing reporter genes, such as
chloramphenicol acetyl transferase (CAT)and lacZ (164, 165). Furthermore, lacZ
expression could be detected in live embryos by the use of fluorescein-digalactose, a
lipophilic dye which releases fluorescein when cleaved by the lacZ gene product.
However, the staining procedure is prone to false positives if the embryos are not
viewed quickly enough after staining, which could make the processing of large
numbers of embryos difficult.
The use of the jellyfish green fluorescent protein (GFP) gene could simplify this
situation. GFP is an intrinsically fluorescent gene product, shown to produce
fluorescence when expressed in other heterologous organisms such as C. elegans
and Drosophila (166, 167). If its expression in zebrafish embryos were easily
detectable, transgenic progeny of injected fish could be rapidly screened for the
presence of inserted DNA by fluorescence microscopy. Furthermore, it would suggest
the possibility of using GFP as a reporter for gene traps, such that only fish harboring
insertions within genes would be raised and inbred. Chapter 2 presents evidence that
the GFP gene can be used as a dominant visible marker when its expression is driven
by a strong promoter. Thus one could make transgenics by DNA microinjection,
possibly aided by one of the above technologies, and screen for transgenic progeny
by fluorescence. However, as explained below, we developed a far more efficient way
to generate transgenic lines which we considered far more suitable for conducting an
insertional mutagenesis screen. Nevertheless, the successful expression and
detection of GFP in transgenic embryos suggests that it might be possible to use GFP
as a reporter in a gene trap; this will be discussed in Chapter 6.
The use of MoMLV/VSV retroviral vectors to generate transgenic zebrafish
As described earlier, retroviruses have been popular vehicles for insertional
mutagenesis because they integrate at a single copy per locus without causing any
further distortions in the genomic DNA which might impede in the cloning of disrupted
genes. Most of this work has used replication defective retroviral vectors, rather than
active retroviruses; these are infectious particles which can integrate like retroviruses,
but whose genetic material lacks the coding sequences for the proteins required to
make more retrovirus. Retroviral vectors are made in "split genome" packaging cells,
in which the genome of the retroviral vector is expressed from one locus, while the
retroviral proteins responsible for packaging, infection, reverse-transcription, and
integration are produced for another locus or loci.
Retroviruses have a host-range, or "tropism" which is determined by several
factors. One of the most important of these factors is the envelope protein, which
recognizes and binds to some component, usually a protein, on the cell to be infected.
Cell types which have a receptor can be infected by that retrovirus, those that do not
are refractory to infection. For example, the ecotropic MoMLV envelope protein binds
to an amino acid transporter expressed by all murine cells (168), thus allowing the
infection of any mouse cell, but not cells of other species. In contrast, the amphotropic
envelope recognizes a different protein which is also expressed in human cells,
allowing infection of these as well.
Pseudotyping is a process in which virions contain the genome and core proteins
of one virus but the envelope protein of another. Pseudotypes were originally
observed in mixed infections, where, in the presence of two viruses, such hybrid
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virions were produced, albeit as a small proportion of the population. There is some
specificity as to which envelope proteins can encapsidate which other genomes; any
given genome can only be pseudotyped with a limited number of envelope proteins.
One such combination that has been naturally observed is the encapsidation of
MoMLV with the envelope glycoprotein (G-protein) of vesicular stomatitis virus (VSV)
(169). VSV is a rhabdovirus which is apparently pantropic; it can infect cells of
species as diverse as insects and mammals (170). It is thought that the VSV G-protein
interacts with a common membrane phospholipid rather than a protein, thus
explaining its broad host range (171).
Next it was shown that such pseudotyped viruses could be produced in the
absence of all VSV proteins with the exception of the G-protein (172). Furthermore,
these virions were produced in the absence of the gene for the retroviral envelope.
This was a very important step because it demonstrated that by using producer cells
which made all of the retroviral proteins except the envelope protein, one could make
exclusively pseudotyped virions. This was followed by the derivation of producer cells
and transfection conditions which could produce this virus to a high titer, and the
establishment of a centrifugation protocol which could concentrate the virus 1,000-fold
(173). Thus it was possible to produce these pantropic viruses at exceedingly high
titers, and it was demonstrated that zebrafish tissue culture cells were within their host
range.
Other members of the Hopkins laboratory were the first to demonstrate that such a
pseudotyped retrovirus could be used in the production of transgenic zebrafish (174).
In these initial studies, upon injection of concentrated virus stocks into blastula stage
embryos, 15% of these fish passed proviral sequences onto their progeny. As with
transgenic founders produced by DNA microinjection, these founders were mosaic,
and transmitted these insertions to only 1-5% of their F1 progeny. However, the
progeny were non-mosaic for the insertions, and transmitted them in a Mendelian
fashion to 50% of their progeny.
Towards insertional mutagenesis
While this frequency of transgenesis was still too low to generate the number of
insertions required to perform an insertional mutagenesis screen in zebrafish, it
seemed possible that if higher titer virus could be produced, this frequency could be
raised enough to make such a screen possible. The bulk of this thesis will
demonstrate that such an improvement could be made, and that insertional
mutagenesis can be performed with this method. Chapter 3 describes how we
produced such a virus and achieved a 100-fold increase in the transgenesis rate.
Chapter 4 describes how we performed a pilot insertional mutagenesis screen in
which we were able to estimate the frequency with which proviral insertions cause
recessive mutations with embryonic phenotypes. Chapters 4 and 5 describe three of
the mutations found in this pilot screen and the identification of the disrupted genes.
Finally, Chapter 6 will describe plans for a large-scale insertional mutagenesis screen
using the current technology, as well as possible improvements, and explore the utility
of such a screen in contributing to our understanding of vertebrate biology.
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CHAPTER 2
THE AEQUOREA VICTORIA GREEN FLUORESCENT PROTEIN CAN BE USED AS A
REPORTER IN LIVE ZEBRAFISH EMBRYOS
(Most of this chapter was published as: Amsterdam, A., Lin, S., and Hopkins, N. (1995)
Dev Biol 171: 123-129 and Amsterdam, A., Lin, S., Moss, L.G., and Hopkins, N. (1996)
Gene 173: 99-103. The discussion includes unpublished data and references
published subsequently.)
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Abstract
The Green Fluorescent Protein (GFP) from the cnidarian A. victoria is capable of
producing fluorescence without an exogenously added substrate. Here we
demonstrate that a cDNA for GFP driven by a Xenopus elongation factor la enhancer-
promoter can confer fluorescence upon live zebrafish embryos, either as an injected
plasmid or as a transgene after passage through the germ-line. When injected into
zebrafish embryos at the one cell stage, this construct starts to express detectable GFP
after about 4 hours of development at 28oC, about one hour after the midblastula
transition. Fluorescence can be observed in cells of many tissue types in the embryo
for at least three weeks after injection. We used three different expression constructs,
each employing a modified efla enhancer-promoter, to generate twelve transgenic
lines. Eight out of the twelve lines, including five of five derived from one construct with
an intron, express detectable fluorescence in the F1 and, where tested, in the F2
generation. Most expressing lines showed very similar expression patterns.
Generally, fluorescence is not seen in the transgenic embryos before 20 hours post-
fertilization, at which point it appears uniformly throughout the embryo. Fluorescence
is most visible between 24-36 hours, and it becomes less visible after this, except that
in many lines strong fluorescence remains visible in the eye, for at least five days. A
single inherited copy of the transgene is sufficient to produce detectable fluorescence
in hemizygous F1 and F2 embryos. Additionally, we have injected purified
recombinant GFP into embryos to determine the intracellular GFP concentration
required for detection, both when all of the cells in the embryo contain GFP and when
only a few do. Nearly a ten-fold higher concentration of GFP is required to detect
fluorescence in individual cells than when the whole embryo expresses it.
Introduction
The zebrafish Danio rerio is becoming a popular model organism for the genetic
study of early vertebrate development (1). The fish offers the possibility of combining
rapid early development which is amenable to direct observation and manipulation,
large numbers of progeny from a single mating, and a relatively short generation time
(2-3 months). One additional tool, which has proven so useful in organisms such as
Drosophila and mice is the ability to make transgenic animals. Transgenic technology
in zebrafish has made great gains in the last seven years. First Stuart et al. (2, 3)
showed that DNA injected into the cytoplasm of fertilized zebrafish eggs could
integrate into the genome and be stably transmitted through the germ-line;
furthermore, such transgenes could express a reporter gene, chloramphenicol
acetyltransferase. Culp et al. (4) demonstrated that the frequency of germ-line
transmission of a microinjected transgene could be as high as 20% in zebrafish. Lin et
al (5) have demonstrated another method for making transgenic zebrafish, by infecting
blastulae with a pseudotyped retrovirus, also resulting in a high rate of germ-line
transmission.
A problem with transgenic technology in zebrafish is the high level of mosaicism in
the germ-lines of founders: while up to 40% of Fls can inherit the transgene,
frequencies as low as 2% are not uncommon. This mosaicism makes the identification
and live isolation of the relatively rare transgenic Fls very time consuming unless the
transgene expresses a dominant visible marker. Lin et al (6) used a transgene in
which the upstream regulatory element of a highly expressed gene (the Xenopus efla
gene) was used to drive lacZ and found that four out of five transgenic lines expressed
lacZ protein as determined by Xgal staining. Strikingly, each line showed a very
different pattern of expression, with some lines expressing more extensively. By using
FDG, a substrate for lacZ that can enter live cells and releases fluorescein when
cleaved, live transgenic progeny could be identified from the three lines which
expressed lacZ protein most extensively. However, the staining procedure is prone to
false positives if the embryos are not observed quickly enough after staining. In
addition, some lacZ expressing embryos are overlooked if expression is not as
extensive, and in a line in which lacZ expression was restricted to primary
motoneurons, expression could not be detected at all using FDG.
A reporter gene which is more easily detected in zebrafish embryos might
circumvent these problems and, with the appropriate cis-acting elements, serve as a
dominant visible marker for transgenesis. This could be very useful in developing an
insertional mutagenesis strategy because it would vastly improve the rate at which fish
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harboring insertions could be identified. An additional use for such a reporter gene in
insertional mutagenesis would be in gene traps, promoter-less transgenes in which
the reporter gene would only be expressed when it has integrated into a transcribed
gene. Gene traps can thus be used to identify, and potentially mutate, novel genes
with interesting expression patterns (7-9). If one could selectively isolate zebrafish
embryos which contain insertions in genes, this would be a very efficient pre-selection
for insertions to be inbred.
Recently, Chalfie et. al. (10) described a reporter gene that could be used in live C.
elegans embryos, the Green Fluorescent Protein of the jellyfish Aequorea victoria.
This gene product is intrinsically fluorescent due to a post-translational modification
and therefore requires no externally added substrate. The GFP gene has also been
shown to make a fluorescent product in E. Coli and Drosophila, (10, 11). Here we
demonstrate that when driven by a strong promoter, the GFP gene product is easily
visible in zebrafish, both in embryos injected with plasmid DNA and in stable
transgenic lines. A single copy of the transgene was sufficient to confer detectable
fluorescence in hemizygous embryos.
This result suggests that such a construct could serve as a dominant visible
marker for transgenesis. The cis-acting sequences in this construct are very strong
and provide for ubiquitous expression, thus it is unclear whether GFP could be
detected when expressed only in a subset of cells in the embryos and at the level of
most cellular genes. This would be a requirement for the use of GFP in a gene trap.
Towards addressing the question of how much GFP is required for detection in
zebrafish embryos by simple epifluorescence microscopy, we transplanted cells from
these transgenic embryos or embryos injected with recombinant GFP (re-GFP) into
embryos which did not contain GFP. The results from these experiments indicate that
the concentration of GFP required for detection in individual cells in an embryo is
nearly ten times higher than that required when all of the cells in the embryo contain it.
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Results
Expression of Xex-GFP in injected embryos
Kreig and Johnson have constructed a modified Xenopus efl1a enhancer-
promoter, consisting of a 185 bp enhancer, which lies 4.5 kb upstream of the
endogenous gene, and 280 bp of promoter and 5' untranslated leader (12). A plasmid
containing this regulatory element driving the GFP cDNA (pXex-GFP, Fig. 1) was
injected into one cell stage embryos, which were later observed for fluorescence.
About 4 hours after injection, shortly after the midblastula transition when zygotic
transcription begins, patches of fluorescent cells could be observed in the embryo (see
Fig. 2A, B). At twenty-four hours post-fertilization, fluorescence can be observed
extensively throughout the embryo, though the number of fluorescent cells and the
intensity of fluorescence was highly variable from embryo to embryo (see Fig. 2C).
Strong fluorescence can still be observed at forty-eight hours post-fertilization, though
most visibly in muscle fibers (data not shown). For any given injected embryo, the
pattern of fluorescence appeared stable after forty-eight hours; suggesting that the
same cells appeared fluorescent at five days as at two.
The expression patterns observed are similar to those seen following injection of
plasmids containing lacZ driven by this same promoter (data not shown), the RSV-
LTR, the SV40 enhancer-promoter (4, N.H, unpubl. obs.) or the entire 4.6 kb upstream
regulatory region of efloa (6, S.L., Gaiano, N. and N.H., unpubl. obs.) upon fixing and
staining with X-gal. This suggests that the expression pattern is a reflection of
distribution of the injected DNA, rather than tissue-specific restrictions of the promoter
or reporter gene activity. As fluorescence can be observed in embryos microinjected
with the Xex-GFP plasmid as early as four hours post-fertilization and for several days
in similar patterns as seen in embryos microinjected with lacZ plasmids, it appears that
the GFP gene product is capable of conferring fluorescence upon cells at all stages of
zebrafish embryonic development.
Germ-line transmission of GFP transgenes
Three constructs were used to produce stable transgenic zebrafish lines (Fig. 1).
In addition to the plasmid described above, we also used one in which the GFP coding
region is preceded by the second intron from the rabbit 1 globin gene (pXIG). This
sequence has been shown to increase gene expression in stably transfected murine
tissue culture cells and in transgenic mice (13, 14). We also injected a third construct
in which the entire transcription unit of pXIG was flanked by two copies, on
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ef-lacZ ef upstream (4.6 kbl
Xex-GFP E P GFP pA
XIG E IVS GFP pA
14XIG ins ins E P IVS IGFP pA ins ins
Figure 1. Maps of the plasmids used or referred to in this study. ef upstream: Xenopus
efla gene -4600 to +35; lac Z: bacterial lac Z gene; pA: SV40 polyadenylation signal;
E: 185 bp enhancer fragment from efla; P: efla promoter -243 to +35; GFP: GFP gene;
IVS: rabbit 3 globin second intron; ins: 1.2 kb "insulator" element from human B globin
locus. Straight lines indicate plasmid vector sequences. Plasmids are drawn as
linearized for microinjection. The diagonal lines between eflacZ and Xex-GFP
illustrate the position of the enhancer and promoter fragments in the larger regulatory
unit.
either side, of an "insulator" element from the human B globin gene (pl4XIG), which
has been shown to prevent position-effect variegation in Drosophila (15).
Each plasmid was injected individually into one-cell stage embryos, which were
raised to sexual maturity and screened for germ-line-transmitting founders in a two-
step process. The fish were mated, and their progeny were examined by
epifluorescence microscopy daily for the first three days of their development. Any
embryos which appeared fluorescent were separated and saved for raising. DNA was
then prepared from pools of non-fluorescent embryos from single matings (both the
batches which had no fluorescent embryos, and the non-fluorescent embryos from
those which did) and analyzed by PCR for the presence of the transgene. In cases
where non-fluorescent embryos were PCR positive, the fish were remated and the
progeny checked again for fluorescence. If there were no detectably fluorescent
embryos in the second batch, the litters were raised and transgene-positive Fls
identified by preparing DNA from individual fin clips and PCR analysis (5).
We have isolated four transgenic lines from pXexGFP, five from pXIG and three
from pl4XIG-injected embryos; the frequency of germ-line transmitting founders ranged
from 5-9% (see Table 1). As has been seen previously in the production of transgenic
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CONSTRUCT;
TRANSGENIC LINES
POTENTIAL FOUNDERS LINE
INHERITANCE OF GFP EXPRESSION
AND/OR TRANSGENE:
F1 F2
Xex-GFP XG-1 29/73 (40%) 561/1183 (47%)
4/59 (7%) XG-2 2/39 (5%) 436/1041 (42%)
XG-3 5/84 (6%) * N.D.
XG-4 3/87 (3%)* 23/46 (50%)*
XIG XIG-1 12/138 (9%) 156/332 (47%)
5/104 (5%) XIG-2 9/243 (4%) 164/339 (48%)
XIG-3 84/386 (23%) 194/398 (49%)
XIG-4 5/49 (10%) 91/177 (51%)
XIG-5 10/571 (2%) 35/76 (46%)
IXIG IXIG-1 12/48 (25%) N.D.
3/34 (9%) IXIG-2 18/36 (50%) N.D.
IXIG-3 8/36 (22%) * N.D.
Table 1. Generation of germline transgenics and inheritance of GFP
expression and the transgene. Potential founders were tested for germline
transmission as described in the text. Transgenic F1 and F2 embryos were
identified by fluorescence, unless noted by an asterisk, in which case
transgenics were identified by PCR analysis. F1 data come from 1-3 matings;
F2 data come from 5-10 matings, except for those for lines XG-4, XIG-4, and
XIG-5, each of which was from a single mating. N.D.: not determined.
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DETECTABLY FLUORESCENT LINESCONSTRUCT TOTAL TRANSGENIC LINES
XEX-GFP 2/4 (50%)
XIG 5/5 (100%)
IXIG 1/3 (33%)
Table 2: Detectable expression of GFP in transgenic lines
fish lines (2-4), founder fish had mosaic germ-lines, with F1 inheritance rates ranging
from 2-40% (see Table 1). In all 8 cases examined , 47-50% of the F2 generation
inherited the transgene when a hemizygous transgenic fish was mated to a
nontransgenic fish, indicating Mendelian inheritance of the transgene (Table 1).
Expression of GFP in transgenic lines
As shown in Table 2, two out of four transgenic lines derived from the XexGFP
construct expressed detectable levels of GFP in the embryo, while five of five
transgenics for XIG and one of three transgenics for 14XIG did so. Most of the lines
showed a very similar expression pattern, as shown in Fig. 2D-F. Unlike the
microinjected Go embryos, fluorescence could not be observed before twenty hours
post-fertilization in any of the transgenic F1 or F2 embryos. At about twenty hours,
fluorescence was observed uniformly throughout the transgenic embryo (with the
exception of one line, XIG-5, see below). The intensity of fluorescence varies from line
to line. In all cases, fluorescent transgenic embryos could be distinguished from non-
transgenic siblings while still in their chorions (e.g. Fig. 2D).
By forty-eight hours post-fertilization, fluorescence was reduced in most lines. In
one line (XIG-1), fluorescence above background could not be seen at all at forty-eight
hours. In others (XG-1 and XG-2 ), fluorescence in the body completely disappeared,
but fluorescence was still visible in the eye. And in the stronger expressers (XIG-2,
XIG-3, XIG-4, and IXIG-1), those which were brightest at twenty-four hours, the body
still showed florescence at forty-eight and seventy-two hours (e.g. Fig. 2F), though at a
reduced level compared to the earlier stage, while the eye showed very strong
fluorescence. The expression pattern observed at forty-eight hours appeared stable in
all of the lines for at least three more days, i.e., like the microinjected embryos, they
looked about the same at five days as at two.
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Figure 2. Expression of GFP in injected and transgenic embryos. Injected Go embryos
were observed by epifluorescence microscopy at five hours (B) and twenty-four hours
(C), as compared to uninjected embryos (five hours, A). F1 embryos from lines XIG-3
(D) and XIG-2 (E, F) were observed alongside non-transgenic siblings at twenty-four
hours (D), thirty-two hours (E) and seventy-two hours (F) post-fertilization. Chorions
were removed with pronase in e and f. An F1 embryo from line XIG-5 was observed
alongside a non-transgenic sibling at twenty-four hours (G); fluorescent ectodermal
cells in the eye can be seen in the eye at forty-eight hours (H). All photographs were
taken using UV excitation filters except figure h, which used a fluorescein filter.
Figure 2
Only line XIG-5, one of the five lines transgenic for the XIG construct, showed a
substantially different pattern of expression. At twenty hours, the embryos were
extremely bright, but clearly did not express GFP uniformly; there is a fine patchy, salt
and pepper appearance of fluorescence (Fig. 2G). At forty-eight hours, this is even
clearer; aside from fluorescence in the eye, most of the fluorescence is seen in strips of
epidermal cells in the head (see Fig. 2H). The exact pattern is variable from embryo to
embryo, and from side to side of the same embryo. As with the other lines, this forty-
eight hour pattern appears to be stable for at least several more days.
The absence of detectable fluorescence until 20 hours post-fertilization is neither
due to a lack of transcription before this point in time or a general inability to detect
GFP in early embryos. As fluorescence can be detected in injected (Go) embryos as
early as four hours post-fertilization, only an hour after the beginning of zygotic
transcription, the enhancer/promoter must be transcriptionally active at this time.
Furthermore, in situ hybridization on embryos from two of the transgenic lines (XIG-2
and XIG-3) demonstrated the presence of GFP RNA as early as 10 hours post-
fertilization (Y. Grinblat, A.A., H. Sive, and N.H., unpubl obs.). Thus, it appears that
there is a significant delay between the onset of transcription and the appearance of
detectable fluorescence. Presumably it takes this much time to accumulate sufficient
GFP for detection in the transgenic embryos; fluorescence is probably seen earlier in
the injected embryos because, due to the high number of plasmid molecules per cell,
there is much more GFP produced. This delay may may be due to a requirement for
both the accumulation of GFP protein and its correct posttranslational modification for
chromophore formation.
Maintenance of transgene expression in subsequent generations
Reduction of transgene expression after successive passages through the germ-
line has been seen in zebrafish (S.L. and N.H., unpubl. obs). Five of the GFP-
expressing transgenic lines have been analyzed in the F2 generation so far. GFP
expression in F2 embryos from four of these lines, XG-1, XIG-1, XIG-2 and XIG-3
(progeny of a transgenic F1 mated to a non-transgenic), appears identical to that seen
in the F1 transgenic embryos. Furthermore, consistent with Mendelian inheritance,
approximately half of the embryos are fluorescent (Table 1). When individual F2s of
the XG-1 line were analyzed by PCR, every fluorescent F2 proved transgene-positive
and every non-fluorescent sibling proved transgene-negative (142 embryos tested)
For the XIG-2 line, all 24 fluorescent F2s proved transgene positive, and only 1 of 29
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'non-fluorescent' F2s was transgene positive, which could have been an error in
sorting.
A perfect correlation of DNA inheritance and GFP expression in the F2 generation
was not observed, however, with the XG-2 line. The percentage of fluorescent
embryos in the F2 generation varied from 29% to 50% in different matings with the
same transgenic Fl. Furthermore, 10-20% of the embryos which had detectable
fluorescence in their eyes at forty-eight hours had not shown detectable fluorescence
at thirty hours. In all cases (seven matings), PCR analysis of DNA from a pool of non-
fluorescent F2 embryos indicated the presence of at least one transgenic fish.
Individual-embryo-PCR analysis was performed on the progeny from one mating in
which 42% of the embryos were fluorescent. All 71 fluorescent embryos tested proved
to contain the transgene, while 10/47 non-fluorescent embryos (21%) did as well.
Another mating showed 71/148 (48%) transgene-positive F2s, but only 66 of these
(93%) were fluorescent. Thus, while the transgene in the XG-2 line does show
Mendelian inheritance, expression of the transgene in the F2 generation is not fully
penetrant.
Transgene copy number in fluorescent and non-fluorescent GFP transgenic fish
In order to estimate the copy number of the transgenes in the different lines, 10 Rg
of genomic DNA prepared from transgenic fish was digested with Eco RI,
electrophoresed, transferred to nylon membrane, and probed with both the gfp gene
and, as a quantitative internal control, the zebrafish RAG-1 gene (16). The intensity of
the bands was then quantified with a phosphor imager and the ratio of [gfp
hybridization]/[RAG- 1 hybridization] was calculated (Fig. 3). The four lines that were
most fluorescent, XG-1, XG-2, XIG-2 and XIG-3, all had ratios within twenty percent of
each other (Fig. 3, lanes 1,2,6,7). Additionally, when digested with HindIll or BgIIl,
which cut the plasmid only once, and probed with the entire plasmid, DNA from each
of these four lines revealed only two bands, neither of which was unit length, which is
what would be expected if the transgene was present in a single copy (data not
shown).
The other three lines all have very strong bands where the expected Eco RI
fragment should be, as well as one or two larger, fainter bands (Fig. 3, lanes 3-5).
When DNA from these three lines was cut with Hindlll or Bglll and probed with the
entire plasmid, most of the signal is in a band migrating at a size unit length for the
plasmid, though a few other fainter bands are also present (data not shown). This
suggests that in these lines, the transgene integrated as a tandem array of head to tail
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Figure 3. Southern analysis of DNA from transgenic lines: Eco RI digests of DNA from
seven transgenic lines probed with sequences from gfp and RAG-I. The band
hybridizing to the RAG-1 probe is indicated by the lower double-line arrow; the upper
two single-line arrows indicate the bands which hybridize to the gfp probe. The ratio of
the intensity of the two bands (gfp/RAG-1) was: XG-1, 1.1; XG-2, 1.3; XG-3, 8.2; XG-4,
12.4; XIG-1, 9.0; XIG-2, 1.2; XIG-3, 1.2. The estimated copy numbers are calculated by
dividing these ratios by the average ratios for the apparently single copy lines (1.2).
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copies, along with a few copies that may be rearranged or partially deleted. A
comparison of the [gfp hybridization]/[RAG- 1 hybridization] ratio for these multicopy
lines to the ratio for the single copy lines implies copy numbers of 7, 10 and 8 for XG-
3, XG-4 and XIG-1, respectively (see Fig. 3).
It is interesting to note that among this group of 7 lines, the strongest gfp-
expressing lines appear to have integrations of a single copy of the gfp gene. Thus,
single copy transgenes are capable of producing sufficient GFP to be detected in
zebrafish embryos.
Microinjection of re-GFP
While the result that detectable quantities of GFP could be produced by a single
copy of an integrated transgene is encouraging, it should be noted that the
enhancer/promoter used to drive gfp expression in these lines is both very strong and
ubiquitously active. This raises the question as to whether weaker and tissue-specific
promoters would be able to provide sufficient levels of gene expression to readily
detect GFP. In order to estimate the minimum amount of GFP per cell required for
detection by epifluorescence microscopy, we microinjected serial dilutions
ofbacterially produced re-GFP into one-cell stage embryos. The early cell divisions in
the embryo occur without a significant change in total cytoplasm volume, i.e., the cells
become smaller with each cell division. After 10 h of development, at the closure of
the blastopore, there are approximately 5x10 4 cells, and they are no longer
decreasing in size with each division (17). Thus the lowest concentration of protein
injected that is detectable can be used to calculate how many molecules of GFP there
are per cell. When this experiment was performed, we found that when as little as 100
pg of protein were injected, fluorescence could be observed both at the one-cell stage
(at the time of injection) and at blastopore closure (data not shown). This represents
approximately 5x10 4 molecules of GFP per cell. However, when only 50 pg of GFP
were injected, the injected embryos were not distinguishable from uninjected control
embryos even immediately after injection (data not shown). This implies a threshold of
detection of 2.5-5x10 4 molecules per cell, though the actual threshold may be less
than this (see below).
It is possible that fluorescence is detectable at an intracellular concentration of 2.5-
5x10 4 molecules of GFP per cell only when all of the cells in the embryo contain GFP
and thus produce an additive effect. In order to assess the threshold of detectability of
GFP when only a limited number of cells express the gene, it is important to see what
concentration can be detected in single cells in an embryo in which most cells lack
GFP. To do this, approximately fifty one-cell stage embryos were injected with a given
concentration of GFP, allowed to develop to the 1000 cell stage and then dissociated.
Ten to twenty cells from the dissociated injected embryos were transplanted into
equivalent stage uninjected embryos, and the resultant chimeras were allowed to
develop to blastopore closure. When this experiment was performed with as much as
400 pg of protein, an amount four times higher than that required to detect
fluorescence in the undissociated embryo, the transplanted cells could not be
identified in the host embryo, either immediately after the transplant or at blastopore
closure (Figure 4A). 800 pg of injected protein were required for the transplanted cells
to fluoresce noticeably above background, an amount representing 4x10 5 molecules
per cell at blastopore closure (Figure 4B, C). This is nearly ten times the amount of
GFP required for detection when all of the cells in the embryo contained GFP. It is not
clear why this should be the case, though it is likely that, when using conventional
microscopy, one can see fluorescence from many focal planes, essentially adding
these together. Thus the fluorescence is easier to see when it is present throughout
the entire thickness of the embryo, rather than just a single focal plane.
It should be noted that these numbers represent an upper limit on the minimum
number of GFP molecules per cell required for detection, because several
assumptions have been made regarding the stability and activity of the recombinant
protein. First, since the number of GFP molecules per cell is calculated from the
number of molecules originally injected, this assumes that there has been no protein
degradation. Though protein levels were not directly measured (e.g. by Western blot)
after the 10 h in the embryo, the injected protein does seem to be quite stable; at the
lowest concentration detectable at the time of injection, fluorescence could still be
observed in the embryo 10 h later. Thus degradation of the injected protein over the
course of the experiment probably did not greatly affect the results. Second, the
calculated number assumes that the bacterially produced protein has the same
extinction coefficient as endogenously produced GFP. This may not be correct, both
because the modification required to form the fluorophore may not happen as
efficiently in E. coli as in the fish cells, and because the purified protein sample could
be contaminated with GFP leached from inclusion bodies, which would likely be
inactive. Thus the threshold of detection actually observed here might be lower than
the calculated 5-40x10 4 molecules per cell. Furthermore, this threshold could
probably be lowered by the use of brighter GFP variants and more sensitive
microscopy techniques (see below).
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Figure 4. Embryos injected with re-GFP and chimeras derived from them. Embryos
were injected with re-GFP at the one cell stage; cells were transplanted from injected
embryos to uninjected embryos at the 1000-cell stage. A) Embryos were injected with
200 pg (5 X 109 molecules) of re-GFP. B, C) Embryos were injected with 800 pg (2 X
1010 molecules) of re-GFP. A and B) The embryo on the left is an injected embryo at
the 1000-cell stage, the embryo on the right is an unoperated control, and the embryo
in the middle has received a transplant of 10-20 cells from an injected embryo.
Embryos were photographed immediately after transplant. C) The embryo on the left
has had cells transplanted into it; the embryo on the right is an unoperated control.
Embryos were photographed 7 hours after the transplant, when there are about 5 X
104 cells; the injected protein concentration is thus about 4 X 105 molecules per cell.
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Figure 4
Discussion
We have shown that a transgene in which the cDNA for GFP is under the control of
a strong constitutive promoter is capable of producing a readily detectable fluorescent
product in live zebrafish embryos, either as injected plasmid or as an integrated
transgene after passage through the germ-line.
Fluorescence can be observed in embryos injected at the one cell stage soon after
the midblastula transition. The observed fluorescence in these embryos is very
mosaic, presumably due to unequal distribution of the injected DNA during the
embryonic cell divisions. The observation of fluorescence so soon after the beginning
of zygotic transcription indicates that the post-translational modifications required to
make the fluorophore in GFP can take place in cells in the early embryo, although it
does not prove that these modifications happen at their maximal possible rate.
A comparison of constructs used in this and other studies suggests that the
regulatory sequences used in the XIG plasmid (the short eflao enhancer and promoter
fragments and the B globin IVS) may provide the best and most consistent expression
of a transgene in zebrafish seen to date. The RSV-lacZ transgene used by Culp (4)
failed to express detectable lacZ activity in nineteen independent lines and only
expressed detectable RNA in one of the nineteen. The ef-lacZ transgene used by Lin
expressed in four out of five lines, but expression patterns were highly variable. And
while all four transgenic lines produced by Stuart et al (1990) using SV40 and RSV
regulatory sequences to drive the CAT gene expressed the transgene, transgenics
were selected by expression, not presence of the transgene; thus non-expressing
transgenics would have been missed by their analysis. Here, five of five XIG
transgenic lines express the transgene, with ubiquitous (or near ubiquitous)
expression in twenty-four hour embryos. Thus these regulatory sequences may prove
to be an excellent tool for ubiquitous expression of any gene in the early embryo.
Furthermore, a comparison of the reproducibility of expression from the XIG and Xex-
GFP constructs, which are identical except for the inclusion of the intron sequences in
the former, suggests that the intron may be an important component of the more
consistent expression by the XIG transgene. Thus it may also be useful in improving
the expression of transgenes driven by tissue-specific promoters, as well as the
ubiquitous one used here. On the other hand, the insulator elements used in the 14XIG
construct did not seem to aid in transgene expression, as only one out of three
transgenics made from this construct consistently expressed the transgene.
One of the goals of this study was to identify a transgene which would act as a
dominant visible marker for its presence. Using the pXex vector, fluorescence was
observed in most transgenic lines in which the plasmid integrated stably into the fish
genome and was inherited through the germ-line. While two out of four lines inheriting
the XexGFP plasmid showed fluorescence, all five lines inheriting the XIG plasmid did
so. This suggests that this construct, including the efla enhancer-promoter, B globin
intron, and the GFP gene, could be a useful tool in the generation of transgenic fish; by
adding these sequences to one's construct of interest, the identification of both
founders and transgenic Fls could be performed merely by observation under
epifluorescence instead of the more laborious PCR procedures. Furthermore, as
fluorescence is detectable through the chorion, embryos do not even require
dechorionation, as they do for FDG staining to detect lacZ-expressing embryos. For
the purpose of insertional mutagenesis, however, a dominant visible marker must be
coupled with a very efficient method for generating independent germ-line transgenic
lines. Subsequent to the completion of this work, the use of a high-titer pseudotyped
retroviral vector was shown to be a far more efficient method for making germ-line
transgenics than DNA microinjection, the method used in this study (see Chapter 3).
Efforts to make a retroviral vector which would express GFP, thus acting as a dominant
visible marker as the XIG plasmid did here, have not yet been successful (A.A., S.L., N.
Gaiano, S. Burgess, and N.H., unpubl. obs.). Thus the application of a GFP-
expressing transgene for insertional mutagenesis has not been pursued, in favor of
the more efficient retroviral delivery method (see Chapters 3-5).
The fact that fluorescence appears evenly distributed throughout transgenic
embryos at twenty-four hours suggests that all cell types are capable of correctly
processing GFP, thus raising the possibility that GFP could also be a very effective
reporter for analyzing the expression pattern of genes of interest, by using their
regulatory elements to drive a GFP transgene. More importantly, from the point of
view of developing an insertional mutagenesis strategy, GFP might be used as a
reporter in a gene trap. We do not know why fluorescence is not seen before twenty
hours in the XIG transgenic embryos, or why it seems to fade in many lines after thirty-
six hours. Injection of recombinant protein suggests that 50,000 molecules of GFP per
cell are required to readily detect fluorescence; it may take many hours to accumulate
this much GFP in the transgenic embryos, and expression from the truncated
regulatory unit used in this study may decrease to below this level by forty-eight hours
of development.
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The experiments here imply a requirement of 5-40x10 4 molecules of GFP per cell
for detection by epifluorescence microscopy, which is probably higher than the
intracellular levels of most proteins, especially developmentally interesting ones such
as transcription factors, receptors and signaling molecules. While many proteins,
especially structural ones and certain cell-type specific proteins (e.g., albumin or
globin), may be present at up to 106 molecules per cell, many receptors are present at
about 104 molecules per cell, and transcription factors as low as 102-103 molecules
per cell. However, this need not mean that GFP cannot be used as a reporter for the
genes encoding these proteins. First, because of the reasons stated above, the
calculated detection threshold for GFP may be an overestimate. Second, the levels of
many proteins are regulated in post-transcriptional ways, including polyadenylation
efficiency, mRNA stability, translation efficiency, and protein stability. Thus transgenes
might be constructed which, while utilizing tissue-specific promoters, have more
favorable post-transcriptional efficiencies than the endogenous genes from which
these promoters are taken. Third, GFP is exceptionally stable in vitro, and as noted
above, the protein injections presented here imply that it is quite stable in zebrafish
cells as well. Thus the steady state level of GFP may be higher than that of another
(less stable) protein produced at the same rate. Overall, a transgene expressing GFP
from a tissue-specific promoter could produce more GFP than that promoter's usual
gene product, and thus may produce enough GFP to be above the actual detection
threshold.
Several improvements upon the methods used here could decrease the detection
threshold for GFP; for example, the use of intensifying cameras, confocal microscopy,
or two-photon microscopy (18). Additionally, the use of mutated versions of GFP with
higher extinction coefficients and/or altered codon usage (19-23) would also lower the
detection threshold. Targeting the GFP to intracellular organelles might further
decrease the detection threshold by increasing the local concentration of the protein.
Thus the numbers presented here should be viewed as an upper limit on the threshold
of detectability of GFP in zebrafish embryos, which can be improved upon with existing
technological advances.
Subsequent to this study, Long et al. (24) demonstrated that a brighter variant of
GFP could be used as a reporter for the GATA-1 gene in germ-line transgenic
zebrafish, confirming that GFP can be used as a cell-type specific reporter. It is not yet
known what the copy number of the transgene is in these lines, or whether the level of
expression of the transgene is equal to or lower or higher than that of the endogenous
GATA-1 gene. Nevertheless, this result shows that the cis-acting sequences of an
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endogenous zebrafish gene can be used to produce readily detectable levels of a
bright GFP variant. Coupled with the fact that a single integrated copy of a transgene
in which wild type GFP is driven by a strong ubiquitous reporter produces easily
detectable fluorescence in zebrafish embryos, it seems likely that a brighter GFP
variant should be detectable when used as a gene trap, under the transcriptional
control of the cis-acting sequences of an endogenous a zebrafish gene.
Materials and Methods
Fish, Plasmid DNA, and Microinjection: The source of fish used for injection and their
maintenance was as described by Culp et al. (4). XexGFP was constructed by
inserting the GFP cDNA as a Kpn I-Sac I fragment from TU65 (10) into pXex (12),
which has 175 bp of enhancer sequence and 278 bp of promoter and 5' untranslated
sequence form the Xenopus efla gene and an SV40 polyadenylation signal. XIG was
made by inserting the rabbit 3 globin IVS2 as a 640 bp Sal I-Xho I fragment into pXex
between the efla 5' untranslated sequence and the GFP ORF. 14XIG was constructed
by first removing the 1 globin LCR Eco RI fragment from p539 (15) and then replacing
the y globin-neo gene with a blunted Xho I-Bgl II fragment from pXIG, containing the
efla sequences, the IVS, the GFP ORF and the polyadenylation site. Plasmids were
linearized with either Sca I (XexGFP) or Bgl I (XIG, 14XIG), each of which cut the
plasmid once, at least 750 bp into bacterial vector sequence, and injected at 50-100
jg/ml into one cell stage embryos as described in Culp et al. (4).
DNA Isolation and PCR: DNA was extracted from pools of 50-150 three day old fish by
incubation overnight at 550C in 0.5-1.5 ml of 100 mM Tris pH 8, 200 mM NaCI, 5 mM
EDTA, 0.4% SDS, and 100 jg/ml proteinase K. Samples were extracted once with
one volume of phenol, once with one volume of chloroform, precipitated with two
volumes of ethanol, washed with 70% ethanol and resuspended in TE pH 8. DNA was
extracted from individual embryos or fin clips by incubation in 100 Il of the same buffer
overnight at 550C; these samples were centrifuged and nucleic acid precipitated from
the supernatant with three volume of ethanol. Pellets were washed in 70% ethanol
and resuspended in 50 jl of TE.
PCR reactions were carried out with an upstream primer in the efla enhancer and
a downstream primer at the beginning of the GFP gene (for XexGFP) or in the globin
IVS (for XIG and 14XIG), which amplified a 400 bp band from their respective plasmids.
All reactions contained primers in the Zhox2.2 gene (25) as an internal control. PCR
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was performed with 100-300 ng of DNA in 20 pl of 66 mM Tris pH 8.8, 16 mM
(NH 4)2 SO 4 , 8 mM MgCl 2 , 10 mM BME, 150 gg/ml BSA, 600 gM dNTPs, 0.5 gM
primers, and 0.5 units of Taq DNA polymerase (BMB). Reactions consisted of 35
cycles of 45 seconds at 940C, 1 minute at 600C, and 1 minute at 720C, with a 2 minute
initial 940C denaturation step and a 5 minute final 720C elongation step.
Southern Blotting and Quantitation: Genomic DNA was extracted as described above
and resuspended in 10mM Tris-HCI pH 8/1mM EDTA. DNA (10gg) from each line was
digested with 40 units of Eco RI for 6 h at 370C, electrophoresed through 0.7%
agarose in 1X TAE (26), and blotted to Hybond N+ membrane (Amersham) in 0.5 N
NaOH/1.5 M NaCI. After rinsing briefly in 20X SSC (26), blots were baked in a
vacuum oven at 800C for 45 min, prehybridized for 2 h at 650C in 5X SSC/200 glg per
ml denatured salmon sperm DNA/1X Denhardt's/0.1% SDS, and hybridized for 16 h at
650C in the same solution containing probes labeled with [a 32P]dATP with a random
primed labeling kit (Boehringer Mannheim). Blots were then rinsed two times 15 min
in 1X SSC/0.1% SDS at room temperature and two times 30 min in 0.1X SSC/0.1%
SDS at 420C, and exposed both to X-ray film and a phosphor screen. Quantitation
from the scanned phosphor image was carried out with ImageQuant software
(Molecular Dynamics); numbers presented represent the average from two
independent experiments.
Purification and injection of re-GFP: Re-GFP protein was bacterially expressed in the
form of an N-terminal fusion with T7 phage residues using the pET derived TU58
construct in the BL21(DE3) E. coli strain (10). Purification from the bacterial lysate
supernatant followed a modification of Cody et al. (27) with the addition of a final FPLC
mono Q chromatography step. GFP used for microinjection was >90% pure as
determined by SDS-PAGE and the e400nm (= 30,000). One-cell stage embryos were
dechorionated in 0.5 mg/ml pronase and rinsed extensively with Holtfreter's solution.
Microinjection of protein into one cell stage embryos was performed as described for
DNA by Culp et al. (14). When the embryos reached the 1000-cell stage, cells from
approximately fifty of these embryos were then dissociated in 10 ml of Holtfreter's
solution, pelleted by centrifugation at 500 rpm, resuspended in 50 pl Holtfreter's
solution, and loaded into a transplant pipette. Approximately twenty cells were then
transplanted into host uninjected 1000-cell stage embryos.
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Epifluorescence Observation of Embryos: Embryos were observed on a Nikon
microphot-SA microscope with an EPI-FL3 attachment and one of two epifluorescence
filter sets (one for each excitation peak of GFP). Most photographs were taken using a
370-420 nm excitation filter and a 455 nm LP emission filter. When noted, a
fluorescein filter set was used: excitation 450-490 nm, emission 520-560 nm.
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PREFACE TO CHAPTERS 3 AND 4
As I was finishing the work with GFP presented in Chapter 2, others in lab were
beginning to investigate the possibility of using pseudotyped retroviral vectors to make
germ-line transgenic zebrafish. The initial success of this procedure produced
transgenics at a rate comparable to that observed with DNA microinjection; about 15%
of the founders transmitted insertions to their progeny, most founders transmitted only
a single insertion, and insertions were inherited by a small proportion of the founders'
offspring. While this frequency appeared far too low to conduct a large scale
mutagenesis screen, it was possible to conduct a pilot screen to determine the
frequency with which such proviral insertions would be mutagenic. As a logical follow-
through to my work with GFP transgenics, I began to try to develop GFP expressing
and GFP gene trap viral vectors (efforts which to this date have still been
unsuccessful), which I thought might make the use of this technology more feasible.
Simultaneously, I became involved in this pilot screen, the results of which would be
very important in deciding whether the pursuit of retrovirus-mediated insertional
mutagenesis would be worthwhile at all. I was one of four people in the lab who
began generating and identifying the necessary transgenic lines for such a screen.
This consisted primarily of screening founders for transmission of proviral sequences
to their progeny by PCR analysis of DNA prepared from pools of their embryos, raising
the progeny of those that transmitted insertions, identifying the few fish that were
positive amongst these F1 pools, and further identifying which of these transgenic fish
carried identical insertions so that they could be crossed to screen for mutations. As
the frequency of transmission was so low, it was evident that we would need to screen
over 1,000 potential founders, and subsequently raise and analyze hundreds of
progeny each from 150-200 of the founders in order to be able to get multiple fish for
each of 200 insertions such that the insertions could be inbred.
Meanwhile, another member of the lab had made another viral vector which he
was able to produce at much higher titer than the one that we had been using. When
we began to screen potential founders which had been injected with this virus, we
found that nearly every one transmitted proviral sequences to their progeny! We then
shifted nearly exclusively to founders injected with this virus to conduct the pilot
screen. While analyzing the F1 fish for the purpose of identifying those with identical
insertions, we found that with this higher titer virus founders transmitted many different
insertions through their germ-lines, an average of about a dozen per founder. I
conducted most of this analysis, and over time built up a large amount of data on the
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distribution of different insertions within F1 pools. This analysis formed the basis for
Table 2 in Chapter 3. It was also an essential step in generating the 217 different lines
inbred in the pilot screen. Equally important though, it gave me an appreciation for the
way different insertions were distributed amongst the progeny of these mosaic
founders, and this would be critical in developing modifications to the screening
protocol later.
I also took over the organization of the screen, which ultimately involved five of
us. This meant both physically organizing the fish and determining the schedule for all
of the activities required to generate, inbreed, and screen the lines as quickly as
possible. Part of this organization also included rapidly assessing whether an
observed mutation was in fact caused by the inbred insertion, beginning with very
rough linkage (determining whether or not all of the phenotypic embryos carried the
insertion; if the mutation and insertion were unlinked, only three quarters of the
embryos would be expected to do so). When the results indicated linkage, I continued
the analysis with junction fragments to show the complete absence of recombination
between the insertion and mutation in hundreds of meioses. The culmination of this
pilot screen is presented primarily in Chapter 4, in which I demonstrate that we found
three insertional mutants in 217 inbred insertions. We were also able to rapidly clone
the genes disrupted in two of these; I was primarily (though not exclusively)
responsible for cloning the first of these, no arches. The pilot completed, I then moved
on to trying to extend the screen, while making it more efficient.
CHAPTER 3
HIGHLY EFFICIENT GERM-LINE TRANSMISSION OF PROVIRAL INSERTIONS IN
ZEBRAFISH
(Most of this chapter was published as: Gaiano, N., Allende, M., Amsterdam, A.,
Kawakami, K., and Hopkins, N. (1996) Proc Natl Acad Sci USA 93: 7777-7782.
Additional data regarding further improved transgenesis has been added (Experiment
3 in Table 2.)
Abstract
An important technology in model organisms is the ability to make transgenic
animals. In the past, transgenic technology in zebrafish has been limited by the
relatively low efficiency with which transgenes could be generated using either DNA
microinjection or retroviral infection. Previous efforts to generate transgenic zebrafish
using retroviral vectors utilized a pseudotyped virus with a genome based on the
Moloney murine leukemia virus and the envelope glycoprotein of the vesicular
stomatitis virus. This virus was injected into blastula-stage zebrafish and 16% of the
injected embryos transmitted proviral insertions to their offspring, with most founders
transmitting a single insertion to about 2% of their progeny. In an effort to improve this
transgenic frequency we have generated pseudotyped viral stocks of two new
Moloney-based genomes. These viral stocks have titers up to two orders of magnitude
higher than that used previously. Injection of these viruses resulted in a dramatic
increase in transgenic efficiency: over four different experiments 87% (148/171) of the
injected embryos transmitted proviral insertions to 29% of their offspring. Furthermore,
founders for one of the viruses transmitted an average of 11 different insertions
through their germ line. These results represent a 50- to 100-fold improvement in the
efficiency of generating transgenic zebrafish, making it now feasible for a single lab to
rapidly generate tens to hundreds of thousands of transgenes. Consequently, large-
scale insertional mutagenesis strategies, previously limited to invertebrates, may now
be possible in a vertebrate.
Introduction
Traditionally, the generation of transgenic zebrafish has been achieved by the
microinjection of plasmid DNA into the cytoplasm of the one-cell stage embryo (1-3).
Although this method is useful, efficiency is variable, and transgenes are frequently
present in tandem arrays and can have complex unpredictable structures (1, 3). More
recently retroviral infection has emerged as a method for generating transgenic
zebrafish (4). In initial studies, Burns et al. demonstrated that a pseudotyped retroviral
vector, containing a genome based on the Moloney murine leukemia virus (MLV) and
the envelope glycoprotein (G-protein) of the vesicular stomatitis virus (VSV), was able
to infect a cultured zebrafish cell line (5). This result was important because previously
the host range of the standard retroviral vectors did not permit infection of fish cells (5),
and as a result the zebrafish was inaccessible to retroviral vector technology.
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Subsequently, our laboratory showed that retroviruses pseudotyped with the
VSV G-protein are able to infect the zebrafish germ line following injection of a
concentrated stock of an MLV/VSV pseudotyped virus into blastula-stage zebrafish
embryos (4). In these studies, 16% (8/51) of the potential founders tested transmitted
proviral insertions to 2-3% of their F1 progeny, with founders transmitting 1-2 different
insertions. These results suggested that pseudotyped retroviral vectors could be
useful tools for generating transgenic zebrafish, and that if the transgenic frequency
could be increased substantially that they might also prove to be effective insertional
mutagens.
To determine if we could improve the efficiency of generating transgenic fish
using retroviral vectors, we constructed two new MLV-based genomes and generated
viral stocks from these constructs with titers up to two orders of magnitude higher that
the previously used viral stock (4). Injection of these new viral stocks into blastula-
stage embryos resulted in as much as a 50- to 100-fold increase in the efficiency of
generating transgenic insertions as compared to previously obtained results using
either plasmid microinjection (3) or retroviral infection (4). These results suggest that
the efficiency of generating transgenic zebrafish using pseudotyped retroviral vectors
is correlated with the titer of the viral stock in vitro, and that at the highest titer tested to
date, the germ line of every injected fish can harbor many different proviral
integrations. Consequently it is now feasible for a small lab to generate tens to
hundreds of thousands of proviral transgenes in zebrafish. This work represents a
major advance in transgenic technology in zebrafish, and may make large-scale
insertional mutagenesis and the rapid identification of phenotypically interesting
genes possible in this vertebrate system.
Results
High frequency germ-line transmission of proviral integrations
Two pseudotyped viruses, SFG(G) and NK(G), were constructed for these
studies and have MLV-based genomes (see Fig. 1A) and an envelope containing the
VSV G-protein. These viruses are similar to the MLV/VSV pseudotyped virus
previously shown to be capable of stably integrating proviral DNA into the zebrafish
genome (4, 5). Concentrated stocks of SFG(G) and NK(G) were prepared from stable
producer cell lines, and were titered on both mouse 3T3 cells and zebrafish PAC2
cells. Because of complications in determining the titer of these viruses on PAC2 cells
(see Materials and Methods) only the titers on 3T3 cells will be given hereafter.
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Figure 1 Schematic representation of the plasmids used, and of the predicted and
observed proviral structures. (A) Maps of pSFG-nlacZ (with 3'-LTR modified to contain
the Xenopus eFl a promoter), pNK-lacZ, and of the construct used to confer resistance to
puromycin. The locations of primer sets 1 and 2 are indicated, as is the region of pSFG-
nlacZ used as a probe for Southern blots. (B) The expected SFG proviral genome and
the actual SFG proviral genomic structures.
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The SFG(G) virus stock (-2 x 109 cfu/ml on 3T3 cells) was microinjected into
zebrafish embryos at about the 1000-cell stage. Following microinjection the embryos
were incubated at either 260C or 280C. Although many embryos (50-80%) did not
survive to the next day, or were malformed, the majority of those that appeared normal
at 24 hours grew to adulthood. To detect germ-line transmission of proviral DNA, the
injected embryos were raised to adulthood and mated, and genomic DNA from pools
of 24-hour-old F1 embryos was tested for the presence of proviral sequences by PCR.
As shown in Table 1, 128/144 (89%) of the potential SFG founders tested
(experiments 1-3) were found to transmit proviral DNA to their F1 progeny.
Although aliquots of the same virus stock were used in experiments 1-3 listed in
Table 1, the frequency of germ-line transmission in the first experiment, 71% (40/56), is
significantly lower than the 100% (88/88) obtained in the second and third
experiments. The primary difference between these two sets of experiments was the
temperature the embryos were incubated at after injection, suggesting that viral
infection occurs more efficiently at 280C than at 260C. We have obtained similar
results which support this conclusion using two other MLVNSV viruses (N. Gaiano, M.
Allende, and N. Hopkins, unpublished data).
Initial injections with an undiluted stock of the virus NK(G) (2 x 109 cfu/ml on 3T3
cells), resulted in all injected embryos being dead or severely malformed by the next
day. Injection of four-fold dilutions of the concentrated NK(G) stock resulted in survival
rates similar to those observed using SFG(G) and were used to generate the potential
NK founders. Of 27 potential NK founders tested, 20 (74%) were found to transmit
proviral DNA to their F1 progeny (Table 1).
The toxicity observed upon injection of some viral stocks into blastula-stage
embryos could be a function of the fusogenic nature of the VSV G-protein (6). Due to
the inherent variability in the efficiency of transient transfection of the VSV-G
expressing plasmid, a step required to make MLV/VSV pseudotyped viruses (see ref.
7), the amount of VSV G-protein may vary between virus stocks. Such variability could
account for the difference in toxicity seen between the SFG(G) and NK(G) viruses used
here, although contaminants in the viral stocks, derived from the producer cells used to
make the virus, could also be responsible.
Germ-line mosaicism of founders
To identify individual transgenic F1 fish without sacrificing them, genomic DNA
was isolated from caudal fin clips of 6-8 week-old F1 progeny of identified founders,
and tested by PCR for the presence of proviral DNA. As shown in Fig. 1B and as
Potential Founders
Virus Titer on Founders Identified
Expt. Injected Tempt 3T3's (cfu/ml)tt Tested No. (%)
1 SFG(G) 260C 2.4 x 109 56 40 (71%)
2 SFG(G) 28°C 1.6 x 108 50* 50 (100%)
3 SFG(G) 280C 1.6 x 108 38 38 (100%)
4 NK(G) 280C 5 x 108 27 20 (74%)
Table 1. High-frequency germ-line transmission of proviral insertions. Injected
embryos were raised, genomic DNA was isolated from pools of their F1 progeny and
was tested by PCR for the presence of proviral DNA. In some cases, F1 pools were
not tested in this manner but instead F1 embryos were raised and tested by isolating
DNA from fin clips.
t The temperature at which embryos were incubated for 24 hours after injection.
tt The titer on 3T3 cells is shown for comparison because an accurate determination
of SFG(G) titer on PAC2 cells was complicated by limited or no lacZ expression (see
Materials and Methods). The titer for SFG(G) stocks is listed as twice that observed as
only 50% of the proviruses contain an intact lacZ gene.
* In experiment 2 a total of five potential founders with between 8 and 21 F1 progeny
tested were found to be negative but were considered inconclusive, due to the small
number of progeny tested, and are not listed.
discussed below, the SFG(G) virus stock contains a mixture of three viral genomes.
Primer set 2 (see Fig. 1A), which detects all three SFG proviruses, was used to detect
Fl's transgenic for SFG proviruses. Primer set 1 (see Fig. 1A) was used to detect Fl's
transgenic for NK proviruses.
The percentage of transgenic offspring from SFG founders ranged from 8-79%
with an average of 33% (Table 2). The percentage of transgenic offspring from NK
founders was somewhat lower and ranged from 3-28% with an average of 12%. A
plausible explanation for the difference in both the frequency of germ-line transmitting
founders (see above) and the frequency of transgenic Fl's from these founders
between the SFG(G) and NK(G) injections would be that the SFG(G) stocks used for
injection were 4-fold higher in titer than the NK(G) stock used (see Table 1).
SFG founders transmit an average of 11 proviral insertions to their F progeny
In order to examine the number of different insertions being transmitted through
the germ line of the founder fish, Southern blot analysis was performed on genomic
DNA from fin clips of individual transgenic Fl's from SFG founders. The DNA was
digested with Bgl II, which cuts once within the all three SFG proviral genome types
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(EXP 1)
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33%
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5
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12
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14
14
12
12
10
10
19
9
22
6
6
12
11
to R's
ransgenic
1 progeny
(%0)
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transmitted
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Table 2. Analysis of germ-line transmission of proviral insertions from representative
individual SFG and NK founders. Transgenic Fl's were identified by isolating
genomic DNA from caudal fin clips and testing by PCR for proviral sequences.
Genomic DNA from identified transgenic F1 fish was then digested with Bgl II which
cuts once in the proviral sequence, and Southern blot analysis was performed.
Junction fragment sizes were compared between fish and those with identical patterns
were classified as having the same insertion.
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(see Fig. 1B, and below), and analyzed by Southern blot. Depending upon the
location of Bgl II sites in the genomic DNA adjacent to the insertion, each different
insertion was expected to yield two junction fragments of diagnostic sizes. An
example of a Southern blot used to compare insertions is shown in Fig. 2. The proviral
insertions in 19 transgenic offspring from founder SFG77 were compared. Among
these fish, 14 have one insertion, 4 have two insertions, and 1 has three insertions
(lane 6) with some insertions being present in more than one fish. In total these fish
harbor 16 different insertions among them.
Progeny from 18 outcrossed founders were analyzed by Southern blot and
were found to contain 194 different insertions, indicating that on average each founder
transmits 11 different insertions to its F1 progeny (see Table 2, experiment 2).
Although the majority of transgenic F1 fish (65%) were found to have 1 proviral
insertion each, individual F1 fish were frequently found with 2, 3 or 4 different proviral
insertions (26%, 7%, and 2%, respectively). The mosaicism of individual insertions in
the germ line of founders varied, with some insertions being present in <1% of the F1
progeny from a given founder, and others being present in as much as 14% of the F1
progeny from a given founder. Of 187 insertions analyzed roughly 30% were found to
be transmitted to at least 3% of the founder's progeny.
Analysis of SFG proviral genome structures
As mentioned above, the SFG(G) virus stock contains three different viral
genomes. To examine the structures of these proviruses in transgenic fish, genomic
DNA from individual fish harboring the different proviruses was digested with various
combinations of the following restriction enzymes: Xba I, Pvu II, Eco RV, Eco RI, Bam
HI, Nhe I, Hinc II, Sac I, Hind III, Nco I, Sph I, and Dra I. Based on Southern blot
analysis of these digests, restriction maps were constructed which were consistent
with every digest examined. Structural maps of the three SFG proviral genomes (SFG
provirus types I, II, and III) are shown in Fig. 1B. All three SFG proviral genomes were
found to have wild-type MLV LTR's. This result was surprising because based on the
plasmid used to generate the SFG producer cell line (pSFG-nlacZ, see Fig. 1A), SFG
proviruses were expected to possess modified LTR's with the Xenopus eFlo promoter
in the U3 region (see Fig. 1B). In addition to the unexpected LTR structure found, two
of the three SFG proviral genomes (type II and III) were found to have large deletions
in the lacZ gene and to contain sequences from the puromycin resistance construct
which had been used to allow drug selection of stable producer clones (see Materials
and Methods, and Fig. 1A). The absence of the desired viral genome in the SFG(G)
Figure 2. Southern blot analysis of genomic DNA from transgenic F1 progeny of
founder SFG77. DNA was digested with Bgl II and probed with the sequence
indicated in FIG. 1A. Each insertion is expected to produced two junction fragments
with sizes characteristic of the site of integration. The result of segregation during
meiosis is apparent in lanes 2-7, and 10-12. For example, the F1 represented in lane
11 has four bands representing 2 insertions. These two insertions can be seen
independently in the Fl's represented in lanes 10 and 12.
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stocks, and the presence of the three different viral genomes in these stocks is likely to
be the result of DNA rearrangements which occurred during the transfection of pSFG-
nlacZ and the puromycin resistance construct into the 293-derived packaging cell line.
Discussion
The results presented here demonstrate that MLV/VSV pseudotyped retroviral
vectors can be used to generate transgenic zebrafish with extremely high efficiency.
At previous transgenic frequencies, using either DNA microinjection or retroviral
infection, the generation of 100 potential transgenic founders would typically result in
the germ-line transmission of 10-20 transgenes (3, 4). The current work represents a
dramatic improvement in transgenic frequency and shows that it is now possible, using
retroviral infection, for 100 potential founders to result in the germ-line transmission of
over 1,000 transgenes. One possible explanation for the increased transgenic
frequency seen here as compared to previous results using the pseudotyped
retrovirus LZRNL(G) is that the titers of both the SFG(G) and NK(G) stocks used here
were roughly 100-fold higher than that of the LZRNL(G) stock used previously (4).
Based upon the transgenic frequencies reported here, large-scale insertional
mutagenesis, a technique which has not been practical in vertebrates model systems,
may now be possible in zebrafish. Although large-scale chemical mutagenesis can be
performed in zebrafish (8, 9) and has yielded many interesting mutants, an insertional
mutagenesis strategy could be a powerful alternative. This is because mutagenic
insertions provide a molecular tag to facilitate the cloning of mutated genes,
circumventing the laborious positional cloning methods often required to clone
chemically mutated genes.
In fruit flies, large-scale insertional mutagenesis is possible because P
elements can be used to generate many thousands of insertions which can be
screened for integration events of interest (10). While previously the generation of
many thousands of transgenic insertions was theoretically possible in vertebrate
systems such as the mouse and the zebrafish, the resources and time required to do
so were prohibitive. The present work, however, indicates that it is now feasible for a
single lab to rapidly produce as many as 100,000-200,000 transgenes in zebrafish.
This could be achieved by generating 10,000-20,000 founders, each of which would
transmit at least 10 insertions to its F1 progeny as shown here (Table 2). We estimate
that it would take 4-6 people roughly three months to generate the founders.
Based upon the size of the zebrafish genome (1.6 x 109 bp), a screen involving
200,000 insertions would have, on average, one insertion every 8 kb. If the average
gene spans roughly 10 kb, then a screen of this size would be expected to have
potentially mutagenic insertions into most of the genes in the genome. The actual
efficiency of such a screen would depend upon whether or not proviruses integrate
randomly into the zebrafish genome and upon the mutagenicity of proviral DNA
integrated into zebrafish genes. If, for example, proviral insertions into the zebrafish
genome preferentially occur into intergenic sequences, then the likelihood of
integrating into and mutating genes would be greatly reduced. However, studies of
retroviral integration in the mouse and chicken suggest that proviral insertions occur
either at random (11) or possibly with a preference for transcribed regions of the
genome (12, 13). Preliminary results from our lab indicate that proviruses can and do
integrate into single-copy sequences, as well as transcribed regions of the zebrafish
genome (K.K, N.G., and N.H., unpublished data)
There are several possible ways a large-scale insertional mutagenesis screen
in zebrafish might be conducted. One strategy would simply be to generate insertions,
breed them to homozygosity, and screen for mutant phenotypes. Although such a
screen is labor intensive and limited by the time and space required, it should be
possible to screen several thousand insertions in this manner. It is unknown how
many mutants would be generated in a screen of this size, because the number of
proviral insertions into the zebrafish genome required to produce a mutant phenotype
remains to be determined. We have conducted a pilot screen to determine this
number (see Chapter 4). In mice 5% of proviral insertions disrupt essential genes
(14).
The inbreeding strategy mentioned above might be an effective way to isolate
insertional mutants, although it is limited by the need to maintain very large numbers of
individual lines. As a result, using such a strategy a lab could only screen a small
fraction of the hundreds of thousands of transgenes that could be generated. An
alternative strategy, which would permit the screening of a much larger number of
insertions, would be to screen haploid embryos. Haploid zebrafish embryos are easy
to generate, and undergo relatively normal early development (15). Transgenic F1
fish, hemizygous for proviral insertions, could be used to generate haploid F2 embryos
to be screened for mutant phenotypes. A phenotype observed in 50% of the haploid
embryos would indicate the presence of a mutagenic insertion.
Another possible approach to insertional mutagenesis in zebrafish could utilize
retroviral gene traps. Gene traps are constructs containing a reporter gene which can
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only be expressed after integration into a transcribed endogenous gene (16). Such
'activated' integrations are likely to disrupt the function of the gene into which they
have integrated and typically express the trap reporter in a temporal and spatial
pattern similar to that of the endogenous gene (17,18). The generation of 20,000
founders, which could be maintained in 100 15-gallon fish tanks, would permit the
screening of 200,000 gene trap insertions. F1 embryos from founder matings could be
screened for trap activations and those containing expression patterns of interest
could be isolated for further study. If gene traps are activated in fish cells at
efficiencies similar to those in mice (16), then 200,000 gene trap insertions in zebrafish
could contain as many as 20,000 activated trap patterns, a significant percent of which
would be expected to have a mutant phenotype when bred to homozygosity (17).
Materials and Methods
Plasmids Used to Make Retroviral Constructs: pSFG(ECT-) (obtained from R.
Mulligan, MIT) contains deletions in the U3 region of the 3'-LTR which remove the MLV
transcriptional regulatory elements. The Xenopus eFla promoter (19) was placed into
the 3'-LTR and the resulting construct, pSFG-nlacZ (Fig. 1A), was expected to
generate proviruses with this promoter driving a nuclear localized E. coli 13-
galactosidase (lacZ) gene (Fig. 1B). pNK-lacZ (Fig. 1A) was derived from pLZRNL
(20). The eFl a promoter was placed upstream of the lacZ gene, and the RSV LTR
and neomycin phosphotransferase gene were removed.
Generation of Stable Retroviral Producer Clones: pSFG-nlacZ (SFG), and pNK-lacZ
(NK) were each transfected into a 293 gag-pol packaging cell line (293GP; obtained
from Viagene, Inc.) with a construct containing the puromycin acetyltransferase gene
driven by the SV40 early promoter and with an MLV LTR providing the
polyadenylation signal (Fig. 1A). The packaging cell line used does not express any
envelope protein but does express the gag-pol protein required to make infectious
retroviral core particles (5). Puromycin resistant cell clones were screened for virus
production by transient transfection of a construct expressing the VSV G-protein from
the human cytomegalovirus promoter and subsequent titering on mouse 3T3 cells.
This construct, pHCMV-G (7), provides the envelope protein necessary to produce
infectious pseudotyped virus, and such virus is indicated with the designation (G).
Titering was performed by infecting mouse 3T3 cells and zebrafish PAC2 cells
(4, P. Culp and N. Hopkins, unpublished data) with serial dilutions of virus and then
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staining 48 hours later with the chromogenic substrate X-gal to detect b-gal activity in
infected cells. An SFG(G) producing clone was identified which produced titers of 5-
10 x 106 cfu/ml on 3T3 cells, and 1 x 104 cfu/ml on zebrafish PAC2 cells. The SFG(G)
virus was unexpectedly found by Southern blot to be a mixture of three different viral
genomes, representing recombinants of the plasmids used to construct the virus-
producing cell line (see Results). Consequently, titers listed in the text represent twice
the observed number of X-gal staining colonies. An NK producer clone was identified
which produced lacZ titers of 5-10 x 106 cfu/ml on 3T3 cells, and 1 x 105 cfu/ml on
PAC2 cells. Southern blot analysis indicated that virus from this clone produces the
expected proviral genome (data not shown).
Virus-containing supernatant from the selected SFG and NK clones was
concentrated as previously described (5, 7) to lacZ titers of 1-2 x 109 cfu/ml on 3T3
cells. The lacZ titers of the concentrated SFG(G), and NK(G) stocks on PAC2 cells
were 5-10 x 106 cfu/ml, and 1-2 x 108 cfu/ml, respectively. Previous studies in our lab
have indicated that lacZ may be a substantially less effective reporter in zebrafish
PAC2 cells than in mouse 3T3 cells (P. Culp and N. Hopkins, unpublished data).
Therefore the relative titer of these stocks on 3T3 and PAC2 cells was estimated by
comparing the amount of integrated proviral DNA in both cell types after infection with
the same dilution of a virus stock. For both SFG(G) and NK(G) the amount of
integrated proviral DNA in PAC2 cells was found to be roughly 2-fold less than that in
3T3 cells (data not shown). The lacZ titers of the concentrated SFG(G) and NK(G)
stocks used for injection into embryos were -2 x 109 cfu/ml on 3T3 cells and were
therefore estimated to be roughly 1 x 109 cfu/ml on PAC2 cells.
Generation and Identification of Transgenic Founder Fish: Ten to twenty nanoliters of
the concentrated SFG(G) and NK(G) viral stocks, containing 8 mg/mi polybrene, were
injected into 4-5 locations among the blastomeres of blastula-stage zebrafish embryos
(roughly 512-2,000 cell stage). Injected embryos were raised to sexual maturity and
mated either to each other or to wild-type fish. Genomic DNA was prepared from pools
of the F1 progeny as previously described (4), and was tested by the polymerase
chain reaction (PCR) for the presence of proviral DNA. The nucleotide sequence of
the primers used to detect both SFG and NK founders (primer set 1, see Fig. 1A) is as
follows: The upstream primer sequence is 5'-ATATCGACGGTTTCCATATGGG-3' and
is within the coding sequence of the lacZ gene. The downstream primer sequence is
5'-GTACTCTATAGGCTTCAGCTGG-3' and is within the MLV-derived sequences
downstream of the lacZ gene. This set of primers amplifies a 232 bp sequence in SFG
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and about a 200 bp sequence in NK. Primers designed to detect sequences within
the zebrafish Wnt5a gene were used as internal controls in each reaction and are the
same as those previously described (4). The PCR program used is as follows: 1
minute at 940C, 1 minute at 600C, 1 minute at 720C for 32 cycles, with an initial
denaturation step at 940C for 2 minutes, and a final elongation step at 72 0C for five
minutes.
Identification of Transgenic F1 Fish: The F1 progeny of founders were raised and
individual genomic DNA samples were prepared from caudal fin clips by incubation in
10 mM Tris-HCI (8.0), 10 mM EDTA, 0.2 mg/mi proteinase K for at least 3 hours at
55 0C. PCR was then used to detect the presence of proviral sequences. Primer set 1
(Fig. 1A) was used to identify transgenic progeny from NK founders, while a second
set of primers, primer set 2 (see Fig. 1A), was used to identify transgenic progeny from
SFG founders. Primer set 2 was designed when it was found that the SFG(G) stock
generated three different proviruses, two of which were not detectable by primer set 1
(see Results). The nucleotide sequence of primer set 2 is as follows: The upstream
primer sequence is 5'-ATCCTCTAGACTGCC-ATGG-3' and includes the start codon of
the lacZ gene. The downstream primer sequence is 5'-ATCGTAACCGTGCATCTG-3'
and is within the coding sequence of the lacZ gene. This set of primers amplifies
about a 340 bp sequence. All identified transgenic offspring from a single founder
were kept together, and subsequently tail DNA was re-isolated from these fish for
Southern Blot analysis.
Southern Blot Analysis: Genomic DNA was digested with the indicated restriction
enzymes, electrophoresed through a 0.8% agarose gel and blotted to Hybond N+
nylon membranes (Amersham). Radiolabeled probes were made using the Random
Primed DNA Labeling Kit (Boehringer Mannheim). Hybridizations were carried out at
650C in a Robbins Scientific Model 2000 Hybridization Incubator in a solution
containing of 0.25 M Na2 HPO 4 (pH 7.4), 1 mM EDTA, 10 mg/ml BSA, and 7% SDS.
Filters were washed 3 x 20 minutes with 0.1x SSC and 0.1% SDS at 650C.
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CHAPTER 4
INSERTIONAL MUTAGENESIS AND RAPID CLONING OF ESSENTIAL GENES IN
ZEBRAFISH
(This chapter was published as: Gaiano, N., Amsterdam, A., Kawakami, K., Allende, M.,
Becker, T., and Hopkins, N. (1996) Nature 383: 829-32.)
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Abstract
Large-scale chemical mutagenesis screens in zebrafish have led to the isolation
of thousands of lethal mutations in genes essential for embryonic development (1,2).
However, the cloning of these mutated genes is difficult at present as it requires
positional cloning methods. In Drosophila, chemical mutagenesis screens were
complemented with P-element insertional mutagenesis which facilitated the cloning of
many genes that had been identified by chemical lesions (3,4). To facilitate the
cloning of vertebrate genes that are important during embryogenesis, we have
developed an insertional mutagenesis strategy in zebrafish using a retroviral vector.
Here, in a pilot screen of 217 proviral insertions, we obtained three insertional mutants
with embryonic lethal phenotypes, and identified two of the disrupted genes. One of
these, no arches, is essential for normal pharyngeal arch development, and is
homologous to the recently characterized Drosophila zinc-finger gene clipper, which
encodes a novel type of ribonuclease (5). As it is easy to generate tens to hundreds
of thousands of proviral transgenes in zebrafish (6, Chapter 2), it should now be
possible to use this screening method to mutate and then rapidly clone a large number
of genes affecting vertebrate developmental and cellular processes.
Results and Discussion
Retroviral insertional mutagenesis in zebrafish
The infection of blastula-stage zebrafish embryos with murine leukemia
virus/vesicular stomatitis virus (MLVNSV) pseudotyped retroviral vectors (7, 8) results
in the germ-line transmission of proviral insertions (6, 9, Chapter 3). Integration of
proviral DNA into the mouse genome has been shown to be capable of disrupting
essential genes (10). In an effort to isolate insertional mutations in zebrafish we
generated and inbred 217 proviral transgenes and screened for mutant phenotypes
that were linked to those transgenes. The virus used to generate the insertions,
SFG(G), has been described elsewhere (6, Chapter 3). Three proviral transgenes,
referred to as 38M, 67D, and 80A, were found to be linked to mutant phenotypes as all
mutant embryos were transgenic as determined by PCR (data not shown). These
three phenotypes are lethal, including a variety of defects in the head, visceral organs,
and fins, and in all three cases mutant embryos develop edema by day 5 of
development (Fig. 1).
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Figure 1. Comparison of wild-type
Wild-type embryo. (B, C, and D)
38M, 67D, and 80A, respectively.
previously (1).
and mutant embryos on day 5 of development. (A)
Mutant embryos obtained by inbreeding insertions
Inbreeding crosses were screened as described
CFigure
Fragments of the genomic DNA flanking the three potentially mutagenic
insertions were isolated, then single-copy sequences were identified and these
sequences used as probes on Southern blots to determine the genotype of embryos
generated by inbreeding the insertions (Fig. 2). For insertion 38M, we analyzed 110
mutants and 272 wild-type siblings; for insertion 67D, 133 mutants and 252 wild-type
siblings; and for insertion 80A, 109 mutants and 241 wild-type siblings. In all three
cases, every mutant embryo examined was found to be homozygous for the insertion
in question, and every phenotypically wild-type sibling was found to be either
heterozygous or non-transgenic. With the number of embryos examined in each case,
if a mutation and the associated insertion were 1 cM apart, we would have observed 3-
4 recombinants. No recombinants were observed, indicating that in all three cases the
insertions and mutations are tightly linked.
These linkage data suggested that proviral insertions, 38M, 67D, and 80A, were
likely to have induced the mutant phenotypes observed upon inbreeding. In an effort
to identify the genes mutated by these insertions, 2-5 Kb fragments of genomic DNA
flanking the three proviruses were sequenced. These sequences were used to search
the Genbank sequence database using the BLAST algorithm (11). DNA sequence
adjacent to the site of insertion 38M was found to be highly homologous to a
Drosophila zinc-finger gene, as well as to putative gene sequences identified by the C.
elegans and yeast genome projects and a human expressed sequence tag (EST).
The Drosophila gene, clipper (clp) was identified in an expression screen for proteins
that bind single-stranded nucleic acids (12), and has recently been shown to encode a
novel type of ribonuclease (5). DNA sequence at the site of insertion 67D were found
to be highly homologous to a human EST of unknown function, as well as to putative
gene sequences identified in the C. elegans and yeast genome projects.
Intron and exon structures for both putative fish genes were predicted within the
cloned genomic regions on the basis of the homologous sequences in the other
organisms (Fig. 3A), and both genes were found to be expressed in zebrafish
embryos, using reverse transcriptase with the polymerase chain reaction ( RT-PCR)
(Fig. 3B). To determine whether the expression of the genes adjacent to insertions
38M and 67D was disrupted by the proviral insertions, northern blot analysis was used
(Fig. 3C). RNA isolated from wild-type embryos on day 5 of development was found to
contain a 1.9 Kb transcript when probed with a complementary DNA (cDNA) fragment
from the gene at the site of insertion 38M, and a 2.3 Kb transcript when probed with a
cDNA fragment from the gene at the site of insertion 67D (Fig. 3C, lanes 1 and 4,
respectively). Insertions 38M and 67D were inbred and RNA was made on day 5 of
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Figure 2. Linkage analysis between insertion 38M and the mutant phenotype resulting
from its inbreeding. Phenotypically wild-type and mutant embryos from a cross of two
fish heterozygous for insertion 38M were sorted on day 5, and individual embryos
were genotyped by Southern blot. Tg, transgenic
Figure 3. Proviral insertions 38M and 67D have integrated into and disrupted
expressed zebrafish genes. (A) The genomic site of insertion 38M contains amino
acid homology to the Drosophila gene clp (shaded) (22). The genomic site of insertion
67D contains amino acid homology to a human expressed sequence tag (shaded). In
both cases the exons depicted encode only the 5' portion of the fish genes. (B) RT-
PCR showing that insertions 38M and 67D have both landed in exon sequence. The
primers used are shown in (A). The identity of these PCR products and the predicted
splicing events were confirmed after subcloning and sequencing. In both cases, the
amplified sequences extend upstream (white boxes) of the exon sequences identified
by homology to other species (shaded). The absence of open reading frames which
extend past the homologous regions suggests that the insertions have occurred into
the 5'-UTR of these genes. (C) Northern blot analysis of embryos on day 5 showing
the disruption of zebrafish genes by insertions 38M and 67D. See text for details. An
o-tubulin probe was used to confirm the presence of RNA in all lanes.
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development from sorted pools of phenotypically wild-type and mutant embryos. For
both insertions, the phenotypically wild-type embryos expressed transcripts of the
expected size (Fig. 3C, lanes 2 and 5), whereas no transcripts could be detected in the
mutant embryos (lanes 3 and 6).
These results demonstrate that the proviral insertions 38M and 67D have either
disrupted the expression of the genes into which they have integrated, or in
homozygous embryos have resulted in a reduction or deletion of the tissues in which
those genes are normally expressed. Considering also the tight linkage between
these two insertions and the associated mutations, we believe that the insertional
disruption of these genes is responsible for the observed phenotypes, although
definitive proof will require rescue of the mutant phenotypes by addition of functional
copies of the disrupted genes.
The no arches phenotype and gene
The gene mutated by insertion 38M is of interest because its disruption results in
defects in the head, and in particular the pharyngeal arches, a set of structures unique
to vertebrates and derived in large part from the cells of the neural crest (22). We have
called this gene no arches (nar), and have initiated studies to address its role in
vertebrate development. Initial observations of nar mutant embryos reveal that while
they appear normal during the first 2 days of development, by day 3 they have smaller
heads and eyes than their wild-type siblings, and the growth of their pectoral fins is
stunted. On days 4 and 5 the difference in head size between mutant and wild-type
embryos becomes more extreme, and the pharyngeal arches are largely absent in the
mutant. Not all head structures are equally affected, however, as the otic vesicles in
the mutant are comparable in size to those in the wild type. Furthermore, no obvious
defects are present in the trunk and the tail of mutant embryos, although the
development of the liver and gut is slightly retarded.
To examine the structure of the head skeleton, day 5 mutant and wild type
embryos were treated with alcian blue which stains cartilaginous structures (13).
Staining of wild-type embryos shows the seven pharyngeal arches which include two
jaw arches, the mandibular and the hyoid, and five branchial arches (Fig. 4A, B). Also
evident is the cartilage of the ethmoid plate, the most anterior portion of the
neurocranium. In mutant embryos the cartilage of the branchial arches is largely or
entirely absent, and that of the jaw arches is absent or malformed (Fig. 4C). The
cartilage of the neurocranium is present but reduced in size and the ethmoid plate
extends far less anteriorly than in wild-type embryos. Interestingly, the cartilage of
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Figure 4. Alcian blue staining of wild-type and nar mutant embryos on day 5 of
development. (A) Schematic representation of the ventral view of a wild-type embryo.
(B, C) Ventral view of stained wild-type and mutant embryos, respectively. The
absence of the cartilage of the branchial arches in the mutant is apparent and
malformed pieces of the jaw arches are present (arrow).
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both the pharyngeal arches and of the ethmoid plate is thought to be neural crest
derived (14).
A nar cDNA sequence of length 1,879 bp was obtained from an adult zebrafish
cDNA library (obtained from D. Grunwald). This fish sequence was compared to the
cDNA sequences of the homologous Drosophila zinc-finger gene mentioned above
and the homologous human gene, and the putative coding sequences were aligned
(Fig. 5). The fly gene, clp, contains seven zinc-finger motifs, and has been shown
biochemically to encode a new type of endoribonuclease that specifically cleaves RNA
hairpins (5). Six of the seven zinc-fingers present in the clp protein (Clp) are
conserved in both the fish and human putative nar proteins (Nar) including the five at
the N-terminus which possess the nuclease activity in Clp (Fig. 5). The conserved C-
terminal zinc finger is similar in structure to those of retroviral nucleocapsid proteins
which bind to the single-stranded RNA genome of retroviruses (15). The presence of
an RNA binding motif at the C-terminus of Nar, in conjunction with a putative
ribonuclease at the N-terminus, suggest that the Nar protein may function during
zebrafish embryogenesis by binding to and cleaving RNA.
To examine the temporal pattern of expression of nar during zebrafish
development, as well as expression in adult fish, northern blot analysis was performed
(Fig. 6). Two different nar transcripts of roughly 1.9 Kb and 1.2 Kb were detected in
unfertilized eggs indicating that these messages are maternally supplied. During
embryogenesis only the 1.9 Kb transcript was detected and was found to be present
during gastrulation, neurulation, and somitogenesis (6-24 hours) (Fig. 8A). The
transcript level increases significantly during this period and remains high through 48
hours but then decreases by 96 hours. The timing of nar expression during
embryogenesis is consistent with a role in the formation of the pharyngeal skeleton,
which normally takes place during days 2 and 3 of development (14).
MQELIATVDHIKFDLEIAVEQQLGAQPLPFPGMDKSGAAVCEYFMRAA--CMKGGMCPFRHISGEKTVVCKHWLRGLCKK zebrafish
MQEIIASVDHIKFDLEIAVEQQLGAQPLPFPGMDKSGAAVCEFFLKAA--CGKGGMCPFRHISGEKTVVCKHWLRGLCKK human
MDILLANVSGLQFKAERDLIEQVGAIPLPFYGMDKSIAAVCNFITRNGQECDKGSACPFRHIRGDRTIVCKHWLRGLCKK Drosophila
GDQCEFLHEYDMTKMPECYFYSKFGECSNKECPFLHIDPESKIKDCPWYDRGFCKHGPDCRHRHTRRVICVNYLVGFCPE zebrafish
GDQCEFLHEYDMTKMPECYFYSKFGECSNKECPFLHIDPESKIKDCPWYDRGFCKHGPLCRHRHTRRVICVNYLVGFCPE human
GDQCEFLHEYDMTKMPECYFYSRFNACHNKECPFLHIDPQSKVKDCPWYKRGFCRHGPHCRHQHLRRVLCMDYLAGFCPE Drosophila
159 GKSCKFMHPRFELP----MGATE-QPPLPQ-------QVQTQQKQQNMQPINRSS-QSLIQLTNPNISNNNHQRIPNAV
159 GPSCKFMHPRFELP ---- MGTTE-QPPLPQ-------QTQPPAKQSNNPPLQRSS- - SLIQLTSQN -SSPNQQRTPQVI
161 APSCKHMHPHFELPPLAELGKDQLHKKLPTCHYCGELGHKANSCKQYVGSLEHRNNINAMDHSGGHSGGYSGHSGHIEGA
225 GIVHSNSHMGGA-----RGPRPLDQVTCYKCGEKGHYANKCTKGHLAFLSGQ
223 GVMQSQNSSAGN-----RGPRPLEQVTCYKCGEKGHYANRCTKGHLAFLSGQ
241 DDMQSNHHSQPHGPGFVKVPTPLEEITCYKCGNKGHYANKCPKGHLAFLSNQHSHK
zebrafish
human
Drosophila
zebrafish
human
Drosophila
Figure 5. Alignment of the putative zebrafish and human Nar proteins with the Drosophila
homologue Clp. The amino acid identity (shaded) and the zinc-finger motifs (underlined) are
shown. The fish and human proteins are 86% identical, while the fish and fly proteins are
roughly 50% identical. This alignment was obtained using the Lasergene software (DNAStar,
Inc.).
Figure 6. Northern blot analysis of nar expression during embryogenesis and in adult
fish. Comparable amounts of total RNA are present as judged by the amounts of 18S
rRNA present (not shown). UE, unfertilized egg.
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Summary
Our pilot insertional mutagenesis screen in zebrafish using a retroviral vector has
identified three insertional mutants. In two cases we have found that the proviruses
have inserted into and disrupted highly-conserved genes essential for zebrafish
embryogenesis. One of these genes encodes a zinc-finger endoribonuclease whose
expression is temporally regulated during development and is essential for normal
pharyngeal arch development. The other shall be described in more detail in Chapter
5.
Using this methodology on a larger scale, it should now be possible to isolate
hundreds of insertional mutants in zebrafish and to easily clone the mutated genes.
The use of alternative strategies, such as the screening of haploids or gynogenotes
(16), or the development of a retroviral gene trap (17, 18) for use in zebrafish, could
make the isolation of thousands of insertional mutants possible (see Chapter 6 for
further discussion).
Materials and Methods
Southern and Northern blots: Genomic DNA was isolated after lysis at 550C in 100
mM Tris (8.0), 5 mM EDTA, 200 mM NaCI, 0.4% SDS, and 100 mg/ml Proteinase K.
Total RNA was prepared using the RNAzol B method (Tel-Test, Friendswood, Texas).
All gels were transferred to Hybond N+ membranes (Amersham), and filters were
hybridized and washed as previously described (6).
Reverse transcriptase PCR: First strand cDNA synthesis was performed at 420C for 1
hr using 1 mg of total RNA. PCR was performed in 67 mM Tris (8.8), 16.6 mM
(NH4)2SO4, 10 mM BME, 170 mg/ml BSA, 2 mM MgCI2, with 0.2 mM of each dNTP,
and 0.4 mM of each primer. The PCR program used was as follows: 30 cycles of 15
seconds at 940C, 30 seconds at 550C, and 45 seconds at 720oC with an initial 2
minute denaturation step and a final 5 minute elongation step.
Alcian blue staining: Embryos were fixed in 4% paraformaldehyde for 2 hours at room
temperature, and then stained overnight with 0.1% alcian blue in 80% ethanol/10%
glacial acetic acid. Embryos were rehydrated into PBS, treated for 1-2 hours in a 1%
trypsin solution saturated with sodium borate, and were bleached in 1% KOH (w/v),
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3% H20 2, and 100 mM NaCI. Stained embryos were then washed with PBS and
cleared with glycerol.
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PREFACE TO CHAPTERS 5 AND 6
The most important fact to emerge from the pilot screen was probably the
mutagenic frequency: that using this retroviral vector, about one in seventy insertions
would cause a recessive embryonic lethal mutation. However, perhaps equally
important was what I learned about using this reagent to conduct a screen, and how it
could be done more efficiently. I was still responsible for organizing the ongoing
screen as we continued past the initial pilot, and began to implement some of these
changes. In analyzing the F1 pools from many founders, I concluded that most
insertions were present in only one or two percent of the Fls. Thus even when we
raised about 200 progeny from a founder, fewer than half of the insertions could be
inbred between F1 fish because too few fish inherited any given insertion. In order to
screen the rest of the insertions, one fish from each insertion had to be outcrossed to
form an F2 generation; half of these fish would contain the insertion, so small families
could be raised, and the transgenic fish could be identified and crossed. From
organizing the pilot screen, I realized the inefficiency in time and space (i.e. number of
fish tanks) of trying to inbreed Fls, when in fact most of the time we had to bring
insertions to the F2 generation anyhow. I reorganized the screen in a streamlined,
space-efficient manner whereby fewer Fls were raised, and one fish per insertion was
kept and outcrossed to raise an F2 family. By this methodology, we were able to
screen the next few hundred mutations much faster than the first two hundred; this
resulted in the identification of dead eye and the three other insertional mutants
mentioned at the end of Chapter 5.
I also learned from our experience in cloning the first two genes. In both cases,
small pieces of DNA adjacent to the insertion were cloned by inverse PCR, which is
quite quick, and then larger pieces were isolated from phage libraries, which takes
much longer. Putative exons were located in these longer pieces by homology to
sequences in the public database; these exons could then be used as anchors for
RACE (rapid amplification of cDNA ends) or probing a cDNA library. In both cases, an
exon with homology to a gene in the database was found within one kilobase. I
reasoned that for subsequent mutants it would probably be easier to clone a few
kilobases of sequence by inverse PCR, sequence this, and look for database
homologies, rather than to routinely turn to phage library screening. Then we would
only need to turn to larger pieces, which take longer to clone and much longer to
sequence, when the first strategy failed. In fact, when the next mutant, dead eye, was
found, I was able to clone the disrupted gene in only three weeks. The next mutant
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found, not really finished, was approached by another lab member in a different way,
and took much longer to clone; in retrospect it (as well as the first two) would have
been cloned much more rapidly had they relied exclusively upon inverse PCR and
homology searching - which is how it ultimately was cloned. As explained in Chapter
6, I don't think that this method will be able to clone all of the genes mutated by
retroviral insertions, but it provides a good starting point for a streamlined plan to clone
the genes as quickly as we can mutate them.
After cloning dead eye, I began to think very seriously about how to do a very
large scale insertional mutagenesis screen. The methodology that I had laid out for
the extension of the pilot seemed faster than the initial pilot, but still was not efficient
enough. Turning back to the F1 transgenesis data that I had accumulated, I tried to
ascertain whether it would be feasible to do the screen a whole different way, utilizing
the F1 fish with multiple insertions instead of those with single insertions. The details
of this strategy are laid out in Chapter 6, along with the pros and cons of such an
approach. I have begun to work out some of the protocols and develop some of the
reagents necessary to conduct the screen on this scale. While continuing to pursue
possible improvements in the technology that will make the screen even more efficient
(as also discussed in Chapter 6), I am beginning to bring this "current technology" plan
to fruition.
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CHAPTER 5
INSERTIONAL MUTAGENESIS IN ZEBRAFISH IDENTIFIES TWO NOVEL GENES,
pescadillo AND dead eye, ESSENTIAL FOR EMBRYONIC DEVELOPMENT
(A major part of this chapter was published as: Allende, M.L., Amsterdam, A., Becker,
T., Kawakami, K., Gaiano, N., and Hopkins, N. (1996) Genes Dev. 10:3141-3155.
This paper had a shared first authorship (Allende and Amsterdam). In situ
hybridization data on dead eye (Figure 5) and information summarizing subsequently
isolated insertional mutants (Figure 11 and Table 1) has been added.)
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Abstract
Recently our laboratory described an efficient method for generating retroviral
provirus insertions in the zebrafish germ-line and we showed that provirus insertions
induce embryonic mutations at a frequency of roughly 1 mutant per 70 insertions. To
date we have isolated four insertional mutants, and using the proviruses as a
molecular tag, have cloned the genes disrupted in three of them. The proviruses in all
three mutants lie within or just 5' of the first coding exon, point in the opposite
transcriptional orientation from the gene, and disrupt transcription. Here we present a
molecular characterization of two genes identified by this method and describe the
associated mutant phenotypes. The pescadillo (pes) gene is predicted to encode a
protein of 582 amino acids with no recognizable functional motifs, which is highly
conserved from yeast to humans. pes mRNA is expressed widely and dynamically
during the first three days of embryogenesis. Prominent sites of expression are the
eyes and optic tectum on day 1, the fin buds, liver primordium and gut on day 2, and
the branchial arches on day 3. Beginning at day 3 of embryogenesis, pes mutant
embryos exhibit small eyes, a reduced brain and visceral skeleton, shortened fins, and
a lack of expansion of the liver and gut, and then die on the sixth day of development.
The dead eye (dye) gene encodes a protein of 820 amino acids which is homologous
to genes of unknown function in human, mouse, and Xenopus, and which has weak
homology with the yeast NIC96 (Nucleoporin Interacting Component) gene. dye
mutants can be recognized on day 2 of embryogenesis by the presence of dying cells
in the tectum and eyes. dye mutants die on day 5 of development. These results
demonstrate the power of insertional mutagenesis in zebrafish for rapidly finding and
characterizing novel genes essential for embryonic development. Using our current
methodology, we estimate that our lab could screen about 25,000 insertions in 2-3
years, identifying perhaps 250-300 embryonic lethal genes. Assuming that all genes
are accessible to proviral insertion, the wider application of this approach could lead to
the rapid identification of the majority of genes that are required for embryonic
development of this vertebrate.
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Introduction
The zebrafish is a superb model organism for identifying genes essential in
vertebrate development (1-4). The ability to breed and maintain large numbers of
adult animals in the laboratory makes classical genetics feasible, while the optical
transparency of the zebrafish embryo makes it ideal for visualizing early
developmental processes. This year two labs completed systematic large-scale
mutant screens for embryonic lethal and visible mutations in the zebrafish (5-8). Using
ethyl nitrosourea (ENU) as the mutagen, the labs of NOisslein-Volhard and Driever
recovered several thousand chemically-induced point mutations which affect diverse
aspects of early development in the zebrafish. About 70% of the mutants were
considered to be nonspecific, while about 30% are associated with more specific,
usually lethal, defects in patterning and morphogenesis. The latter include mutations
affecting gastrulation, pattern formation, organogenesis, structural organization of the
CNS, and basic behaviors. Altogether about 350 genes with relatively specific
developmental defects have been identified by complementation tests based on
phenotypes encountered in these screens. It is estimated, although very roughly, that
there are about 2,400 genes with essential or visible functions in the fish embryo and
that about half were identified in the chemical mutagenesis screens (8).
Despite the wealth of new genetic information emerging from chemical
mutagenesis screens in the zebrafish, knowledge about the molecular nature of the
affected genes and their products will not be immediately forthcoming. Cloning the
mutated genes will depend upon the development of reagents for positional cloning in
the zebrafish. For now this technology remains laborious and expensive due to the
large size (approximately 1.6x10 9bp) of the zebrafish genome.
As an alternative to chemical mutagenesis, we recently developed a method for
generating insertional mutants in zebrafish utilizing integration of retroviral proviruses
into the genome (9-11, Chapters 3 and 4). Although the frequency of mutagenesis is
considerably lower than that of chemical mutagenesis, the molecular tag provided by
the inserted retroviral provirus allows the immediate isolation of flanking genomic
fragments, which are likely to include the disrupted gene. Of the four zebrafish
insertional mutants isolated thus far, we quickly cloned genes disrupted in three of
them. We believe these disrupted genes are likely to be responsible for the
phenotypes of the respective mutants. Cloning was extremely rapid because in all
three cases the provirus that is genetically linked to the mutant phenotype integrated
close to coding sequences of the gene it disrupted, because so many gene sequences
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are now available in the database, and because the disrupted genes are highly
conserved evolutionarily (11, and this work).
Here we describe the molecular characterization of the genes mutated in two
insertional mutants, pescadillo (pes) and dead eye (dye), and present a preliminary
characterization of the mutant phenotypes. The pes gene encodes a novel protein of
unknown function that is very highly conserved across species: homologous
sequences are present in human, mouse, C. elegans and yeast. The dye gene
encodes a protein homologous to predicted proteins identified in human, mouse, and
Xenopus (12, 13). Vertebrate dye proteins share limited similarity with the product of a
yeast gene, NIC96 (Nucleoporin-Interacting Component of 96 kDa), which has been
shown to be essential for viability (14).
These results provide strong support for the prediction that genetic analysis in
zebrafish will identify many novel genes essential for vertebrate development. If the
retroviral mutagen we have used integrates at random into the fish genome, given the
efficiency of mutagenesis we have observed to date, it should be possible for a
number of fish labs together to identify and clone the majority of the genes essential for
the early development of this vertebrate species within a few years.
Results
In an ongoing insertional mutagenesis screen, visible or lethal phenotypes were
sought among the progeny of crosses between pairs of F2 fish heterozygous for a
single identical proviral insertion (11, Chapter 4). We screened by observing at least
25 live embryos under a dissecting microscope on days one, two, and five post-
fertilization, and scored for consistent abnormalities visible in 25% of the embryos as
described by Haffter et al. (8). Four recessive lethal mutations tightly linked to proviral
insertions have been identified. The nar mutation and gene are described elsewhere
(11, Chapter 4). The 80A mutation has not been studied further since a disrupted
gene has not yet been identified for this mutant. Here we describe the genes and
phenotypes associated with proviral insertions 67D and 404 which have been named
pescadillo (allele designation peshi2, referred to hereafter as pes) and dead eye
(allele designation dyehi4 , referred to hereafter as dye), respectively.
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Evidence that dye is an insertional mutant and preliminary characterization of the
mutant phenotype.
The dye mutation was recovered from a cross between two F2 fish heterozygous
for a single proviral insertion designated 404 (Fig. 1). Defects are first apparent in
embryos at day 2 of development when mutant embryos display extensive cell death
in the tectum and the eyes. By day 5, most of the anterior head structures are reduced,
including the eyes and the forebrain. Most, if not all, of the pharyngeal skeleton is
absent, and the tectum and cerebellum are barely discernible. The embryos display
edema and fail to develop a swim bladder, characteristics present in most embryonic
lethal mutations in fish.
Because our zebrafish are not inbred and background mutations are present, I
first sought evidence of whether the dye mutation was caused by proviral insertion.
PCR analysis showed that in crosses of fish heterozygous for the 404 provirus
insertion, all mutant embryos were transgenic, a result consistent with linkage of the
insertion to the mutation. To determine if the provirus and mutant phenotype are tightly
linked, I tested whether mutant embryos are invariably homozygous for the insertion-
bearing chromosome. Using inverse PCR I cloned a fragment of fish DNA adjacent to
the provirus and identified a single-copy probe from this fragment. This probe yielded
bands on a Southern blot that were diagnostic for either the transgenic chromosome
or for its nontransgenic homologue. I used this probe on a Southern blot of DNA
samples isolated from 57 mutant embryos and 110 phenotypically wild-type siblings
(data not shown). All the mutant embryos were homozygous for the chromosome
carrying the 404 insertion, while wild-type embryos were either heterozygous or were
homozygous for the chromosome lacking the insertion. This result indicates that the
insertion is tightly linked to the mutation and suggests that the insertion caused the
mutation.
To obtain a preliminary characterization of the dye mutant phenotype, we
prepared sections of mutant and wild-type embryos at day 5 post-fertilization (Fig. 2).
By this stage, dye/dye embryos show severe defects in the structure of the brain and
cranial skeleton (Fig. 2B and 2D). Although the major brain subdivisions (fore-, mid-,
and hindbrain) can be recognized in the mutant (Fig. 2B and 2D), they are
substantially reduced in size compared to the same structures in the wild-type (Fig.
2A). There is also a near complete absence of the pharyngeal skeleton, and only the
posterior neurocranium is evident.
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Figure 1. Wild-type (top) and dead eye (bottom) zebrafish embryos at 72 hours post-
fertilization. dye mutants are recognized by the small head structures and protruding
eyes. Bar= 100pm.
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Figure 2. Sagittal sections of five day old wild-type (A), dead eye (B, D) and pescadillo
(C) mutant embryos. Anterior is to the left and dorsal is up. The plane of section is
medial in A, B and C, and medio lateral (to include the eye) in D. dye mutant embryos
lack most structures in the ventral head such as elements of the visceral skeleton
(indicated by an asterisk, black arrowhead and arrows in A, compare to B). At this
stage, the forebrain (f) and tectum of the midbrain (t) are grossly reduced; the
hindbrain (hb), albeit smaller, appears less affected. Cartilage can be seen underlying
the caudal brain in the dye mutant but anteriorly it is short and fragmented when
compared to wild-type (A vs. B, white arrowhead). The trabeculae, normally
connecting the ethmoid plate and the posterior neurocranium, jut into the eyes (e, in
D), which are recessed medio-caudally in dye mutants (D). In pes mutant animals, the
brain, particularly the tectum (t), are smaller than in wild-type, the neurocranium is
shorter and thicker, and the posterior pharyngeal arches (arrows) lack differentiated
cartilage (A vs. C). At the position of the five branchial arches however (arrows in C),
mesenchymal tissue is organized into segmental bundles. The liver (li) is very
reduced and the yolk (y) has not been consumed. e, eye; f, forebrain; h, heart; hb,
hindbrain; Ii, liver; t, tectum (dorsal midbrain); y, yolk; asterisk, Meckel's cartilage (first
arch, P1); black arrowhead, hyoid (second arch, P2); black arrows, branchial arches
(P3 through P7); white arrowhead, anterior neurocranium. Bar=100pm.
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Low power microscopic analysis revealed cell death in the eyes and brain of
dye/dye mutant embryos relative to wild-type beginning at approximately 48 hours
(Fig. 3B vs. 3A). To determine whether apoptotic cells are present in dye embryos, 2-
day old wild-type and mutant embryos were injected with acridine orange, a vital dye
diagnostic for apoptotic cell death (15, 16). This analysis revealed extensive staining
in the brain and neural tube of dye/dye mutant embryos relative to their wild-type
siblings (Fig. 3D vs. 3C, respectively). Sections of two day old embryos revealed the
presence of dead cells by this stage in the midbrain, cerebellum, hindbrain and eyes
of dye mutant embryos relative to wild-type (Fig. 3F vs. 3E, respectively).
Isolation of the dye gene and demonstration that its expression is disrupted in mutants.
If insertion 404 is responsible for the dye mutation, a prediction is that it lies in or
near, and disrupts the expression of, a gene expressed during embryonic
development. I cloned sequences adjacent to the 404 insertion and sequenced 1.4 kb
on the 3' and 2.1 kb on the 5' side of the provirus. This 3.5 kb of sequence was used
to search the Genbank database using the BLAST algorithm (17). This search
identified a region of 180 nucleotides whose predicted translation product was highly
homologous to the first 60 amino acids of proteins encoded by genes from human,
mouse and Xenopus. This sequence begins 450 bp to the 5' side of the provirus, such
that the transcription units of the provirus and the putative gene are divergent (Fig. 4A).
The human gene was cloned from the myeloid cell line KG1 and designated
KIAA0095 (12; Genbank accession number D42085). The Xenopus gene, which is
84% identical to the human gene, was identified by differential display PCR and
designated An4a (13); Genbank accession number U63919). In addition, translations
of Expressed Sequence Tags (ESTs) from both human and mouse were highly
homologous to these sixty amino acids. Both the human and Xenopus genes share
large regions of homology with the S. cerevisiae NIC96 gene, whose product is part of
the nuclear pore complex (14, 18); however, the BLAST search with the fish genomic
sequence did not identify the NIC96 gene as there is no homology between the yeast
and vertebrate genes in the first 60 amino acids.
Two nested oligonucleotides corresponding to sequences within the putative
zebrafish protein coding region were used to perform 3' RACE from 48 hr embryonic
RNA (see Methods, Fig. 4A), resulting in the isolation of a 2.4 kb cDNA fragment,
approximately the size expected based upon the human and Xenopus genes. This
product was subcloned and both strands were sequenced. Additionally, RT-PCR was
performed between a downstream primer matching sequences within the 3' RACE
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Figure 3. Cell death in dye mutants. A, B. Two day old wild-type (wt, A) and dye mutant
(dye, B) embryos are shown. Cell death is evident in mutants but it appears restricted
to the tectum (delimited by arrowheads) and eyes (arrows). C, D. Acridine orange was
injected into the yolk sac of day 2 sibling wild-type (C) and dye mutant (D) embryos,
which were visualized under fluorescence illumination to reveal apoptotic cells. Note
the heavily labeled neural tube in the mutant compared to the wild-type (white
arrowheads). Background fluorescence occurs in the yolk (where the reagent was
injected) and in melanocytes which causes the eyes of wild-type embryos to appear
labeled. E, F. Sagittal sections through the head of day 2 wild type (E) and dye mutant
(F) embryos. Note the widespread cell death in the tectum (black arrows), hindbrain
(white arrows) and eyes (white arrowheads) of mutant embryos in F. Anterior is to the
left and dorsal is up. ot, otic vesicles. Bar A to D=100pm; E, F=20m.
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product and an upstream primer corresponding to the genomic sequence, which
produced a fragment of the expected size (450 bp, Fig. 5). This fragment was also
sequenced confirming that the RNA which produced the 3' RACE product includes the
genomic sequences identified adjacent to the proviral insertion. Since both the 3'
RACE and RT-PCR products were generated from 48 hr RNA, the dye gene must be
transcribed by this time, when the phenotype is first apparent in the mutant.
5' RACE was also performed in order to identify the 5' end of the gene. Only 18
nucleotides preceding the putative ATG in the resulting 5' RACE product were found to
be colinear with the genomic sequence. However, the entire sequence preceding this
(78 bp) was found to lie on the other side of the proviral insertion (see Fig. 4A). There
are stop codons in all three reading frames in the 96 bp preceding the putative ATG,
further suggesting that this is the translation initiation codon. Thus the 404 proviral
insertion integrated into the first intron of the dye gene, whose first exon is exclusively
5'-UTR.
The RT-PCR and 3' RACE sequences were compiled and translated. The
predicted amino acid sequence is shown in Fig. 4B, along with the predicted amino
acid sequence of the human and Xenopus homologs. The zebrafish gene is 83%
identical to the human gene (with one gap) and 79% identical to the Xenopus gene
over its entire length. Additionally, when the full length predicted protein sequence of
dye was used in a database search, significant but limited homology was found to the
yeast NIC96 gene product, as was found previously with the other vertebrate dye
homologs (12; data not shown). In the frog, there are two related An4 genes, An4a
and An4b (13); the latter is shorter at both the 5' and 3' ends, and encodes a much
shorter protein as it does not code for the first 226 amino acids of An4a, and due to a
frameshift relative to An4a is divergent after amino acid 481, terminating at amino acid
499. Both Southern analysis of zebrafish genomic DNA cut with several restriction
enzymes and Northern analysis of embryonic RNA show only a single band when
hybridized with a probe including the first coding exon of the dye gene, indicating that
there is likely only one copy of this gene in zebrafish (data not shown).
To determine whether the 404 proviral insertion affects expression of the dye
gene, I performed RT-PCR on RNA extracted from 3 day old phenotypically wild-type
or mutant embryos obtained from a cross of two fish heterozygous for this insertion. As
shown in Fig. 5A, a dye-specific RT-PCR product is detected when RNA from
phenotypically wild-type embryos is used as a template, whereas no band can be
detected when RNA isolated from phenotypically mutant embryos was used. This
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Figure 4. Proviral insertion 404 lies adjacent to the dye gene. A. 3.5 kb of sequence
flanking proviral insertion 404 was cloned by inverse PCR (see Methods). The region
of homology to the human KIAA0095 and Xenopus An4a genes is shaded. As there
are no in frame ATG codons preceding the methionine which begins the block of
homology, it is assumed that sequence upstream of this (white boxes) is untranslated.
The provirus has inserted in the first intron, 307 bp downstream of the splice donor and
438 bp upstream of the splice acceptor, and its transcription runs in the opposite
direction to that of the open reading frame. The position of the putative ATG and of
primers 404-2 and 404-3, used in 3' RACE, is indicated.
B. The predicted amino acid sequence of the dye gene was compared to that of the
human and frog genes using the Lasergene alignment tool. Amino acids identical
between any two or all three of the genes are shaded. There is a one amino acid gap
at position 215 in the human gene. Amino acid identity between the fish and human
genes is 83%, between the fish and Xenopus 79% and between the human and
Xenopus 84%. Amino acids 1-60 of the dye gene were obtained from the genomic
sequence originally found to lie adjacent to the proviral insertion, amino acids 49-820
were deduced from the 3' RACE product. Four independent RT-PCR reactions were
carried out between primers 404-2 and 404-8 or 404-9 (see Methods) and the product
from each was subcloned and sequenced to confirm the continuity of the expressed
sequence. All four RT-PCR isolates contained two base pair changes relative to the 3'
RACE product. Amino acids 111 and 114 reflect the sequence contained in these RT-
PCR products. The zebrafish dye cDNA sequence has been deposited in the
Genbank database (accession number U77595).
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404-2 404-3
dyedye 390bp 430bp
83bp bp 180bp
ATG >
B.
1 MDTEGFGELLQQEQLAAETEASELPHERNLQEIQQAGERLRSRTLTRTSQDTADVKASILLGSRLDIFHISQRLESLSAATTFEPLEPVKDTDIQGFLKNERDNALLSAIEESRRR fish
1 MDTEGFGELLQQAEQLAAETEGISELPVERNLQEIQQAGERLRSRTLTRTSQETADVKASVLLGSRGLDISHISQRLESLSAATTFEPLEPVKTDIQGFLKNEKDNALLSAIEESRKR human
1 MDGEGFGELLQAEQLAAETEGVTELPERNLQEIQQAGCRLRSKTMTRTSQESANVKASCTAGSRGLDISHISQRLESLSAATTFEPLEPVKDTDIQGFHKNEKDNALLSAIEESRKR frog
121 TFLLAEEYHRDSMLVQEQVKQRVLHTLLGAGEDALDFSQEVEPSFVSEVGVPGRSALDSVEVAYSRQIYVFNEKIVNGHLQPNLGDLCASVAESLDDKNVSEMNLKQMTDVLLVPAK fish
121 TFGMEEYHRESMLVEWEQVKQRILHTLLASGEDALDFTQESEPSYISDVGPPGRSSLDNIEMAYARQIYIYNEKIVNGHLQPNLVDLCASVAE-LDDKSISDMTTWKQMTDVLLTPAT human
121 TFVEEYHRESMLVEWEQVKQRVLHTLASGEDALDFTQESETSYISESGAPGRSSLDNVEMAYARQMYMYNEKVVSGHLQPSLDLCTEAAERLDDKNVSDL KQMTDVPLIPAS frog
241 DTLKSRVSVDTQVAFVRQALQFLENSYKNYTLVTVFGNLHQAQLGGVPGTYQLVCSFLNIKLPTPLPGMQDGEVEGHPVWAL IYFCLRCGDLSAAMVVNKAQHQLGDFKIWFQEYMNSP fish
240 DALKNRSSVEVRMEFVRQALAYLEQSYKNYTLVTVFGNLHQAQLGGVPGTYQLVRSFLNIKLPAPLPGLQDGEVEGHPVWALIYYCRCGDLLAAnSVVNRAQHQLGEFKTWFQEYMNSK human
241 DTLKSRCSGQMQFVRQALYLEQYKNYTLISVFANLQAQLGGVPGTYNLVRSFLNRLTTVPGLQDGEIEGYPVWALICMRCGDLMAAQQVVNRAQHQLGDFKNCFQEYIHNK frog
361 DRRLSPATENKLRLHYRRVLRNSAGPYKRAYCLIGKCDIGDNHGEADKTEDYLWLKLNVCFDEDGSSSPQDRMTLAQLKQLLEDYGESHFSASHQPFLYFQVLFLTAQFEAAIAFL fish
360 DRLSPATENKLRLHYRRALRNNTDPYKRAVYCIGRCDVTDNQSEVADKTEDYLLKLNQVCFDDDGT RLTLSQFQKQLLEDYGESHFTVNQQPFLYFQLFLTAQFEAAAFL human
361 DRRLSPTTENKLRLHYRRARATDPYKRAVYIIGRCDVSDNNSEVADKTEDYLWLKLSQCFEDEANSSPEDRLTLPQFQKQLFEDYGESHFAVNQQPYLYFVLFLTAQFEAAIAFL frog
481 FRVERLRSHAVHVALVLYELKLLLKSSGQSAQLLSQEAGDPPMVRRLNFIRLLMLYTRKFESTDPREALQYFYFLRNEKDSQGENMFMRCVSELVIESREFDMLLGRLEKDGSRKPGVID fish
480 FRMERLRCHAVHVALVLFELKLLLKSSGQSAQLLSHEPGDPCLRRLNFVRLLMLYTRKFESTDREALQYFYFLRDEKDSQGENMFLRCVSELVIESREFDMILGKLENDGSRKPGVID human
481 FRLERTRCHAVHVALALFELKLLLKSTGQSAQLLSQEPGEPQGVRRLNFIRLLMLYTRKFEPTDPREALQYFYFLRNEKDNQGESMFLRCVSELVIESREFDMLLGKLEKDGSRKPGAID frog
601 KFAGDTRAIITKVASEAENKGLFEEAVKLYELAKNADKVLELMNKLLSPVIAQVSEPQSNKERLKNMAVAIAERYRANGVAGfEKSVDNTFYLLLDLMTFFDEYHAGHIDRAYDVIERLKL fsh
600 KFTSDTKPIINKVASAENKGLFEEAAKLYDLAKNADKLELMNKLLSPVVPQISAPQSNKERLKNMLSIAERYRAQGISAKFVDSTFYLLLDLITFFDEYHSGHIDRAFDIIERLKL human
601 KFTRDTKTIINKVASVAENKGLFEEAAKLYDLAKNPDKVLELTNKLLSPVVSQISAPQSNRERLKNMALAIAERYKSQGVSAEKSITFYLLLDLITFFDEYHAGHIDLSFDVIERLKL frog
721 VPLSQDSVGERVAAFRNFSDEVRHNLSELLATMNILFTQYKRLKGAAAGTPGRRRTLEDRDMLLRQARALITFAGMIPYRMAGDTNARLVQMEVLMN fish
720 VPLNQESVEERVAAFRNFSDEIRHNLSEVLLATMNILFTQFKRLKGTSPSSSSRPQRVIEDRDSQLRSQARTLITFAGMIPYRTSGDTNARLVQMEVLMN human
721 VPLSQDSVEERVAAFRNFSDEIRHNLSEILLATMNILFTQYKRLKGSGPTTLGRPQRVQEDKDSVLRSQARALITFAGMIPYMGDTNARLVWEVLMN frog
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indicates that expression of the dye gene is abolished or is decreased beyond the
level of detection by proviral insertion 404.
I also used in situ hybridization to demonstrate that dye expression is disrupted
by the 404 proviral insertion. Digoxigen-labeled RNA probes corresponding to either
the sense-strand or anti-sense strand of the dye 3' RACE product were hybridized to
embryos obtained from either from crosses of wild type fish or crosses between two
fish heterozygous for the insertion at 22 hr post-fertilization. No staining was observed
when the sense probe was used (data not shown). When the anti-sense probe was
used, all of the embryos (126/126 in three experiments) from the wild type cross
displayed very strong staining in the eye, tectum, tegmentum, and hindbrain (Fig. 5B).
When the same probe was hybridized to embryos from the heterozygote cross, only
about one quarter of the embryos showed this strong staining (25/93 in two
experiments). About one half (49/93 in two experiments) showed weaker staining in
the same tissues (Fig. 5C), while nearly one quarter (19/93 in two experiments)
showed no staining at all (Fig. 5D). Presumably these classes represent non-
transgenic, heterozygous, and homozygous embryos, respectively, which would be
expected in a 1:2:1 ratio as observed.
Interestingly, dye expression is restricted to the tissues in which the dye
phenotype is first observed: the eye, midbrain, and hindbrain, where extensive cell
death is observed in dyeldye embryos. This expression pattern is very similar to that
seen for the Xenopus homolog, An4a (13). An4a and An4b were originally identified
in a differential display PCR screen to find localized RNAs in Xenopus oocytes; the
"An" designation indicates that this cDNA was found to be enriched in the animal half
of the oocyte. While An4a and An4b transcripts are maternally supplied, zygotic
expression is limited to the eye and central nervous system during neurulation. In
zebrafish, dye RNA is also maternally supplied (data not shown), and, like An4a,
zygotic expression is restricted to the developing central nervous system. Thus dye
appears to be conserved both in sequence and expression pattern between
amphibians and fish. As dye RNA is normally expressed in the eye and central
nervous system, while this RNA is absent in dye mutant embryos in which many cells
in these same tissues undergo apoptosis , the dye gene product is required in these
cells for their survival.
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Figure 5. Proviral insertion 404 disrupts transcription of the dye gene. A) RT-PCR.
Embryos from a cross between fish heterozygous for insertion 404 were sorted by
phenotype on day 3, and RNA was prepared from pools of wild-type or mutant
embryos. RT-PCR was performed either with primers to detect the dye transcript
(lanes 2-5), or the pes transcript (lanes 6-9) as a positive control. Lanes 2, 3, 6 and 7
used wild-type RNA as template; lanes 4, 5, 8 and 9 used dye/dye RNA as template.
Wild-type embryos contain both dye and pes transcripts (lanes 2 and 6) while dye/dye
embryos express pes but not dye (lanes 8 and 4). Lanes 3, 5, 7 and 9 are the products
of reactions lacking reverse transcriptase. Both products span introns, and in both
cases the bands were isolated, subcloned, and sequenced to confirm that they truly
represent their respective genes. Lane 1, 123 bp ladder. B-D) In situ hybridization.
Embryos from a cross between fish heterozygous for insertion 404 were hybridized to
an antisense-strand RNA probe at 22 hr postfertilization. Embryos shown represent
the three classes of staining, which were present in a 1:2:1 ratio - strong (B), weak (C),
or none (D)
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The pes gene encodes a highly conserved novel protein.
The pescadillo mutation was introduced in Chapter 4, where its phenotype was
described (Chapter 4, Figure 1) and evidence was presented to demonstrate that the
proviral insertion designated 67D is genetically linked to, and presumably causes, the
mutation (Chapter 4, text and Figure 3). This insertion lies within the first coding exon
of a gene which was discovered because of high homology between genomic
sequences flanking the 67D insertion and a human Expressed Sequence Tag (EST)
(Genbank accession number R13806). The regions of homology were presumed to be
exon sequences and were used to design primers for RT-PCR. Analysis of the
amplified RT-PCR products confirmed the predicted intron-exon structure in the region
and showed that the provirus lies 80 base pairs upstream of the putative methionine
initiation codon (11, Chapter 4; data not shown).
To learn more about the pes gene and its encoded protein, we screened a
zebrafish cDNA library prepared from day 3 embryonic mRNA (kind gift of Dr. Kai Zinn)
using a 300 bp cDNA fragment amplified by RT-PCR as a probe. Two clones with
cDNA inserts of apparently equal size were obtained and one was sequenced. This
clone includes a 2214 base pair insert. A putative protein coding region was identified
in this sequence based on homology with the human EST sequence. This coding
region corresponds to the longest ORF found and encodes a protein of 582 amino
acids (Fig. 6). The region surrounding the presumed methionine ATG initiation codon
conforms to the consensus translation start site (19) and is preceded by an in-frame
stop codon located 21 nucleotides upstream. The 5' and 3' untranslated regions are
99 and 368 bp, respectively. The entire cDNA sequence upstream of the proviral
insertion point is contiguous with the genomic DNA, suggesting that the insertion is
within the first exon. It cannot be ruled out, however, that the cDNAs obtained are
incomplete and that there are additional exons further upstream. No poly(A) sequence
was found at the 3' terminus of this cDNA.
Three human cDNA clones containing the EST identified by computer search
were obtained from ATCC and the longest was sequenced in its entirety. Comparison
of the putative proteins encoded by the human and zebrafish transcripts show 74%
identity (Fig. 6).
Further database searches using the predicted pes amino acid sequence were
carried out against the translated Genbank database (TBLASTN) (17). Significantly
homologous sequences were identified in cosmid clones of genomic DNA isolated in
the C. elegans and yeast genome projects (Genbank accession number D75131 and
yeast ORF name YGR103W, respectively), and in mouse EST sequences (Genbank
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Figure 6. Zebrafish pes predicted protein sequence and amino acid alignment with
pes homologs. The amino acid sequence of the predicted zebrafish pes protein is
shown aligned with the human and yeast homologs as compiled by the Lasergene
alignment tool. Shaded regions correspond to identities among the sequences.
Double underlined region corresponds to the BRCT domain (amino acids 327-415);
single underlined amino acids correspond to a highly acidic region conserved in pes
homologs (amino acids 450-544). The zebrafish and human cDNA sequences have
been deposited in the Genbank database (accession numbers U77627 and U78310,
respectively).
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1 MGGLQKKKYESGSATNYITRNKARKKLSLSLADFRRLCILKGIYPHEPKHKKKVNKGSTAARTYYLLKDIRFLLHEPIVGKFREYKIFVRKLRKAYGKAEWSAVERLKENKPGYKLDHII fish
1 MGGLEKKKYERGSATNYITRNKARKKLQLSLADFRRLCILKGIYPHEPKHKKKVNKGSTAARTFYLIKDIRFLLHEPIVNKFREYKVFVRK~LRAYGKSEWNTVERLKDNKPNYKLDHII humn
1 MR--IKKKNTRGNARNFITRSQAVRKLQVSLADFRRCIFKGIYPREPRNKKKANKGSTAPTTFYYAKDIQYLMHEPVLAKFREHKTFARKLTRALGRGEVSSAKRLEENRDSYTLDHI yeast
121 KERYPTFIDALRDVDDALSMCFLFSTFARTGKCHVQTIQLCRRLSVEWMNYIISSRSLRKVFLSIKGIYYQAEVLGQTITWIPYQFAHNHPTDVDYRVMATFTELYTTLLGFVNFRLYQ fish
121 KERYPTFIDALRDLDDALSMCFLFSTFPRTGKCHVQTIQLCRRLTVEFMHYIIAARALRKVFLSIKGIYYQAELGQPIVWITPYAFSHDHPTDVDYRVMATFTEFYTTLLGFVNFRLYQ hunan
119 KERYPSFPDAIRDIDDALNMLFLFSNLPSTNQVSSKIINDAQKICNQWLAYVAKERLVRKVFVSIKGVYYQANIKGEEVRWLPFKFPENIPSDVDFRIMLTFLEFYSTLLHFVLYKLYT yeast
241 TLNLVYPPKLDGQGEISLKAEFEEDYALES- -ESYTEKL----------------SALSASLARMVASVEEEEAELDHFPTEGEDQEKMEVREKMEQQQSKQKK ---------------- fish
241 LLNLHYPPKLEGQAQAEAKAG-EGTYALDS- -ESCMEKL----------------AALSASLARVVVPATEEEAEVDEFPTDGEMSAQEEDRRKELEAQEKHKK ---------------- huan
239 DSGLIYPPKLDLKKDKIISG--LSSYILESRQEDSLLKLDPTEIEEDVKVESLDASTLKSALNADEANTDETEKEEEQEKKQEKEQEKEQNEETELDTFEDNNKNKGDILIQPSKYDSPV yeast
327 -- LFEGLKFFLNREVPRESLAFVIRCFGGEVSWDKSLC-IGSTYEATDETITHHIVDRPSMDKQYINRYYIQPQWVYDSVNAKIQLPVEEYFLGVTLPPHLSPFVEETEGDYVPPEKLKL fish
326 --LFEGLKFFLNREVPREALAFIIRSFGGEVSWDKSLC-IGATYDVTDSRITHQIVDRPGQQTSVIGRCYVQPQWVFDSVNARLLLPVAEYFSGVQLPPHLSPFVTEKEGDYVPPEKLKL human
357 ASLFSAFVFYVSREVPIDILEFLILSCGGNVISEAAMDQIENKKDIDMSKVTHQIVDRPVLKNKVAGRTYIQPQWI FDCINKGELVPANKYLPGALPPHLSPWGDA--GYDPTA---- yeast
444 MALQRGEKP ---- QAEEDEEEEGEEEEDDEEDEEDDEQSEDEE---EAEEEANLAEMEEKRSQGKSLSVKVTPGKAKAENRARAAEEEKAEEKRLAIMMMKKKEKYLYDKIMFGKKRKVR fish
443 LALQRGEDPGNLNESEEEEEEDDNNEGDGDEEGENEEEEEDAEAGSEKEEEARLAALEEQRMEGK--KPRVMAGTLKLEDKQRLAQEEESEAKRLAIMMMKKREKYLYQKIMFGKRRKIR humn
471 -PVEEGEEEESESESESEDQVE-EEDQEVVAGEEDDDDDEELQAQKELELEAQGIKYSETSEADKDVN--------KSKNKKRKVDEEE-EEKKLKMIMMSNKQKKLYKKMKYSNAKKEE yeast
557 EANKLAAKRKAHDDASKADKKKKK - -- KC 582 fish
561 EANKLAEKRKAHDEAVRSEKKAKKARPE 588 human
580 QAENL--KKKKKQIAKQKAKLNKLDSKK 605 yeast
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accession number AA003101). Amino acid identity between the zebrafish pes protein
and the S. cerevisiae homologue is about 54% in the amino-terminal third of the
protein, 39 % overall (Fig. 6).
Analysis of the predicted pes protein sequence revealed the presence of a very
loosely defined motif known as the BRCT domain, comprising amino acids 327-415
(20, 21, S. Altschul and E. Koonin, pers. comm., double underline in Fig. 6). This motif
is shared by a number of genes involved in either control of the cell cycle or DNA
replication and repair, such as the breast cancer gene BRCA1, Rb, p53-binding
protein, and DNA ligases and polymerases from both eukaryotes and prokaryotes.
Additionally, a highly acidic region at the carboxy terminus of the protein is conserved
among the zebrafish, human and yeast genes (underlined in Fig. 6). Most of the pes
protein is predicted to have an alpha-helical structure as determined by analysis with
the Robson/Garnier secondary structure algorithm (M. Robinson, pers. comm.).
Expression of the pes gene is developmentally regulated.
If mutation of the pes gene is responsible for the mutant phenotype in pes/pes
embryos, gene expression would be expected to occur at or before the mutant
phenotype becomes visible at day 3 of embryogenesis. Thus, we analyzed the timing
and tissue distribution of expression of the pes gene during embryogenesis by
northern blot and in situ hybridization.
A 300 bp pes cDNA fragment was radioactively labeled and was hybridized to
RNA prepared from several embryonic stages and adult fish in a northern blot (Fig. 7).
Two transcripts, 2.2 and 1.9 kb, were detected, with the larger being more prevalent
during embryogenesis. Unfertilized eggs and gastrulating embryos (6 hours post-
fertilization) have low levels of the transcripts, while strong zygotic expression is seen
by 12 hours. Transcript levels decrease after about 24 hours. In adult fish, only females
have detectable pes RNA and dissection of the ovaries shows that it is restricted to this
organ (Fig. 7).
A 2 kb cDNA fragment of the pes gene was used to synthesize digoxigenin-
labeled RNA probes for whole mount in situ hybridization. Sense-strand-specific probe
did not produce signal at the stages examined. Using antisense-strand probe, pes
transcripts could not be detected in 3 or 6 hour embryos, but were detected beginning
at 12 hours in the eye and brain primordia (not shown). Between 18 hours and three
days of development, the expression of pes message is highly dynamic. At 18 to 24
hours, strong expression is detected in the eye, forebrain, tectum, and somites, while
lower levels of transcript are seen in the hindbrain and in cells flanking the hindbrain
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Figure 7. Northern analysis of pes expression. A pes cDNA fragment was hybridized
to total RNA isolated from the indicated embryonic stages and adult zebrafish by
northern analysis. The numbers shown correspond to hours post-fertilization; ue,
unfertilized egg RNA; ov, ovary. The last four lanes on the right correspond to RNA
from adult female, adult male, adult female without ovary, and ovary. A 2.2kb product is
prevalent during embryogenesis while a 1.85kb band is expressed at low levels in the
embryo but is the more abundant product in adult ovary. RNA from adult male and from
females whose ovaries have been removed have no detectable pes product.
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(Fig. 8A and data not shown). During the second day of development (28 to 36 hours)
expression levels begin to decrease and by 48 hours the distribution of transcripts is
restricted to the ganglion cell layer of the eye, the ventral forebrain, cells in the
posterior tectum at the midbrain-hindbrain boundary, rows of cells in the pharyngeal
arches, the pectoral fin buds, the liver and pancreatic primordia, and the presumptive
gut (Fig. 8B and data not shown). At 72 hours, the tectal row of cells continues to
express pes transcripts. RNA levels in the liver are lower than at 48 hours while the
developing gut continues to express high levels of pes mRNA. Striking expression is
seen in a series of stripes coincident with the expanding branchial arches (Fig. 8C).
The distribution of pes transcripts in embryos older than 72 hours was not analyzed in
whole mount material due to the difficulty in obtaining efficient penetration of probe to
all tissues.
In situ hybridized embryos were sectioned to confirm and further specify the sites
of expression inferred from the whole mount preparations (data not shown). We
ascertained that high levels of pes message are found in all pharyngeal arch
primordia and in the nascent anterior neurocranium (the ethmoid plate) at day 2 post
fertilization. We also observed heavy expression in the gut epithelium and in the
pancreas at day 3.
Previous Northern blot analysis had shown that pes transcripts could not be
detected in five day old homozygous mutant embryos (11, Chapter 4). To rule out the
possibility that the absence of pes RNA at day 5 is due to loss of expressing tissues, in
situ hybridization was carried out on progeny obtained from crosses of heterozygous
pesl+ parent fish prior to the appearance of the mutant phenotype. When one or two
day old embryos were tested, approximately 25% of the animals showed no
detectable staining (38/163 over 6 experiments) whereas 100% of embryos obtained
from wild-type crosses (177/177 over 7 experiments) were stained (data not shown).
This furthers the notion that in homozygous mutant embryos pes transcripts are either
not synthesized at all or are present in undetectable amounts. A similar analysis done
on three day old embryos, when the pes phenotype becomes apparent, confirmed that
it is the mutant animals in which hybridization signal is not observed.
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Figure 8. Restricted expression of pes between days one and three post-fertilization. A.
28 hour old embryo whose yolk has been removed, observed dorsally, anterior is to
the left. Note heavy expression in the eye primordia, in the forebrain, the tectum
(arrowhead), and in the asymmetrically localized liver primordium (arrow). B. 30 hours.
The embryo was dissected as in A and shows heavy hybridization in the developing
liver (arrow) and in the fin buds (arrowheads). Anterior is to the left. C. 72 hours.
Expression of pes in the tectum is reduced to a row of cells (arrowhead), compare to
stain at 28 hours (A). Expression in the pharyngeal arches can be seen at this stage
(arrow). The pancreas and gut express heavily (dark stain to the right of arch staining).
Anterior is to the left and dorsal is up. Bars A, C=100m; B=50 pm.
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The pes mutation affects the development of a subset of embryonic primordia which
correlate with sites of strong pes gene expression.
The pes mutant phenotype is first evident under a dissecting microscope on the
third day of development as a reduction in the size of the head and eyes and
incomplete extension of the jaw when compared to wild-type. To further analyze the
deficiency within the cranial skeleton, we stained differentiated cartilage in mutant and
wild-type embryos with alcian blue (22). The early pharyngeal skeleton normally
consists of a series of seven distinct arches: the mandibular (P1) and hyoid (P2), both
of which will form the jaw, and five branchial arches (P3 to P7), which eventually will
support the gills (23) (Fig. 9). In addition, alcian blue labels the developing
neurocranium, which underlies the brain, and cartilage in the fin primordia.
A striking aspect of the pes phenotype is the absence of stained cartilage in the
five branchial arches (P3 to P7) and a severe reduction of the jaw arches (P1 and P2)
relative to wild-type. This is apparent by 80 hours post-fertilization, shortly after
cartilage begins to develop in the arches (Fig. 9A top, 9B). In day 5 wild-type embryos,
the skeletal architecture is more complex than at day 3, whereas in mutants, cartilage
in the anterior jaw arches appears unchanged (Fig. 9A, center). Although cartilage
fails to differentiate in the branchial arches of mutant embryos, mesenchymal tissue is
organized segmentally in this region as can be seen in longitudinal sections through
the head region of pes/pes embryos (Fig. 2B). Occasionally, a few cells within the first
(P3), and less often the second (P4), branchial arch stain lightly by day 5, and in some
mutant embryos, muscle fibers can be seen juxtaposed to the undifferentiated
branchial arch primordia (not shown). In addition to the arch defects, the ethmoid plate,
the anterior portion of the neurocranium, appears shortened in mutant embryos and
cartilage in the pectoral fins is reduced, resulting in short fins (Fig. 9A, top, and not
shown).
Transverse sections through the trunk region reveal that the internal organs of
mutant and wild-type embryos are indistinguishable in size at day 3 of embryogenesis
(Fig. 10A vs. 10B). However, between days three and five of development, striking
differences appear: In wild-type embryos the liver grows and extends over the yolk
surface and, concomitantly, the yolk is rapidly consumed (Fig. 10C); In mutants the
liver does not grow substantially after day 3 and the yolk is not consumed (Fig. 10D).
Moreover, the gut is markedly reduced in mutants and the anterior expansion of the
intestine that forms the stomach in cyprinid fishes (24) does not develop. In addition to
the striking differences in the expansion of the liver and gut, the pancreas, which
appears darkly labeled by the counterstain in sections of five day-old wild-type
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Figure 9. Pharyngeal cartilage formation is defective in pes mutants. A. Ventral views
of three (top) and five (center) day old wild-type (wt) and mutant (pes) embryos stained
with alcian blue. Note the differing head sizes between wild-type and mutant at day 3
and the lack of growth of cartilage in the mutant by day 5. The principal cartilaginous
elements of the wild-type and mutant pharyngeal skeleton are shown schematically
below the stained embryos: the first arch (P1), including Meckel's cartilage (m) and
palatoquadrate (pq); the second arch (P2), including the hyomandibular (hm), the
paired ceratohyals (ch) and the medial basihyal (bh), and branchial arches, P3 to P7.
In the mutant, both elements of Meckel's cartilage have fused at the midline, the
hyomandibular is reduced, the ceratohyals are pointing ventro-caudally, and branchial
arch cartilages are absent. B. Lateral views of day 5 wild-type (wt) and mutant (pes)
embryos stained with alcian blue. The short, ventrally protruding, Meckel's cartilage
(m) and ceratohyal (ch) are the only stained structures seen in the pharyngeal region
of the mutant. Bar=100ltm.
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Figure 10. Comparison of day 3 and day 5 cross sections through the anterior trunk
region. A, B. At day 3, relative sizes of liver (thick arrow) and gut (thin arrow) in the
mutant (B) are virtually indistinguishable from wild-type (A), as are trunk muscles (s)
and hindbrain (h). Both animals were sectioned at the level of the pectoral fins (fi).
Circulating blood is visible (b). C, D. At day 5, the liver (thick arrows) has greatly
expanded in wild-type (C), but not in the mutant (D). Also in the mutant the yolk (y) is
unconsumed, the gut (thin arrows) has failed to expand, the body wall muscles (bm),
which surround the abdomen, are absent, the axial musculature has started to
degenerate and all body cavities have expanded and filled with fluid. The renal
tubules (arrowheads), however, appear to be of similar size and position in mutant and
wild-type. Bar A, B=100p~m; C, D=50 tm.
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embryos, was not discernible in mutants. Furthermore, in mutants the axial
musculature shows signs of degeneration and the body wall muscle, which surrounds
the abdominal cavity in wild-type embryos, is absent (Fig. 10C vs. 10D).
At the level of resolution presented here, there appears to be a striking correlation
between defects in pes mutant embryos and regions where pes is normally expressed
at high levels earlier in development: the branchial arches, liver and gut, as well as
brain, eyes, fin buds, and ethmoid plate. In most cases the primordia develop, but
between days three and five they fail to expand. Importantly, other structures appear
normal in mutants at day 5, even though many other regions of the animal are severely
affected. Tissues that appear normal include the notochord, the pronephros and renal
tubules (Figure 10C vs. 10D, and not shown). Expression of pes message was not
detected in these tissues at any stage in wild-type animals. To firmly establish that the
pes phenotype is entirely restricted to cells that normally express pes product will
require further experiments. Likewise, we cannot yet rule out that pes mRNA
expression occurs at some point during embryogenesis in tissues that appear normal
in mutant animals.
Discussion
We have presented evidence that dye and pes are insertional mutants and we
have described the genes whose disruption is likely to be responsible for the mutant
phenotypes. In the case of dye, I showed that 1) a single proviral insertion is
genetically linked to the mutant phenotype; 2) the provirus lies just 5' of the putative
ATG codon of a gene whose transcript is expressed in embryos; 3) the insertion
abolishes detectable expression of this gene; and 4) the gene is specifically
expressed in the tissues affected in the mutant before the onset of the phenotype. In
the case of pes, we had previously shown genetic linkage of a single provirus to the
mutant, shown that the provirus lies in the 5' exon of a gene that is expressed in
embryos, and shown that the provirus abolishes detectable gene expression. Here we
have provided additional strong support that pes is an insertional mutant in the gene
we identified by showing that at least many sites of pes expression in wild-type
embryos correspond to regions of the embryo that fail to reach normal size in pes/pes
mutants. The evidence presented suggests that it is highly likely that mutations in the
pes and dye genes are responsible for the mutant phenotypes observed. Definitive
proof will require either rescue of the mutant phenotype by introducing the gene or its
product into mutant animals, or possibly targeted mutation of these genes. Neither
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technology has yet been reported in zebrafish. Targeted disruption could be
performed in mice (25-28) since the pes and dye genes are so highly conserved
among vertebrates. Only a positive result would be informative in a knockout
experiment however, since mice and fish may differ in their genetic redundancy and
since homologous genes could serve different functions even among vertebrate
species.
Ease of molecular cloning of genes disrupted by proviral insertion.
The virtue of insertional mutagenesis is the ease of cloning the mutated genes. In
mice, this virtue has not always been realized. DNA insertions in the mouse genome
frequently cause complex rearrangements at the site of insertion which can make it
difficult to identify the mutated gene responsible for the observed phenotype (29).
Retrovirus proviral insertions in mice can disrupt genes by integrating into coding or
non-coding exons, introns, or regulatory regions. The location of the provirus relative
to recognizable coding regions or transcripts determines whether it is easy to locate
the gene whose disruption causes the mutant phenotype.
Subsequent to the completion of this work, three more insertional mutants have
been found in our screen, and the disrupted genes have been identified in all three. In
total, we have been able to clone the genes disrupted in six out the seven insertional
mutations we have isolated (Table 1); in most cases this has been achieved very
rapidly. For example, the cloning of dye, required only 3 weeks of work by a single
individual. The reasons for this speed were 1) the proximity of the mutagenic proviral
insertions to coding sequences, and 2) the fact that the coding sequence was
homologous to sequences present in the database. In one case (D1), the cloning of
the affected gene was very difficult because the mutagenic provirus had inserted into a
very large intron (Figure 11). We have not yet located a gene near the 80A insertion.
Possibly we do not yet have enough sequence data (1 kb on one side, 4 kb on the
other). Alternatively, this insertional mutant may involve a gene sequence that is not in
the data base or one that is not evolutionarily conserved, or the 80A insertion may lie
in a large intron or in a regulatory sequence distant from the coding region of the
putative disrupted gene.
It is interesting that the proviruses in all four of the recessive mutations for which
we know the genomic structure of the affected gene have integrated just upstream of
the ATG initiation codon of a gene, either in the 5' UTR or in the first intron (Figure 11).
These numbers are too small to allow conclusions, but the following points are
relevant. Despite much effort, whether mouse and chicken C-type retroviruses
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Disrupted Gene Phenotype
no arches (nar)
pescadillo (pes)
homologue of Drosophila clipper,
a zinc-finger endoribonuclease;
homologous ESTs found in human
and mouse
homologous to genes of unknown
function in human, mouse, and
yeast; contains BRCT family motif
unidentified
dead eye (dye)
not really
finished (nrf)
homologue of genes in human and
Xenopus, similarity to yeast NIC96
homologue of human and chicken
NRF-1, a transcription factor
WD repeat domain containing protein
candidate gene identified;
homologous to C. elegans EST
Absence of most of the
pharyngeal arches; reduction
of some head structures
Reduction of many structures,
including the eyes, ears, arches,
fins, liver, and gut
Reduction of head structures
Excessive apoptosis in the
central nervous system
Retinal photoreceptors absent
or abnormal
Interupted stripe pattern in
adult pigmentation
Rotting in the embryonic
yolk sac
early day 3
late day 3
late day 2
early day 2
day 2
2-3 weeks
day 1
Table 1. Retrovirally-induced insertional mutations in zebrafish
38M
67D
80A
404
399
D1
891
Time of onsetInsertion Mutant Name
PROVIRAL INSERTIONS IN MUTANT LOCI
recessive mutations 500 bp
dye .1
ATG
ATG ->
pes
399
ATG
dominant mutation 5 kb
D1
ATG -- )
Figure 11. The location and orientation of the proviral insertions in four recessive insertional
mutants and one dominant insertional mutant. Shaded boxes represent protein-coding exons,
white boxes represent 5' untranslated exon sequences, straight lines represent introns. The arrows
in the proviruses indicate their transcriptional orientation. The severed intron at the end of each
indicates that the size of this intron and the genomic organization of the 3' end of these genes is not
known. Note that in all four recessive mutations, where expression of the genes is abolished, the
provirus has inserted in the 5' untranslated region or the first intron. In the dominant mutation,
where expression of the gene is not eliminated, the provirus has inserted in a very large
downstream intron.
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integrate randomly into the host cell genome remains controversial (30-34) . Some
studies suggest preferred integration into 5' ends of genes and into actively
transcribed regions, while others suggest that integration is essentially random across
the genome. In many studies biological selection is operating. For example, in our
case only insertions that disrupt genes will be detected as mutants. The position of the
integrations we have observed in mutants might reflect the most probable way for the
virus to disrupt gene expression. Provirus insertions into introns, for example, might
not affect transcription of fish genes as they sometimes do in mice. We have
sequenced 1-2 kb of DNA adjacent to 42 randomly selected proviruses present in
transgenic lines of fish that did not harbor embryonic mutations (K.K., N.G., D.
Grosshans, M.A., A.A., T.B., and N.H., unpublished results). The data do not reveal
preferred sequences and are consistent with random integration, although such data
are limited.
It has been reported that in mice, approximately 1 in 20 provirus integrations
causes an embryonic phenotype (29). The frequency we have obtained for fish
insertional mutants (approximately 1 in 70) is considerably lower. However, our
numbers are still very small, and the genetic requirements for embryonic development
may not be comparable between mice and fish. In addition, it will be important to learn
whether mutagenic insertions are limited to the 5' ends of genes in the fish. If so, re-
engineering the viral vector might increase its mutagenicity at other locations,
increasing significantly the target size for gene disruption and thus the frequency of
mutants.
Relationship of insertional mutants to previously identified zebrafish mutants.
Even more important than the location of the provirus relative to the gene it
disrupts is the related question of whether all genes can be mutated by proviral
insertion. Most insertional systems show bias. In Drosophila, P elements readily target
only about 1/3-1/2 of the genes that can be mutated to an embryonic phenotype by
chemical mutagenesis (35). Even if this is the case with retroviruses, we might expect
that the collection of insertional mutants will ultimately contain a distribution of
phenotypic classes similar to that encountered in the chemical mutagenesis screens.
The seven insertional mutants we identified show distinct phenotypes that encompass
spectrum similar to that of the chemical screens (7,8). While this number is too small to
allow strong conclusions to be reached, it is interesting to note that one in seven (14%)
of the insertional mutants has a CNS degeneration phenotype as compared to 20% in
the chemical screens, three out of seven (43%) have post-hatching non-specific
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phenotypes, as compared to 50% in the chemical screens, and three out of seven
(43%) have specific phenotypes, as compared to 30% in the chemical screens.
Several of the insertional mutants which we have isolated have a late-onset
phenotype (post-hatching). Although most late-appearing mutants were discarded in
the chemical screens (7,8), some were kept that specifically affected the jaw, liver, and
gut, all of which are relatively late-developing structures. Among the collection of
chemically induced mutants classified as having specific defects in pharyngeal arch
development, one designated babyface has deficiencies in the cranial skeleton that
are strikingly similar to those seen in pes mutants (23). Complementation tests will be
needed to determine whether bab or other chemically-induced mutations are allelic to
pes.
The chemical mutagenesis screens isolated a large number of mutants whose
primary phenotype was excessive cell death restricted to the central nervous system
(16). However, because of the large number of mutants that fell into this class,
complementation tests were not performed and therefore, the number of genes
involved remains unknown. Based on the phenotype observed here, it appears that
dye would belong to this class of mutants.
Understanding the dye and pes mutant phenotypes.
The dye and pes mutant phenotypes described here are both distinctive. dye
embryos exhibit extensive apoptosis in the CNS, whereas pes embryos fail to normally
expand at least many of the primordia in which the pes gene is expressed: the
branchial arches, liver, gut, brain, eyes, fin buds and ethmoid plate. To understand the
molecular basis for the mutant phenotypes we observed, it will be necessary to
understand the normal cellular function of the products of the dye and pes genes. pes
is a novel gene; while it may be a member of the BRCT superfamily, genes which
share this motif have many different biochemical functions, making the task
demanding. However, it is intriguing that many of this superfamily's members play a
role in the cell cycle or DNA replication and repair, as the common factor in the
abnormalities seen in the many affected tissues in pes mutants appears to be a
reduction in the number of cells. In the case of dye, a possible function is suggested
by its relation to the yeast NIC96 gene, whose product is part of the nuclear pore
complex. The NIC96 protein physically interacts with several nucleoporins, including
NSP1, the yeast homolog of the vertebrate p62 nucleoporin which is required for the
assembly of transport-competent nuclear pore complexes (14, 18, 36, 37). NIC96 is an
essential gene for cell growth in S. cerevisiae and appears to be required for the
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formation of nuclear pore complexes (14, 37). While the degree of homology between
dye and NIC96 is statistically significant, to determine whether they perform a similar
biological function will require further experiments.
Transcripts for both the pes and dye genes are contributed maternally to the egg,
but then decrease during the first hours after fertilization. Although this could reflect a
"house-keeping" function for pes or dye, some patterning genes in other organisms
also display both maternal and zygotic expression. Zygotic dye expression is specific
to the developing central nervous system and appears to be required for many of
these cells to avoid apoptosis. During embryogenesis, pes expression increases
rapidly during the first day of development, and later decreases gradually. No
expression can be detected in adult animals suggesting a specific embryonic
requirement for this gene. The results described here suggest that the pes gene
product may be required for the growth of a subset of embryonic organs. Regions of
the embryo that express the gene heavily subsequently fail to reach normal size in
mutants. Particularly striking in this respect are the gill arches, liver and gut. In contrast,
regions of wild-type embryos in which expression was not detected by in situ
hybridization appear normal in mutants, including the notochord, pronephros and
renal tubules. The defects observed in pes/pes embryos suggest that cell types of
diverse embryonic origins are affected and, moreover, that the expression pattern of
the gene is not restricted to specific cell types.
The fact that the dye and pes mutations exhibit distinctive embryonic phenotypes,
including defects in the growth or maintenance of specific tissues, suggests that they
may be important in cell biological processes, although possibly not in pattern
formation and morphogenesis. Such genes could also have medical relevance. We
are currently mapping their homologs on human chromosomes to determine if these
genes correspond to disease loci.
Feasibility of genetic screens
Forward genetic approaches are usually powerful only when large scale screens
are possible, because the number of genes that affect any one developmental process
is small. While this will also be true for insertional mutagenesis in zebrafish, the
situation is somewhat different because the mutants that we isolate can be viewed
within the broad picture provided by the chemical mutagenesis screens. Nonetheless,
we have attempted to develop a technology that will make large scale mutagenesis
screens possible, and we are continuing to try to increase the number of insertions that
can be screened.
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Although our current mutagenesis frequency is approximately 70 fold lower than
that in the chemical screens, in chemical mutagenesis, since the mutations are
unmarked, it was necessary to obtain about five successful pair matings for every
mutant identified (5-8). Since we track insertions by PCR and Southern blot and only
mate fish heterozygous for the same lesion, we require only one successful cross to
identify a mutant. Thus, the amount of work, though clearly greater in our case, is not
70 times greater per mutant than in chemical mutagenesis screens.
Given our experience to date, and at the mutation frequency we have observed,
we estimate that eight scientists will be able to screen about 25,000 insertions in 2-3
years, obtaining approximately 250-350 mutants. If the distribution of phenotypes
among these mutants proves to be similar to that in the chemical screens, about 30%
of these should have specific early developmental defects and at least several should
affect the patterning and morphogenesis of almost every embryonic structure.
The zebrafish has long been admired for the ease with which early development
can be visualized and it has been pursued as a model system because of the
possibility that the organism might serve as a tool for rapidly identifying genes
essential for vertebrate development. The results presented here suggest that
insertional mutagenesis, in conjunction with chemical mutagenesis screens, may help
the fish to realize this potential.
Materials and Methods
Animals: Zebrafish (Danio rerio) were kept and raised essentially according to
standard conditions (38) and using practices established in our laboratory (39). The
aquarium systems used were designed specifically for housing large numbers of
animals in small containers (Mullins et al., 1994) and were purchased from K.-J.
Schwarz Glas Aquarienbau (Gattingen, Germany). Fertilization was achieved by
natural spawning and embryos were raised at 28oC and staged according to Kimmel
et al. (40). The insertional mutant pilot screen was carried out by inbreeding fish
harboring identical proviral insertions (11, Chapter 4) and scoring their progeny for
several morphological criteria under low magnification as described (8). Identified
mutants have been named according to the conventions established for zebrafish
(Westerfield, 1995; M. Mullins, personal communication); the superscript letters
indicate the laboratory designation (h) and the insertional nature of the mutation (i).
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Isolation of genomic sequence flanking proviral insertion 404: Inverse PCR was used
to clone genomic DNA fragments on each side of proviral insertion 404. Genomic
DNA from fish heterozygous for the 404 insertion was digested with either Ncol and
BspHI (for the 3' flanking sequence) or BgAl (for the 5' flanking sequence), extracted
with phenol/chloroform, and ethanol precipitated. T4 DNA ligase was then added to
the DNA diluted to 2 tg/ml to circularize the fragments. PCR was then carried out with
Expand High Fidelity PCR System (Boehringer Mannheim) and pairs of primers from
the provirus such that one primer was in the LTR oriented 5' to 3' towards the genomic
DNA and the other was in the middle of the virus oriented 5' to 3' towards either the
Ncol or BgIll site: NU5 (GTAAGATCTCGAGTGATTGACTACCCGTCAG) and NV1
(GTACTCTATAGGCTTCAGCTGG) were used for the 3' flanking sequence and NU3
(GTAAGATCTCGAGCCAAACCTACAGGTGGGGTCT) and NV2 (GCGGTACCAGCCC
TCACTCCTTCTCTAGG) were used for the 5' flanking sequence. The PCR program
was 30 cycles of 940C 15", 551C 30", 681C 4' (plus 20" per cycle after cycle 10),
preceded by a 2' denaturation step at 941C and followed by a 10' extension step at
720C.
3' RACE and RT-PCR: RNA was isolated from day 2 or 3 embryos by the guanidinium
hydrochloride method (38). 3' RACE for the isolation of the dye gene and RT-PCR for
the detection of both dye and pes transcripts was carried out with a commercially
available kit (Gibco-BRL Life Sciences) according to the manufacturers instructions,
with the use of Expand High Fidelity PCR System (Boehringer Mannheim) for the PCR.
For 3' RACE, first strand synthesis of 1 jg of day 2 RNA was performed using the
supplied AP primer. One round of PCR was performed on 10% of this sample using
the supplied AUAP downstream primer and an upstream primer (404-2;
CATGGATACTGAGGGTTTTGGGGAGC) which overlaps the first eight amino acids of
the open reading frame found in the genomic sequence. This reaction was
fractionated on a low melt agarose gel; DNA from a 2.6 kb band unique to the
presence of both primers was purified and 2% of this sample was used as a template
for a second round of PCR in which the upstream primer (404-3;
CACCAGAACCTCTCAAGACACAGC) overlapped amino acids 49-56 of the same
open reading frame. The 2.4 kb product was subcloned into pBluescript II
(Stratagene) for sequencing. Both rounds of PCR utilized the same PCR program as
the inverse PCR except that the annealing temperature was 600C.
For RT-PCR, 0.5 jig of RNA from either wild-type or dye day 3 embryos was used
for first strand synthesis with a primer specific to either the dye gene (404-9;
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TGCTGGCACCAGCAGGACG) or the pes gene (P20; TACTCTCTGAATTTGCCAACG).
PCR was performed on 10% of this sample using either 404-2 and 404-8
(TCCCAGCAGGGTGTGCAAC) which lies upstream of 404-9, or P20 and P15
(TGCAAGCTTCTGGAGACGCACGTTAG) which lies in the 5' UTR of pes. The PCR
program was 30 cycles of 94 0C 30", 600C 1', 720C 2', preceded by a 2' denaturation
step at 940C and followed by a 5' extension step at 720C.
Northern blot and cDNA Isolation: For the northern analysis, total RNA (15 pg) from
each sample was fractionated on a 2M formaldehyde agarose gel and transferred to a
nylon filter (Hybond N+, Amersham). The blot was probed with a radioactively labeled
292bp RT-PCR cDNA fragment (corresponding to nucleotides 61 to 353 of the pes
cDNA). Exposure was performed on Kodak BioMax MS film for 6 days. The same
cDNA fragment was used as a probe to screen a three day embryonic cDNA library
(gift of Dr. Kai Zinn). 5x10 5 plaques were screened and two positive clones were
identified and isolated. Both clones contained inserts of identical length by PCR and
one of them was sequenced in its entirety on both strands. The human cDNA clones
were purchased from American Type Culture Collection (Rockville, MD), and were
sequenced on both strands. Sequence alignment was accomplished by using the
Lasergene software (DNAStar, Inc.).
Histology and acridine orange labeling: Alcian blue staining was done essentially as
described (11, 22, Chapter 4). The nomenclature for skeletal elements is that
described by Schilling et al. (23).
For tissue sectioning, embryos were fixed in 4% paraformaldehyde/PBS,
dehydrated and embedded in Polybed 812 epoxy resin (Polysciences). Specimens
were cut into 1-2pLm sections which were subsequently counterstained with a solution
of 0.05% crystal violet, 0.01% methylene blue, and 0.05% borax at 950C.
For detection of apoptotic cells, anesthetized embryos were injected with a
solution of 1mg/ml acridine orange (Sigma) into the yolk sac (16). Embryos were
allowed to recover for 30-60 min and were visualized under a Nikon Microphot SA
microscope with an EPI-FL3 fluorescence attachment using a 450-490nm excitation
filter and a 520nm long pass emission filter.
In situ hybridization: UTP-11-digoxigenin labeled RNA probes were prepared as
suggested by the manufacturer (Boehringer Mannheim Biochemicals). The probes
used were in vitro transcription products of either a 2 kb fragment of the pes cDNA
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(corresponding to nucleotides 214 to 2214 of the pes cDNA) or 2.2 kb. fragment of the
dye gene (corresponding to nucleotides 240 to 2655) Anesthetized embryos were
fixed in 4% paraformaldehyde in PBS at 40C for 12-16 hours and were dehydrated in
methanol at -200C for at least 1 hour. In situ hybridization was carried out essentially
after Jowett and Lettice (41). Proteinase K treatment was for 10 minutes at 10lpg/ml for
embryos up to 24 hours old and at 25 g/ml for older embryos. Prehybridization and
hybridization temperature was 65 0C with a probe concentration of 1g/ml. Hybridized
embryos were cleared in glycerol or in methyl salicylate and were photographed
under a Leica Wild M3Z dissecting scope or a Nikon Microphot SA microscope.
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CHAPTER 6
LARGE SCALE INSERTIONAL MUTAGENESIS SCREEN IN ZEBRAFISH
(Most of this chapter (along with Chapter 1) will be published as part of a book chapter:
Amsterdam, A. and Hopkins, N. (1998) Insertional mutagenesis in zebrafish, in
Development: Genetics, epigenetics, and environmental regulation, eds. Russo, E.,
Cove, D., Edgar, L., Jaenisch, R., and Salamini, F. (Springer-Verlag: Berlin).)
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The results in Chapters 3-5 have shown that a pseudotyped retrovirus can be
used to cause insertional mutations in the zebrafish and that a very large number of
these insertions can be made. This has led to the proposition that a very large scale
insertional mutagenesis screen could be conducted, identifying a large proportion of
the several thousand genes required for the development of this vertebrate. However,
a number of issues need to be resolved before this approach is assured of success.
The first is whether or not all, or at least most genes are mutable by this method. The
second is the establishment of the most efficient way to utilize the technology as it now
exists. The third is whether improvements in the technology can be made, and how
they would be implemented.
General applicability of retroviral insertional mutagenesis in zebrafish
Any mutagenesis screen must take into account the bias of the mutagen used.
DNA-alkylating chemical mutagens such as ENU cause primarily point mutations and
are thought to act randomly throughout the genome. Thus, they should be able to
mutate all genes, though not necessarily with the same frequency. The size of the
coding regions of genes, as well as the frequency with which a single nucleotide
change will either cause a significant amino acid change or create a stop codon will
vary between genes. Alkylating agents may also have some sequence-context bias,
as demonstrated by the non-random distribution of mutated nucleotides amongst
hundreds of EMS-induced alleles of the lacl gene in E. coli (1). In the specific-locus
tests performed prior to the large-scale chemical screens, a ten-fold range was seen in
the mutability between just four tester loci (2). Such variability in the mutability of
different genes is part of the reason why neither of the chemical screens achieved
saturation. Nevertheless, most genes are thought to be mutable by chemical
mutagenesis; the mutational bias just means that many more mutagenized genomes
must be screened in order to approach saturation.
Similarly, in order for this method of insertional mutagenesis to be of use for a
large-scale screen, it is important that all, or nearly all genes can be disrupted in this
manner. Insertional mutagens in other organisms have had integration biases that
have either reduced or eliminated their usefulness for large-scale mutagenesis. For
example, the Tyl retrotransposon in S. cerevisiae preferentially integrates upstream of
tRNA genes, actually avoiding genes transcribed by RNA polymerase II (3). P
elements appear to be able to disrupt only about half of the chemically-mutable genes
in Drosophila (4). The integration bias of retroviruses has been examined in both
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avian and mammalian cells, and it is still unclear whether bias exists or not. As
mentioned in Chapter 1, some studies, looking at a small number of integration events,
have concluded that retroviruses preferentially integrate into regions of open
chromatin conformation and transcriptional activity. Two studies showed that a
disproportionate number of unselected MoMLV proviral insertions were found near
DNAse I hypersensitive sites (5, 6). Other studies showed a bias of MoMLV
integrations towards transcribed sequences and CpG rich regions, which generally
occur at the 5' and 3' ends of genes (7, 8). While these studies were quite suggestive,
they were based on a very small number of integrations. Two examinations of the
integration preference of avian leukosis virus were performed in the same laboratory
using techniques allowing the sampling of far more integration events. The first study,
which analyzed 20 integration sites for their repetition amongst 15,000 integration
events, appeared to find hot spots of integration (9). It was estimated that there were
800 sites in the genome which are targets at 500,000 times the frequency expected,
representing about 20% of all insertions. The other study, which sampled a dozen
regions of the genome for frequency of insertion amongst millions of integration
events, found that all regions experienced integrations within four-fold of random,
concluding that all regions of the genome are accessible to retroviral integration
without much bias (10). On one specific point, these studies directly contradict each
other, in that when a couple of the "preferred sites" found in the first study were used in
the second, they were not seen as hotspots. The authors concluded that the second
study was more likely to be correct as the first was more open to statistical error. And
even if hotspots do exist, both of these studies support the notion that the vast majority
of integration events would still be essentially random throughout the genome.
It has also been suggested that there is a bias for the 5' end of genes based upon
the observation that many of the mutagenic retroviral insertions in mice have been in
the 5' end of these genes (11-14). However, the number of cases again is very small,
and furthermore these cases were selected for causing gene disruption. It may be that
insertions in these regions are more likely to cause loss of gene function than in, for
example, a downstream intron. The insertional allele of dilute serves in a way as an
example of this; while this insertion in a downstream intron did cause a phenotype, it
was not in fact a complete null allele (15). Furthermore, there are many other
examples of insertions into genes which did not occur in the 5' end. A study of mouse
mammary tumor virus integrations creating dominant loss-of-function alleles in the int-
6 gene showed insertions in one of several downstream introns (16). As these
insertions are thought to cause dominant negative alleles by creating C-terminal
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truncations, the process of identifying these insertions may have selected for
downstream events; but this just underscores the fact that analysis of integration
preference after biological selection can be misleading.
Three different experiences with mammalian gene traps may also suggest that if
integration bias exists, it is relatively minor. One is the frequency with which the
reporter genes in promoter trap retroviruses are activated. As these traps have no
splice acceptor, and as they place in-frame stop codons before the reporter's initiation
codon, these traps can only be activated if they are in the 5' untranslated region of a
gene. Based upon the average target size thus allowed and the estimates of the
number of active genes in a cell from RNA renaturation kinetics, the frequency of
reporter activation matched the proportion of the genome predicted to activate the trap,
implying that insertion was random (17). Another concerns the use of a splice trap that
additionally utilizes an internal ribosome entry site (IRES) between the splice acceptor
and the reporter gene (18). The use of this IRES should make translation of the
reporter independent of the sequences upstream of it, in contrast to a situation
whereby the reporter would have to be made as a fusion protein if it was spliced
downstream of the initiation codon of the endogenous gene and thus would only be
produced if it was in the same frame. This should eliminate any bias for the detection
of insertions upstream of the initiation codon. Use of this IRES increased the
frequency of trap events three fold, which implies that most of these insertions were not
5' of the initiation codon, where the IRES would not be expected to make a difference.
Furthermore, analysis of the site of insertion in 11 of these activated traps revealed that
integrations occurred in the full range from the 5' to 3' end of the genes. This further
suggests that the apparent preference for the 5' end of genes seen in mutagenic
insertions might be more a consequence of selection for gene disruption than proviral
integration bias. In contrast, however, are the results from experiments in which gene
traps were delivered into cells either by electroporation or by retroviral vector (19). In
these experiments, twice as many retroviral integration events led to trap activation as
was the case with electroporation. While the mechanism by which electroporation
leads to integration of the transfected DNA is not known and thus may not be random
itself, these data suggest a slight bias for integration into genes.
These studies have only focused on bias between regions containing
transcription units and nuclease-accessible chromatin and those which do not; they
have not addressed the question of whether all genes can be equally targeted or
some genes will be preferential targets over others. If, for example, there is bias for
transcribed genes or regions of open chromatin, then genes transcribed/accessible at
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the developmental stage of integration would be more likely to be targets than others.
In the case of the genes mutated in the mouse by retroviral infection, all of these gene
were either expressed or contained a DNAse I hypersensitive site at the time of
integration, regardless of the time of onset of the phenotype, from early
postimplantation to postnatal (20-23). However, the number of cases analyzed is
small.
Thus the available evidence suggests that, at least to a rough approximation,
integration of retroviruses is random throughout the genome in avian and murine cells.
If there is a slight bias, it may be towards preferential insertion into genes. It should be
remembered that these analyses were all made with retroviruses in their natural hosts,
murine viruses in murine cells and avian viruses in avian cells. If there is some bias, it
may come from specific interactions between elements of the integration machinery
and host proteins. For example, the integrase of the human immunodeficiency virus
(HIV) has been shown to interact with a protein in human cells, ini-1 (24). This host cell
protein shares homology with the yeast transcription factor SNF5, suggesting a
mechanism by which such an interaction could help target integrations into transcribed
regions. If a bias for the insertion of MoMLV into genes does exist in mouse cells, this
same bias may not exist in a heterologous system such as fish. In fact, the reduction of
a slight bias might explain part of the reason why the mutagenic frequency of retroviral
insertion is lower in zebrafish than in mice (see below).
The existing evidence neither assures a lack of bias nor convincingly proves that
it exists. Furthermore, if there is bias based upon the interaction of species-specific
host proteins with viral components of the integration machinery, bias that exists for
MLV in mice might not exist in fish. Based upon the small number of insertional
mutants found so far, it does not seem likely that there is a preference for genes
transcribed at the time of integration. Though neither the transcriptional state nor the
chromatin conformation of these genes has been established in the primordial germ
cells in which these integrations occurred, the expression level of these genes in the
embryo at the time in which these integrations are likely to be occurring varies from
undetectable to low to high (Chapters 4 and 5, A. Amsterdam, T. Becker, and N.
Hopkins, unpubl. data). Furthermore, the distribution of phenotypic classes of the
insertional mutations are roughly proportional to those in the chemical screens. One
in seven of the insertional mutants has a CNS degeneration phenotype as compared
to 20% in the chemical screen, three out of seven have post-hatching non-specific
phenotypes, as compared to 50% in the chemical screen, and three out of seven have
specific phenotypes, as compared to 30% in the chemical screen. This does not
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guarantee that all of the chemically-mutable loci will be targets for retroviral
integration, but it does suggest that it is likely that all types of phenotypes should arise
in a large scale insertional mutagenesis screen.
In the end, the only way to determine if these pseudotyped retroviruses are
capable of mutating most loci is to begin isolating many more insertional mutants. A
statistical approach can be used to determine if multiple alleles of the same genes are
being isolated sooner than they should based on the proportion of the 2,400
chemically-mutable loci that are represented by insertional alleles. If extreme biases
exist, such that for example only 10% of the essential genes can be disrupted by
proviral insertion, this should be evident after the isolation of only one hundred
mutants. If, like P elements, there is a weaker bias such that only 50% of the genes
can be disrupted, a large scale screen will still be a success.
Protocol for a large scale screen
The ability to pass so many insertions through the germ line as described in
Chapter 3 opens the possibility of a truly large scale insertional mutagenesis screen.
However, it is important to create a breeding scheme that allows the most efficient
screening of the largest number of insertions, efficient in terms of number of fish tanks
for space reasons and in terms of work and people's time. The strategy that I set up for
the extended pilot screen is the "single-insertion strategy" outlined in Figure 1. Briefly,
injected fish are raised, and these founder fish are outcrossed. Transgenic F1
progeny are selected by PCR analysis of the DNA from fin clips. Southern analysis is
performed on the DNA of PCR-positive fish, and fish are selected that have unique
single insertions, as determined by diagnostic junction fragments. Our experience so
far is that on average, we obtain about eight fish with different single insertions in a
clutch of about fifty F1 fish from a typical founder. These single insertion fish can then
be stored in large pools until they reach sexual maturity, at which point they can be
outcrossed to generate F2 families in which half of the fish are transgenic. As each of
these F2 families has only one insertion, DNA from tail clips can now be analyzed by
PCR only to generate small families in which every fish carries the same insertion.
Now a single cross can be screened to determine if that insertion causes a mutation.
This strategy has several very convenient features, mostly due to its simplicity. If
a mutation was observed in the progeny of a cross, any pair from that family should
show the mutation again. Furthermore, cloning of the flanking DNA is simplified by the
presence of only a single provirus. It appears very efficient as well; for every founder
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generated, about eight insertions can be screened. However, this strategy has certain
drawbacks as well. An enormous number of tails must be cut in the F2 generation,
and every family, representing a single insertion, occupies one tank for several months
until it can be screened. Incorporating these pros and cons, a lab of 15-20 people with
3,000 tanks could screen 17,000 insertions in 3 years.
However, by taking advantage of the fact that founders often experience multiple
proviral integration events in the same primordial germ cell, I would now propose a
more efficient screening protocol. This "multiple-insertion strategy" is outlined in
Figure 2. The strategy here is to generate F1 fish with multiple insertions, at least
three, which are then used to make F2 families with six or more segregating insertions.
The basis for the increase in efficiency by this method is that the same number of tanks
can hold at least five times as many insertions, which will ultimately be screened by
the same number of crosses per insertion as the single insertion method. More
founders must be produced because fewer insertions are screened from every founder
generated, but this is more than made up for in time by the lack of a requirement to cut
any tails in the F2 generation. As a result, roughly the same number of people with the
same number of tanks could screen 50,000 insertions in 3 years, three times as many
as by the single-insertion method. I have mapped out a scheme to conduct such a
screen in the Hopkins lab over the next three years and have begun to develop the
necessary assays and improvements in throughput to make this screen possible.
The first step in this method, after the founders are produced, is to test them for
germ line transmission levels. Every set of founders produced so far has shown a
huge range from founder to founder in transmission rate (see Chapter 3, Table 2).
Furthermore, there is a rough correlation between the overall percentage of F1
progeny which are transgenic and the proportion which have inherited multiple
insertions. It is important to cross two founders each of which transmit insertions at a
high rate and have some multiple insertion gametes in order to enrich for the number
of Fls which inherit three or more insertions, one or two from each parent. Based
upon the results of injections over the last three years, a little over half of the founders
injected with high-titer virus should transmit insertions at a sufficient rate. I have
devised an assay to rapidly test founders for transmission rate by the use of a
quantitative Southern upon DNA prepared from a pool of their embryos, such that
hundereds of founders can be tested every week. Thus "good" founders will be
quickly identified and crossed to each other to create F1 pools.
About 30 F1 fish will be raised from each founder cross, and Southern analysis
will be performed on DNA from their tails to find fish with multiple insertions. Among
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Insertional mutagenesis scheme:
Single Insertion Families
1. Inject pseudotyped virus
into blastula-stage embryos
2. Raise and outcross founders
3. Raise F1 pools and isolate
tail DNA from 50 fish from
each pool.
4. Identify transgenics by PCR
12345678
Insertion A: 1, 3, 4, 6
Insertion B: 7, 8 --
Insertion C: 5 =
Insertions A/C: 2
5. Identify fish with identical
insertions by Southern blot.
6. Outcross one fish per insertion
to generate an F2 pool; identify
transgenics by PCR
7. Inbreed fish with identical
insertions and screen for
phenotypes in 25% of their
progeny
Figure 1. Breeding scheme for "single insertion" screen
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Insertional mutagenesis scheme:
Multiple Insertion Families
1. Inject pseudotyped virus
into blastula-stage embryos
2. Raise and inbreed founders
3. Raise F1 pools and isolate
tail DNA from 30 fish from
each pool.
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thirty offspring of two "good" founders, there should be three or four F1 fish with three
or more non-overlapping insertions. These fish will be raised to sexual maturity, and
pairs of them will be crossed to generate F2 families in which there are six or more
insertions. In these F2 families, any given insertion will be in half of the fish. Thus one
quarter of the crosses will homozygous any given insertion. Without cutting any tails to
see which fish have which insertions, we will set up multiple crosses from each F2
family. In principle, this is just like the chemical mutagenesis screens. If six crosses
are screened per F2 family, then 82% of the insertions will have been homozygosed.
If at least five insertions are screened by every F2 family, then one in every 15-20
families should have an insertional mutation.
This method introduces certain complications, the most significant of which is that
when a mutation is found in a family, we will have to figure out which insertion is
responsible. This should be possible either by Southern analysis of the DNA of the
phenotypic embryos or by finding multiple pairs in the F2 family which transmit the
phenotype and analyzing their DNA to see which insertion they have in common. It is
important that this step can be achieved simply, because if a lab is screening 100 F2
families a week, then five or six mutations are being found every week for which the
causative insertion must be isolated.
Another important consideration in using this approach is that the starting
population of fish must be free of background mutations, or at least of background
mutations with common phenotypes. Unlike mice, there are no truly inbred strains of
zebrafish, and most laboratory populations have some background mutations. When
using the single insertion method this is not as much of a problem, because it is very
easy to establish if mutations are linked to the insertion: 1) every cross in the family
should give the phenotype and 2) while only 75% of the embryos would be transgenic
if the mutation were unlinked to the insertion, every phenotypic embryo would be
transgenic if they are linked; this can be determined quickly by PCR. When working
with families with multiple insertions, 1) only a quarter of the crosses should give the
phenotype, the same as if it were a background mutation, and 2) nearly all of the
progeny of crosses will be transgenic, making quick PCR-based linkage analysis
impossible. Thus it must be established, by multiple sibling crosses, that the starting
population for such a screen carries no scorable mutations. Chemical mutagenesis
screens have the same requirement and in some, but not all cases, they have done so.
I have identified two lines of fish in our laboratory which appear to be both lethal-free
and extremely robust and fecund. We will use these lines, as well as a less robust
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lethal-free line derived in Oregon, to generate founders, and plan to cross founders or
multi-insert F1s from the different lines to keep the fish robust through the screen.
The additional burden of identifying and isolating the mutagenic insertions out of
families with six or more insertions is certainly worth the three-fold increase in the
number of screenable insertions. Based on the frequency of insertions found in the
pilot screen, a fifty thousand insertion screen should generate 500 to 700 mutations. If
all of the estimated 2,400 embryonic essential genes are mutable by proviral insertion,
this should represent insertional alleles of 450-600 genes (based upon a random
Poisson distribution). As the chemical screens were thought to reach about half-
saturation, at least half of these can be expected to be easily clonable alleles of
previously identified loci, while the rest should be completely novel.
Alternative screening protocols
As discussed in Chapter 1, one of the features of zebrafish that made it an
attractive model organism for developmental genetics is the ability to create
gynogenetic haploids and diploids (25, 26). While both of these processes generate a
certain percentage of abnormal embryos which can complicate screening, they each
have potential for identifying a subset of developmental phenotypes. It is possible that
while the efficiency requirements of the F3 diploid screen only allow a limited number
of insertions from each founder to be screened, that quite a few more could be
screened for this subset of phenotypes without the space or effort required for raising
another generation for inbreeding. For example, after doing the Southern analysis to
identify the F1 fish which contain non-overlapping multiple insertions which will be
used to generate the F2 families, many of their siblings, which will have two or three
insertions, could be saved and used for the generation of gynogenetic haploids or
diploids.
Haploids could be used to find most mutations whose phenotypes are evident in
the first twenty-four hours. Additionally, some slightly later phenotypes, such as the
absence of blood, could be possibly be found by this method. While haploid embryos
can have a range of defects, genetically caused defects should be starkly visible as
they will be present in 50% of the embryos. Diploids, created by the early pressure
method, can be somewhat more complicated. While many of these will be entirely
normal and viable, a substantial proportion fail to develop properly, exhibiting a range
of retardation and other defects. As this method of generating diploids utilizes sister
chromatids after meiotic recombination has occurred, the percent of embryos
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homozygous for any locus will vary from 5-50%, depending upon the distance from the
centromere. Thus it will be somewhat harder to rely upon the percentage of
phenotypic embryos to separate true genetic defects from the background defects.
Nevertheless, several groups have used early pressure diploids for screens and have
isolated mutations with a wide variety of developmental defects.
One possibility for either of these methods is the use of molecular markers to pick
out very specific phenotypes which could not be seen morphologically. For example,
we could perform antibody staining or in situ hybridization for genes that would mark
cell types not visible to the eye, such as primordial germ cells (27), B cells in the
pancreas (L. Moss, pers. comm.), or the thymus (28). Similarly, we could use
antibodies to any of these markers, or which stain cell populations such as neural-
crest derived neurons (29). Staining for markers present within the first twenty-four
hours would best be done in haploids; while only diploids could be used for cell types
which arise later.
Gynogenetic diploids also hold out the only feasible possibility of screening for
recessive mutations which would be apparent in adults. For example, Johnson and
Weston (30) used adult gynogenetic diploids to screen for mutations affecting fin
regeneration; furthermore, they were able to find mutations which were temperature-
sensitive. Other adult screens could include a screen for maternal effect genes, as
well as adult pigment mutations and behavioral assays. Such screens, however,
require another fish facility of the size required for the F3 diploid screen in order to
maintain these fish until they are old enough to be screened.
Areas for improvement in the technology
The screen outlined in Figure 2, based entirely upon technology in hand, would
allow a lab of twenty people to generate insertional alleles in 450-600 genes in three
years. At the very least, this should include about one quarter of the genes found in
the chemical screens, so the cloning of over 25% of the genes which people are
currently trying or planning to positionally clone should be accomplished by the
cloning from these insertional alleles, plus nearly as many loci not mutated in the
chemical screens. This would represent perhaps 100-150 genes which mutate to a
"specific" phenotype; such an accomplishment alone is worth the effort. But what
could be done to make the mutagenesis even more efficient, to bring the number of
insertional mutants closer to saturation? Three technical improvements could
contribute to such a goal.
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One would be to produce virus of even higher titer in order to drive up the
transgenesis rate. Perhaps as little as a two-fold increase in titer might be enough to
guarantee that all of the founders transmit at a sufficiently high rate. This would
eliminate the entire founder-testing step in the screen; it would also mean that all of the
founders could be used instead of merely half. This alone, however, would not really
increase the number of insertions which could be screened, as the major limiting factor
is the number of F2 families that can be housed and screened. Thus the real benefit
from a raise in titer would come from increasing the number of insertions in each F2
family. If founders injected with higher titer virus had even higher frequencies of
gametes with three or more insertions, then when founders are crossed it should be
possible to reliably select Fls with five or more insertions. Thus it should be possible
to have at least 10 insertions in each F2 family, nearly doubling the number of
insertions that are screened in the same number of crosses and the same number of
tanks. This will make it somewhat more difficult to isolate the mutagenic insertion, but
the increase in the number of mutants would surely be worth it.
A more enticing improvement would be the use of other viral vectors that might be
more mutagenic. The observed frequency in the pilot screen was one mutant per
seventy insertions; this is nearly four times lower than that observed in the mouse. As
discussed above, it is unclear whether some target bias in proviral integration, which
could exist in the mouse and not in fish, could be responsible for some of this
decrease. However, it is also possible that a vector which is designed with strong
splicing signals (and possibly polyadenylation signals, see below) could be far more
mutagenic by increasing the target size within a gene in which the integration of a
provirus would interfere with the production of that gene product. As the majority of the
genomic sequence of most vertebrate genes is intronic, the ability of an insertion to
cause gene disruption when it lands in introns would be an important determinant of
this target size. Of the four cases of recessive mutations that we have completely
cloned so far, all four contain insertions in either the first exon or first intron, and in all
four cases transcription and/or the accumulation of stable mRNA, is eliminated. If there
is not a genuine preference for integration into the 5' ends of genes, then this apparent
bias might result from the fact that the SFG provirus used was only mutagenic when
inserted into exons or transcriptional regulatory regions. In fact, we have one other
mutation in which the provirus has integrated in a very large downstream intron in the
same transcriptional orientation as the gene; in this case, Northern analysis shows no
decrease in the amount of full length message. How this insertion causes the
phenotype, which is dominant, is unclear, but this case does demonstrate that an
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insertion of the SFG provirus in a large downstream intron, despite the presence of the
polyadenylation signals in the LTRs in the correct orientation, can be spliced out,
resulting in normal levels of wild type mRNA.
In order to design a proviral genome which should be able to disrupt genes when
integrated into introns, a strong splice acceptor/exon should be put into the virus in the
reverse orientation. This exon could terminate with either a strong polyadenylation
signal or a splice donor engineered such that inclusion of this exon in an endogenous
mRNA would change the translational reading frame. Studies of splicing mechanisms
have shown that it is not only the splice acceptor which is recognized in the splicing
event, but the whole exon (31,32). This is most efficient when exons are short and end
with strong splice donors, though polyadenylation signals can also serve in this
capacity (33). Furthermore, exon sequences known as splicing enhancers can
increase the efficiency of splicing from a weak splice donor (34), thus inclusion of such
sequences in this engineered exon could increase the frequency of its use. The
inserted exon could also have other features such as stop codons in all three reading
frames, or a small epitope tag in all three reading frames such that it could act as a
recognizable gene trap (see below). Such a virus could very possibly increase the
mutagenic frequency by as much as five-fold, allowing the above screening scheme to
isolate 3,000 insertional mutations, comparable to the number of mutants found in the
large scale chemical screens. Additionally, because insertions of such a vector should
create a fusion transcript containing the designed exon, it should be possible to use 5'
rapid amplification of cDNA ends (RACE) to clone the disrupted genes, which should
be easier than trying to find exons in the flanking genomic DNA as has been done so
far.
A variation of this method which could truly make it possible to achieve saturation
would be the development of a retroviral gene trap with a reporter which is readily
detectable in fish. As described in Chapter 1, these gene traps, which contain a
reporter gene such as lacZ preceded by a splice acceptor instead of a promoter, have
been successfully used to select for insertions into genes in murine ES cells (35). This
provides both an enrichment in mutagenic frequency (nearly half of gene trap-selected
insertions in the mouse create recessive mutations) and the ability to see the
expression pattern of the gene (36-38). Additionally, as with the vector discussed in
the preceding paragraph, it should allow the cloning of most genes by 5' RACE. In
zebrafish, even without ES cell technology, gene traps could be used to select for trap-
activating insertions amongst the progeny of injected fish, and half of a million
insertions could be prescreened from the same number of founders as used in the
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scheme above, truly allowing saturation to be achieved. Furthermore, one could
choose whether to inbreed all insertions which activate the trap, or only those which
have inserted into genes whose expression pattern is of interest to the investigator.
Thus even smaller labs could use this method if only interested in genes with certain
restricted expression patterns.
In order for this to work, one needs a reporter which can be detected at the level
of expression of most endogenous genes. If only very strongly expressed genes could
be detected, preselecting insertions based on trap activation would only allow the
isolation of mutations in these genes. Additionally, it would be best if the trapped-
insertion-bearing fish could be isolated upon their detection. The ideal reporter would
be green fluorescent protein (GFP) because it would allow the detection of trap events
in live animals. As shown in Chapter 2, a single copy of a transgene encoding the wild
type GFP can produce detectable fluorescence in zebrafish embryos when a strong
ubiquitous promoter is used. However, that level of expression does not appear to be
sufficient for easy detection when only some cells in the embryo are expressing it;
furthermore, many genes might express at much lower levels than produced by the
strong enhancer/promoter used in this transgene. Many variants of GFP, incorporating
both amino acid changes (39-41) and codon use changes (42, 43), have been made
which are both brighter and more efficiently translated (in mammalian cells). Such
variants might be readily detectable at these lower expression levels and more
restricted expression patterns.
Other possible reporters which would allow the isolation of live embryos after
detection would be lacZ and luciferase. If lacZ were used, embryos could be stained
with FDG for detection by fluorescence microscopy (44, 45); however, the staining
protocol would need to be improved as the current procedure is prone to the
identification of false positives if the embryos are not observed soon enough after
staining. Also, if very few cells are expressing lacZ, this method may not be able to
detect them; transgenic fish from lines which expressed lacZ either in a subset of
primary motoneurons or in a patchy, variegated pattern could be detected
unambiguously by X-gal staining but not reliably using FDG (45, S. Lin and N.
Hopkins, unpubl. obs.). In the case of luciferase, individual embryos can be placed in
96-well plates in media containing luciferin, and low levels of luciferase activity can be
detected by exposure to X-ray film (46). While this does not allow for the observation
of the pattern of expression, one could determine this after these fish have been used
to establish the next generation by antibody staining or in situ hybridization. Again,
169
whether either reporter will be sensitive enough to detect most genes would have to
be determined.
Alternatively, a number of reporters could be used which could only be detected
in fixed embryos. This would include lacZ, if the live stain proves unreliable, but also
could include any sequence of nucleic acid which could be probed by in situ
hybridization or would encode an epitope which could be detected by an antibody. A
similar possibility would be to use a very sensitive assay such as reverse transcription
- polymerase chain reaction on pools of embryos. In any of these cases, progeny from
injected founders would be fixed and stained (or lysed as a pool and assayed), and
any founders which transmit a trap-activating insertion would be outcrossed, their
progeny raised, and individual insertions tested in the next generation.
In order for any trap to be used in a retrovirus, it must be possible to produce the
virus at a titer comparable to SFG. This was not an issue for gene traps in murine ES
cells because infection and selection could be achieved in culture. However, in the
fish, one can only screen the insertions as they are transmitted through the germ line.
So far, we have tried to make pseudotyped virus for many trap vectors, some identical
to those used successfully in ES cells and some novel constructions (A. Amsterdam,
N. Gaiano, and N. Hopkins, unpubl. obs.). None so far have produced titers high
enough to be used in embryos; thus, this approach will require more work if it is to
become feasible.
There is one other potential concern when using splice-activated traps for
mutagenesis, which was alluded to when discussing the construction of a more
mutagenic vector. On one hand, the trap seems to fulfill the requirement of such a
vector, in that it has a functional splice acceptor, and should polyadenylate the
message after the reporter. However, because most reporter genes are longer than
vertebrate exons, recognition of the trap's splice acceptor might be suboptimal; some
proportion of transcripts might splice to the reporter, but enough may splice around it to
produce a significant amount of wild type gene product. This has been observed
sometimes when using gene traps in mice (e.g. 47). Ideally then, the reporter might
itself be constructed with exons and introns, or splicing enhancer sequences might be
engineered into the reporter. If such a vector could be constructed and produced at
high titer, a lab of twenty people should be able to find disruptive insertions in nearly
every gene expressed in the zebrafish embryo in a period of only 1-2 years.
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Cloning the genes
The rationale behind an insertional mutagenesis screen is that the genes should
be easy to clone. If we are going to undertake a screen which will isolate five mutants
a week, we need a way to clone them at a comparable rate. While perhaps we could
decide to only clone the genes whose mutation caused "interesting" phenotypes, I
think that it would be far better to try to clone them all as the identification of all of the
essential genes required for the development of a vertebrate will surely have its uses
(see below). So in addition to generating the mutants, it is important that we have
protocols to routinely clone the genes, such that five new genes could be initiated per
week.
Of the seven mutations that we have identified so far, genes for six have been
cloned. While these obviously do not represent the full range of possible situations
that will be encountered in trying to clone insertionally disrupted genes, they do
suggest the range of approaches that will be required. In four of the successful cases,
an exon with amino acid homology to a sequence in the public database was found
within 1.5 kbp of the insertion. It is not difficult to clone 2-4 kbp on either side of the
insertion by inverse PCR. Thus as a first step, these small fragments of flanking
genomic DNA will be sequenced, and this sequence used for database searches. If
putative exons are found by homology either to known genes, or more likely to human
or mouse ESTs or sequences from yeast, C. elegans, or other genome projects, RACE
will be used to verify that these really are expressed exons and to isolate the rest of the
cDNA sequence. However, as many as half of the genes are likely not to have
homologs in the database; additionally, some may not have exon sequences as close
to the insertion. One of these situations is very likely to be the cause of our failure to
clone the gene in the still-uncloned insertional mutation, and the latter was certainly
true in the case of the dominant mutation where the insertion was in a very large
intron. Thus, for cases where the first strategy fails, the flanking DNA will have to be
used to probe large insert libraries. The most efficient way to do this will be to have a
gridded library; thus PACs or BACs will be required such that only about 50,000
clones will be required. With these DNA samples, exon-hunting strategies will be
used such as exon trapping, low-stringency zoo blots, or cDNA selection. PCR can be
used to map putative exons to the insertion, and in the end, demonstration of absence
or alteration of the transcript in mutant embryos should be able to confirm that the
correct gene has been identified. This is how the gene for the SFG891 mutation was
cloned; while sequencing nearly two kilobases near the insertion failed to reveal
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homology to any genes in the database, exon trapping found two exons from the same
gene which were about 4 kb form the insertion and whose transcript was absent in
mutant embryos. Additional evidence that the correct gene has been identified will be
obtained using in situ hybridization, which should reveal that the gene is expressed in
a time and space consistent with the phenotype. However, this need not be an overly
restrictive requirement; many genes have expression patterns in regions either more
or less restricted than the manifestation of their phenotype. At the very least, the gene
should be expressed before the onset of the phenotype.
As stated above, if either a gene trap approach or the exon-insertion vector is
used, most mutations should result in the presence of a fusion transcript, allowing the
5' end of the cDNA to be cloned by 5' RACE. This can be followed by 3' RACE to get
the rest of the cDNA, and PCR can be used to confirm that these sequences are
contiguous with the insertion in the genomic DNA. Again, absence or alteration of the
transcript in mutant embryos will need to be demonstrated. The expression pattern of
the gene as determined by in situ hybridization should also match the expression
pattern of the reporter in the trap.
Implications for vertebrate biology
An insertional screen that could mutate and clone 20-30% of the genes required
for the embryonic development and simple embryonic behavior of the zebrafish will
have many benefits in the study of vertebrate biology. The most obvious would be in
the field of developmental biology, where such a screen would aid in the cloning of
many of the phenotypically interesting mutations identified in the chemical screens, as
well as identifying additional loci that were not found in these screens. The cloning of
these genes is essential to understanding the molecular events underlying the
developmental processes affected by these mutations. Once the genes are cloned,
one can begin to determine when and where they are expressed, what their
biochemical function is, and how they interact with each other.
Sequence analysis of the proteins encoded by these genes will often suggest
biochemical function, based upon homology to other known proteins. Thus, for
example, the Nar protein is likely to be an endoribonuclease based upon its homology
to the Drosophila gene Clipper. While the targets and developmental role of these two
gene products may or may not be the same, this biochemical activity provides a
starting point; one could for example next determine what sequences are targets for
this nuclease, what genes contain them, and what the consequences upon their
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message and protein levels is in the absence of Nar protein. Similarly, common motifs
may suggest that a protein is a transcription factor, secreted protein or transmembrane
receptor. In these cases, one can begin to determine targets and proteins with which
they interact.
In other cases, it may be less clear where to start. For example, while dye shares
some homology with a yeast nuclear pore protein, it is far from certain that this
sequence similarity correlates with conservation of protein function, as opposed to
patches of structural similarity. A first step here might be to assess the subcellular
localization of Dye protein in order to see if it is associated with nuclear pores.
Similarly, subcellular localization of Pes protein might demonstrate that it is nuclear, as
suggested by the BRCT motif it shares with certain other nuclear proteins involved in
DNA repair and the cell cycle.
However, the identification of so many essential genes may have value beyond
the principles of only developmental biology. Over two-thirds of the mutants found in
the chemical screen were discarded as "non-specific", or fell in phenotypic classes
with too many mutants to make complementation analysis possible, such as
widespread degeneration in the central nervous system. If positional cloning is the
only option for cloning chemically mutated genes, given the effort required and the
limited number of genes that can be pursued at once, no one would choose to try to
clone these. Many of these genes are probably required for basic cell biological
functions that may be poorly understood in higher eukaryotes. If it were easy to clone
these genes, sequence analysis for some of them might immediately suggest their
function based on cell biology studies, providing a system in which to observe which
gene products are essential for such processes and what the consequences are of
their loss. Thus the genetics could contribute to cell biology and vice versa.
An identification of a large proportion of essential genes in the fish could also
complement functional genomics approaches being undertaken in genome projects.
Currently, a great deal of effort is being applied in the scientific community to identify
all of the genes expressed in several organisms, ranging from yeast to worms to flies
to mammals. Approaches are required to determine the function of these genes in
order to make sense of all of this information. One approach has been a community-
wide effort in the yeast field to disrupt every one of the 6,000 open reading frames
identified in the sequencing of the yeast genome (48). This is not yet feasible with
mammalian genome projects; even in mice where homologous recombination can be
used to disrupt any gene in ES cells, it is impractical to generate chimeras from
hundreds of thousands of ES cell lines. Instead, expressed sequence tags (ESTs) can
173
only be mapped and analyzed at the amino acid sequence level. Sometimes they will
map to the same position as a genetic disorder, in which case they could become a
candidate for such a mutation. Other times their sequence will suggest an interesting
function and they can be studied by overexpression or knock-out in mice. A forward
genetic screen that could find essential genes in a vertebrate is likely to be able to
assign genetic and possibly biochemical function to many of these ESTs.
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APPENDIX 2
PRODUCTION OF TRANSGENIC ZEBRAFISH
(Published as Amsterdam, A. and Hopkins, N. (1997) in Cell Biology: A Laboratory
Handbook, ed. Celis, J.E. (Academic Press, San Diego): 502-509.)
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I. INTRODUCTION
Germ-line transmission of exogenous DNA in zebrafish was first reported by
Stuart, et al. (1988); these transgenic fish were made by the microinjection of plasmid
DNA into the cytoplasm of one-cell stage embryos. Subsequently, transgenic F1 fish
were shown to be capable of expressing reporter genes, such as chloramphenicol
acetyl transferase (CAT, Stuart, et al., 1990), lacZ (Bayer and Campos-Ortega, 1992,
Lin et al., 1994a), and Green Fluorescent Protein (Amsterdam, et al., 1995). Typically
5-10% of injected embryos transmit the foreign DNA to their progeny, although higher
frequencies have been observed (Culp, et al., 1991). The germline of founder fish is
mosaic such that anywhere from 2-50% of the F1 generation is transgenic. F1 fish are
not mosaic and thus transmit the transgenes in a Mendelian fashion. The inherited
transgenes can vary from single copy inserts to arrays of over one hundred copies,
which can include head-to-tail, head-to-head and tail-to-tail multimers of the plasmid
DNA; partial deletions of the plasmid have also been observed.
Lin et al. (1994b) demonstrated another method for the generation of germ-line
transgenic zebrafish: the use of a pseudotyped retrovirus which is capable of infecting
zebrafish cells due to the presence of the glycoprotein (G protein) of the vesicular
stomatitis virus (VSV) in its envelope. When injected into blastula stage embryos,
these viruses can infect and integrate their proviral DNA into the chromosomes of
many cells in the developing embryo, some of which are destined to become the
germ-line. As in the case of microinjected DNA, the germlines of injected fish are
mosaic, with most insertions being passed on to 2-10% of their progeny; F1 fish then
transmit their transgenes in a Mendelian fashion. Unlike microinjected DNA however,
the transgenes are always present in a single copy per locus. The frequency of
achieving germ-line transmission appears to be dependent upon the titer of the virus
stock. Due to the structural stability of retroviruses containing the G protein, virus can
be concentrated to very high titers by ultracentrifugation. If the virus titer is sufficiently
high, every injected fish can transmit proviral DNA to its progeny; furthermore, as
multiple germ cells can be independently infected, a single founder can transmit many
different insertions (Gaiano, et al., 1996a). Additionally, a single germ cell can be
infected by multiple retroviruses resulting in multiple independent insertion events in a
single germ cell. Thus individual F1 fish can inherent multiple proviral insertions at
different loci, and each provirus segregates in a Mendelian fashion.
Currently, DNA microinjection is the preferred method for the generation of
transgenic zebrafish which express their transgene. Any plasmid can be used for DNA
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microinjection, thus there are no constraints on the sequences inserted. In contrast,
expression from retrovirally-delivered transgenes has not yet been observed after
passage through the germline, and the life cycle of the retrovirus does put constraints
on the sequence of the transgene (e.g. the presence of long terminal repeats (LTRs)
on each end, a size limit, the exclusion of introns in the forward orientation which
would be spliced out) However, for the goal of generating large numbers of
independent insertion events, such as would be needed for enhancer-trap screening
or insertional mutagenesis, the remarkable increase in efficiency obtained by the use
of high-titer virus makes retroviral infection the method of choice (Gaiano, et al., 1996b,
Allende, et al., 1996)
The methods laid out below represent what are currently the most well established
techniques for the reliable production of transgenic zebrafish. However, this is a
rapidly advancing field, and new methods are certain to emerge. Examples of these
would be the inclusion of restriction enzymes with the DNA in microinjection
(restriction enzyme mediated integration, as has been done in Neurospora), retrovirus
and transposon derived integrases, or nuclear localization peptides.
II. MATERIALS AND INSTRUMENTATION
A. Zebrafish
Zebrafish can be obtained from local pet stores, or specific strains can be obtained
from other zebrafish labs. The raising and maintenance of the fish is described
extensively in Westerfield (ed.), 1994
B. Injection equipment
Injection systems can be simple or more elaborate. One can use motor-driven
calibrated injection systems. However, it is far less expensive to merely use a
micropipette holder (Narishige HI-6-1) attached to a syringe via Tygon tubing. The
tubing can either be filled with mineral oil (Atochem Voltalef seems to work best, but M-
3516, Sigma is an acceptable alternative) or just air.
For beginners, it is recommended that the needle holder be mounted on a
micromanipulator (though those experienced and dexterous enough can simply hold
the needle holder in their hand). A Leitz (520-137) is one of the simplest to use as it
has a single dial to rotate the vertical angle while a joystick controls left-right and
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forward-back movements; however it is also quite expensive. A less expensive option
is one in which a different dial moves the needle in each of the three planes, such as
the Narishige MN-151.
Injection needles are prepared on a horizontal needle puller (such as Sutter P-87)
from 10 cm hard glass capillaries (Sutter BF100-50-10).
Injections should be performed on a dissection scope with a long working distance
and a zoom facility to provide a magnification range from 10X to at least 50X.
C. CHEMICALS
Pronase (P-5147) puromycin (P-8833) and 3-aminobenzoic acid ethyl ester (A-
5040) are from Sigma; G418 (11811-031), DME (11965-092), L-15 (11415-023),
calcium and magnesium free PBS(14190-144) trypsin-EDTA (25300-047), penicillin-
streptomycin-funguzome (15240-062) are from GIBCO/BRL Life Technologies, fetal
calf serum (A-1115-L) is from Hyclone, Proteinase K (24565-2) is from Boehringer
Mannheim. All other reagents are of the best grade available and purchased from
major suppliers. Solutions should be prepared with double distilled or reverse
osmosis water.
II. PROCEDURES
A. DNA microinjection
It is considered best to inject the DNA while embryos are still at the one-cell stage,
although this precludes eliminating unfertilized eggs. As early embryonic cleavages
are very rapid, it is thought that the earlier DNA is injected, the better the chance it has
of integrating early, and therefore more extensively in the embryo . Thus eggs should
be collected after a very short laying period; females and males can then be
temporarily separated, and placed back together when you are ready for a fresh batch
of eggs.
While supercoiled plasmid DNA can be used, most researchers linearize the
plasmid with an appropriate restriction enzyme such that the break will not interrupt the
desired sequence. In transgenic mice, it has been noted that bacterial vector
sequences have a negative impact upon gene expression, and thus most researchers
cut away the entire backbone of plasmids to be injected. This has not been
investigated systematically in zebrafish; however, it is known that linearized DNA can
be digested (presumable by endogenous exonucleases) on the ends, such that
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varying amounts of sequence (at least a few hundred bases) from the site of
linearization may be deleted. Thus while it is not certain whether the inclusion of
bacterial vector sequences is deleterious to transgene expression, it may be helpful to
provide a buffer zone for the truncation of the ends of the linearized molecule once
inside the cell.
Solutions:
1. Holtfretrer's solution: Dissolve 7 g NaCI, 0.26 g CaCI2, 0.1 g KCI and 0.4 g NaHCO3
in 1 liter of water; pH to 7.2. Always make fresh on day of use.
2. Pronase stock solution (30 mg/ml): Dissolve 1.5 g pronase in 50 ml water. Heat to
37 0C for 1 hr. Aliquot and freeze at -200C.
3. Pronase working solution: Dilute pronase stock 30:1 in Holtfreter's soution.
4. DNA soution: DNA should be purified by banding twice on a cesium chloride
gradient, though some investigators have used plasmid DNA purified by the use of
resin columns such as QIAGEN (12162) or Promega (A7270). If plasmid is linearized,
enzyme digestion should be followed by phenol/chloroform extraction and ethanol
precipitation. The injected DNA should be at a concentration of 100 Rg/ml in 100mM
KCI, ImM Tris pH 8.0. Optional additives (for the visualization of microinjection and
confirmation that injected fluid is retained) include fluorescien-dextran (12%) and/or
phenol red (2%)
Steps
1. Prepare an agarose ramp for the eggs. Pour molten 1% agarose into a 60 mm petri
dish and insert a wide glass slide at a slight vertical angle. Removal of the slide after
the agarose hardens should leave a ramp terminating in a groove upon which the
embryos can rest Pour enough Holtfreter's solution on this to cover most of the ramp.
2. Under the microscope on high magnification, break off the end of the injection
needle with a razor blade. Insert into the needle holder. if oil is being used, force it to
the end of the needle. Place a small drop (2-5 [l) of DNA on a cover slip, and draw it
into the needle.
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3. Collect freshly laid eggs and dechorionate in 1 mg/ml pronase in a glass beaker.
After the eggs have been in the pronase for five minutes, gently swirl the soution. If the
chorions begin to come off, begin rinsing; if not, wait a few minutes and try again.
Rinse by pouring off nearly all of the pronase (do not pour off so much that the eggs
are no longer submerged; once dechorionated the eggs are fragile if they contact air),
filling the beaker with Holtfreter's, pouring this off, etc. about ten times. The chorions
should all come off in the first few rinses; if not, additional time in the pronase will be
required, followed again by about ten rinses with Holtfreter's.
4. Use a Pasteur pipette to transfer eggs to the ramp - be sure to avoid getting air
bubbles in the pipette or the embryos may lyse as they pass through it. Line the eggs
up along the groove. Use the injection needle to orient each egg so that the cytoplasm
is facing the needle and insert the needle into the egg.
5. Apply a little pressure if you are using a syringe (or deliver as appropriate for the
injection apparatus used) You should be able to see a small puddle form - this is more
easily seen if phenol red is present in the DNA solution. Inject enough so that the
diameter of this puddle is about one third the diameter of the egg.
6. Withdraw needle and move on to the next egg. When all eggs on the ramp are
done, move them to a dish of Holtfreter's.
7. Repeat with another rampful of eggs. Note that there is a narrow time window for
injection at the one-cell stage; the first cleavage occurs 45 minutes after fertilization.
Begin procedure with freshly laid eggs as necessary.
8. Move embryos to a 280C incubator. After a few hours, clean out eggs that have not
cleaved (some will be unfertilized) or have exploded due to injection trauma.
9. Leave at 280C in Holtfreter's overnight. The next day, clean out embryos which
have not developed properly and transfer to half Holtfreter's, half fish water. On the
second day, transfer to fish water, and continue to raise as described in Westerfield
(ed.) 1994.
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B. Retroviral Infection
In order to make the pseudotyped virus, you have to use producer cells:
mammalian tissue culture cells which express most of the gene products necessary to
package the retrovirus, such as a 293 line stably expressing gag and pol (293GP,
Burns, et al., 1993). To make virus, you have to express the viral genome and the G
protein within the same packaging cell line. The G protein must be expressed
transiently, as it is toxic to the cells; however the viral genome can be expressed either
transiently or stably. Transient co-transfection of viral genome and G protein is a quick
way to produce virus for testing viral constructs, but will not produce as high titer a
stock as isolating stably-expressing clones. The latter procedure is described below,
but transient co-transfection can be done by skipping to step 9, and adding 5 lag of
genome plasmid per milliliter of DNA- calcium phosphate precipitate.
How you titer the virus will depend on what reporter gene it possesses (if any). If
the viral genome harbors and expresses a selectable marker, such as the neomycin
resistance gene, the titer can be determined as colony-forming units. If it expresses a
visible marker, such as lacZ, the titer can be determined as the number of expressing
cells (or small cell clones). If neither of these is the case, then a more difficult and less
accurate method will have to be used, such as performing a quantitative Southern blot
on genomic DNA harvested from infected cells. As these details will change with
different viral constructs, the procedure here will only describe the steps common to all
viral constructs. As described here, titering is performed on PAC2 cells, an embryo-
derived zebrafish cell line (Lin, et al., 1994b). However, other zebrafish cell lines
could probably be used as well.
This procedure involves basic tissue culture techniques that are beyond the scope
of this section. It is important to note that the pseudotyped retrovirus can infect human
cells as well as fish cells! Therefore, all work with live virus must be done under BL2+
conditions and any dish, pipette or needle that contacts the virus must be bleached
before disposal. Contact the safety office at your institution for further details.
Solutions
293GP ("packaging" cell line) media: Add 50 ml fetal calf serum and 5 ml of penicillin-
streptomycin-funguzome to 450 ml DME
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PAC2 (zebrafish cell line) media: Add 15 ml fetal calf serum, 1 ml of penicillin-
streptomycin-funguzome and 4 ml zebrafish embryo extract to 80 ml L-15
Zebrafish embryo extract: Place 100 3-day embryos per milliliter Ringer's solution (per
liter: 6.78g NaCI, 0.22g KCI, 1.19g Hepes, 0.2g CaC12.2(H20), pH 7.2) in a dounce
homogenizer on ice. Dounce ten times, decant into a centrifuge tube. Spin out
insoluble material (3K, 10 minutes) and use supernatant fresh, or freeze at -700C
2X HBS: Dissolve 1.64g NaCI, 1.19g Hepes, 0.021g Na 2HPO4 in 100 ml water, pH to
7.05, filter sterilize, aliquot and store at -200C
2M CaCI2: Dissolve 2.94 g CaCI2.2(H20) in 10 ml water, filter sterilize, store at 40C
Polybrene stock solution: Dissolve 8 mg polybrene in 10 ml water, filter sterilize, store
at 40C
Steps
1. Grow the packaging cell line (e.g. 293GP) to 80% confluence on a 10 cm plate at
370C, 5% CO02. Add 9 ml fresh media.
2. Mix 8 pIg plasmid encoding the viral vector genome (the genome of the virus you
wish to make a stock of) and 2 g of SV2puro (a plasmid expressing the puromycin
resistance gene) with water to a total volume of 437 p in a 3 ml polystyrene tube. Add
500 p 2X HBS and flick gently to mix. Add 63 I1 2M CaCI2 and flick vigorously to mix.
Let this stand for 20 minutes at room temperature. It should turn very slightly opaque.
3. Add the DNA-calcium phosphate mixture dropwise to the plate of cells. Gently swirl
and return to incubator for 8-12 hours.
4. Aspirate the calcium phosphate precipitate-containing media from cells, wash once
with PBS, add fresh media, and return to incubator for 24 hours
5. Wash cells with PBS, add 1 ml trypsin. When cells begin to come off the plate, add
4 ml of media, and pipet up and down to evenly distribute the cells. Replate in media
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containing 2 jlg/ml puromycin; two plates for each dilution of cells: 1:40 (0.125 ml),
1:20 (0.25 ml), 1:10 (0.5 ml) and 1:5 (1 ml)
6. Grow cells, changing media every 3-4 days (with puromycin). Within a few days,
nearly all of the cells should die from the puromycin; after about a week small colonies
should begin to appear.
7. When colonies are big enough, pick and expand them, keeping them in selective
(puromycin-containing) media It is advisable to freeze down a vial of each clone when
you have expanded enough so that you have a back up stock of each clone.
8. To test the clones for virus production, expand each one to 80% confluence on a 10
cm plate, refeed with 8 ml fresh media and transiently transfect the G-expressing
construct (HCMV-G, a plasmid in which the expression of the G protein is driven by
the cytomegalovirus enhancer/promoter) as follows (scale up for the number of clones
being tested - the amounts listed are per 10 cm dish):
9. Mix 22 gg HCMV-G plasmid with water to a total volume of 974 il in a 3 ml
polystyrene tube. Add 1 ml 2X HBS and flick gently to mix. Add 125 jlI 2M CaCI2 and
flick vigorously to mix. Let this stand for 20 minutes at room temperature. It should turn
very slightly opaque.
10. Add the DNA-calcium phosphate mixture dropwise to the plate of cells. Gently
swirl and return to incubator for 8-12 hours.
11. Aspirate the calcium phosphate precipitate-containing media from the cells, wash
once with PBS, add 7 ml media, and return to incubator for 24 hours.
12. Collect virus-containing supernatant and refeed cells with 7 ml media. Repeat
every twelve hours two or three more times. The harvest with the highest virus titer will
have to be determined, and may vary from transfection to transfection. At each
harvest, it is good to look at the cells under the microscope. The G protein will cause
the cells to fuse into syncytia; widespread syncytia formation is a sign of a good
transfection. After collection, supernatants are then filtered through a 0.45j1m syringe
filter, aliquoted, and stored at -70 0C
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13. Determine the virus titer of each supernatant by infecting a plate of PAC2 cells. As
stated above, just how you titer will depend on the virus construct. One way to cut
down the work is a two stage screening process. In the first stage, fish cells are
infected with each supernatant, and after 48 hours the cells are lysed and genomic
DNA is harvested. PCR is then used to determine the presence of proviral DNA. This
will eliminate from further analysis any clones which produce little or no virus at all.
Supernatants positive for production of proviral DNA can then be more carefully titered
by using appropriate serial dilutions and an appropriate assay, such as selection of
G418-resistant colonies, lacZ-expressing cells, etc. In order to infect PAC2 cells, grow
cells to 50% confluence (at 320C, no C002). Aspirate media, add just enough volume
of appropriately diluted virus (in L-15 plus 8 plg/ml polybrene) to cover (e.g. - 0.2 ml for
6-well plates or 3.5 cm dishes, 0.5 ml for 6 cm dish, 1 ml for 10 cm dish) and return to
incubator. Gently rock plates every twenty minutes to be sure all of the cells remain in
contact with the virus and do not dry out. Infect for 3 hours, then aspirate virus and
refeed cells.
14. Once you have selected the clone which appears to give the highest titer, do a
larger scale transfection of this clone with the G construct, and then concentrate the
virus:
15. Expand the cell line to 8 (or more) 15 cm dishes and refeed with 16 ml fresh
media. Transfect as above with the HCMV-G plasmid, except make 4 ml of precipitate
(double the recipe in step 9) per plate. Again, harvest supernatant (in 15 ml of low-
serum media per plate) at several time points ranging from 24-72 hours.
16. To concentrate the virus, spin the supernatants in a SW28 at 25K for 2 hours at
40C. Aspirate off the media and invert over a paper towel briefly. Resuspend each
tube (40 ml originally) in 40 pI PBS. Let stand at 40C for several hours to fully
resuspend, then aliquot and freeze at -70oC. Test titer as above to select the best
stock
17. To infect blastula, collect eggs and dechorionate as in DNA microinjection. Set up
agarose ramp and injection apparatus (in BL2+ laminar flow hood) as in section IIIA
(DNA microinjection).
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18. Add polybrene to concentrated virus to a final concentration of 8 g/ml and load
about 5 41 of virus into an injection needle. Add 0.5 ml polybrene stock to 50 ml
Holtfreter's solution. Use this solution on the ramp during injection. Once the embryos
have reached early blastula stage (e.g. 256-512 cell stage) place them on the ramp.
Inject virus in between the cells. Once you have finished a row of embryos on the
ramp, go through the same embryos again so that each embryo is injected twice,
several minutes apart.
19. Transfer the injected embryos to a small beaker or dish with Holtfreter's (no
polybrene) and incubate at 280C overnight. The next day, move healthy embryos to
half Holtfreter's, half fish water. On the second day, transfer to fish water, and continue
to raise as described in Westerfield (ed.) 1994.
C. Testing potential founders
For DNA microinjection and retroviral infection with viral stocks with titers below 108
infectious particles per ml, it is more efficient to test potential founders by mating them
to each other, as only a small percentage of the injected fish will transmit the
transgene. For retroviral infection with higher titers, it is best to cross potential
founders to uninjected fish. As the mosaicism of the germline can be variable, it is best
to test 100 offspring per potential founder.
Solutions
Lysis buffer: 200mM NaCI, 100mM Tris pH 8.3, 0.4% SDS, 5mM EDTA. Autoclave and
store at room temperature
Proteinase K: Mix 100 mg lyophilized Proteinase K in 10 ml of water; aliquot and store
at -200C
TE: 10mM Tris pH 8.0, 1mM EDTA
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Steps
1. Collect batches of eggs from each cross and sort the fertilized eggs away from
unfertilized eggs. Incubate in fish water overnight at 28 0C. Add 10 p1 Proteinase K
stock to each ml of lysis buffer. Incubate 100 day-old embryos per ml lysis buffer at
55 0C overnight on a rotator.
2. Remove 300p1 of lysed embryos, add to 1 ml ethanol, and spin for 10 minutes in a
microfuge. Wash pellet with 70% ethanol and resuspend in 300pl TE.
3. Perform PCR on 1 pl of DNA with primers internal to the provirus. It is advisable to
include internal control primers which will amplify a sequence of zebrafish DNA with a
different size band than the expected band for the amplified proviral product. It is best
if both amplified products are under 500 bp. Exact conditions will have to be worked
out empirically, but a suggested reaction mixture and cycle follows:
Reaction mix: 67 mM Tris pH 8.8, 16mM (NH4)2SO4, 3mM MgCI2, 100#pg per ml
bovine serum albumin, 10 mM B-mercaptoethanol, 800kM dNTPs, 1M each primer.
Reactions are carried out in 30pl
Cycle: 940C 2 minutes; 30 cycles of 94 0C 30 seconds, 60 0C 1 minute, 720C 1 minute;
720C 7 minutes.
E. Identification of transgenic fish for raising
The easiest way to isolate viable transgenic F1 progeny is to isolate DNA from tail
biopsies of six week old (or older) fish and perform PCR. Because large numbers of
fish must be analyzed at once, it is best to conduct all of the reactions in 96 well plates.
The procedure below allows you to do this without the precipitation of the DNA. In
order to discriminate between different insertions from the same founder, Southern
analysis must also be performed. For Southern analysis one should digest the
genomic DNA with a restriction enzyme which cuts in the proviral sequence once,
such that two junction fragments of diagnostic lengths can be observed. DNA from
PCR-positive fish must be ethanol precipitated to do this.
Raise fifty to several hundred progeny from each identified founder, depending
upon how many transgenic F1 fish you require. Fish are generally large enough to
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have their tails cut by two months of age; however if extensive Southern analysis is
required, it is recommended to let them grow larger so that larger pieces of tail (and
thus more DNA) can be isolated.
Solutions
Anesthetic: Dissolve 0.2g 3-aminobenzoic acid ethyl ester in 500 ml fish water
Lysis Buffer: 100mM NaCI, 50mM Tris pH 8.3, 0.2% SDS, 5mM EDTA. Autoclave and
store at room temperature
Proteinase K: Mix 100 mg lyophilized Proteinase K in 10 ml of water; aliquot and store
at -200C
Steps:
1. Fill one or more 96-well plate with 1001 per well of lysis buffer (20p Proteinase K
stock per ml).
2. Anesthetize fish in anesthetic solution. You can anesthetize several at once, but not
too many, because if they are in it for more than a couple of minutes they may not
recover.
3. Remove anesthetized fish with a plastic spoon and place on a small piece of
parafilm. Cut off the end of the tail with a scalpel and move the fish to a numbered
beaker.
4. Once all of the fish have been cut, incubate the tails in the lysis buffer at 550C for at
least 3 hours
5. Using a multichannel pipetor, pipet up and down the lysed tails to break up the
pieces. Dilute 5pC of the DNA into 1001l of water, and incubate at 950C for 5 minutes
to inactivate the Proteinase K. Use 11I of diluted DNA per PCR reaction
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6. PCR positive samples can then be ethanol precipitated and analyzed by Southern
blot. For small tails (e.g. those from 6-8 week old fish) the entire DNA sample must be
used. Tails from larger fish will provide enough DNA for several lanes if necessary.
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APPENDIX 3
GREEN FLUORESCENT PROTEIN: USES IN TRANSGENIC VERTEBRATES
(To be published as Amsterdam, A. and Hopkins, N. (1998) in Green Fluorescent
Protein: Uses and Applications, eds. Chalfie, M. and Kain, S.R. (J. Wiley & Sons: New
York).)
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The ability to express exogenous DNA in vertebrate animals has been invaluable
to a wide range of biological studies. Our understanding of processes as diverse as
gene expression, cell lineage relationships, and gene function have all benefited from
the use of "transgenic" animals. Furthermore, transgenesis is a powerful tool for
techniques such as mutagenesis, genetic alteration of animals for commercial uses,
and human gene therapy. Many transgenic studies utilize reporter genes, such as the
bacterial lacZ and chloramphenicol acetyltransferase (cat) genes, that can be used
both to show where the gene was expressed and to quantify the level of expression.
However, the analysis of these reporter genes usually involves killing the animal,
precluding many types of experiments. The discovery that the gene encoding Green
Fluorescent Protein (GFP) could be used as a reporter for gene expression in living
animals (Chalfie et al., 1994) has potentially made many of these experiments
possible. This chapter will briefly summarize different types of transgenesis in a few
vertebrate organisms, the different biological questions best addressed by the use of
these different types of transgenic vertebrates, and the ways in which the GFP gene
could be particularly useful in such studies. This background discussion will be
followed by a review of the successful uses of GFP in transgenic vertebrates to date
and what issues remain to be resolved in order for GFP to be best utilized in these
powerful systems.
TRANSGENESIS IN VERTEBRATES: METHODS AND USES
The word "transgenic" is used to refer to an organism whose cells contain
exogenous DNA. There are two predominant distinctions: whether the DNA is
integrated into the host's chromosome or not (transient vs. stable transgenics) and
whether or not all of cells of the organisms contain the DNA (mosaic vs. non-mosaic).
Often the term "transgenic" is only used for the case where DNA has integrated into the
host genome and is present in every cell in the animal, a situation best confirmed by
passage through the germ line. However, it is equally appropriate to think of animals
in which only some cells contain the foreign DNA, which may or may not be stably
maintained, as "transgenic". For many types of experiments such "transgenics" are the
only feasible option, and for others they are actually more appropriate than
"transgenics" in which every cell harbors the integrated transgene.
Transgenics can be defined methodologically into two major classes: those
organisms into which the DNA was introduced (Go, the founder generation) and those
(F1, F2, etc., subsequent generations) who have inherited stably integrated copies of it
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through the germ line. The former can be divided into three phenomenological
classes: transient and mosaic, stable and mosaic, and stable and non-mosaic. The
last is often treated as functionally equivalent to a germ line transgenic, since both
involve integration of the transgene in all of their cells (see Table 1).
Table 1: Methods for making different types of tr ansgenics
TYPE OF METHODS
TRANS(ENIC
GO DNA microinjection
t ransient episomal virus
particle-mediated gene transfer
GO  int egrati ng virus
stable mosaic cell transplantation
O  microinjection into egg pronucleus (mouse)
stable non-mosaic sperm nuclear transplantation (frog)
g ermline inheritance of integrated transgene
stable non-mosaic through germline of GO transgenic
Transient transgenics
Transient transgenics, where the foreign DNA is not necessarily integrated into the
host's chromosome, can be achieved either by the delivery of plasmid DNA or by the
use of episomal viruses, such as adenovirus, herpes simplex virus, or vaccinia virus.
Such methods generally only deliver DNA to some of the cells of the animal, and this
DNA is not necessarily stable over time. These are most useful either for quickly
testing the tissue specificity of cis-acting elements or for testing the effects of ectopic
expression of a given gene where it is either unnecessary or impossible to express it
in the entire organism.
One example of transient transgenesis is the injection of plasmid DNA into one-
cell stage frogs or fish. Such DNA is highly replicated during blastula stages and is
unevenly distributed amongst the rapidly dividing cells of the developing embryo. In
some proportion of the cells the DNA can integrate, and most, but not all, non-
integrated DNA appears to be destroyed during gastrulation (Rusconi and Schaffner,
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1981; Stuart et al., 1988). Thus, distribution of the exogenous DNA is widespread but
uneven, highly variable, and unstable over time. Nevertheless, these methods can be
used to demonstrate temporal and tissue- and region-specific restriction of a cis-acting
element (Krieg and Melton, 1985; Mohun et al., 1986; Brakenhoff et al., 1991;
Westerfield, et al., 1992) by using fusion genes of the cis-acting DNA to be tested with
a reporter gene. GFP could prove to be a very useful reporter in such experiments as
the expression pattern of the transgene could be observed in live embryos. Instead of
histochemical procedures which require many processing steps, one would only need
to observe the embryos by fluorescence microscopy. More importantly, the same
animals could be observed at several time points, which could help overcome the
problem of variability in the mosaicism of the transgene from embryo to embryo.
Transient mosaic expression by plasmid microinjection can also be used to
investigate the biological effect of widespread ectopic expression of a given gene
product (Giebelhaus et al., 1988, Christian and Moon, 1993, Hammerschmitt et al.,
1996). There are other methods for delivering plasmid DNA later in the development
of an animal that are more appropriate for examining the effect of a specific gene
product in a more select population of cells later in development. Wolff et al. (1990)
demonstrated that plasmid DNA could be injected directly into the muscle tissue of
adult mice and that 10-30% of the cells in the injected area would take up and express
this DNA. Furthermore, extrachromosomal DNA was stable in these cells and
continued to express for at least two months. Another method for delivering DNA into
cells in living tissue is particle-mediated gene transfer, or biolistics, in which micron-
sized gold particles are coated with DNA. These particles are then used to bombard
target tissue at a very high speed, resulting in the uptake of the DNA in many of the
cells (Pecorino and Lo 1992). Recombinant episomal viruses, such as vaccinia virus
(Moss, 1991), herpes simplex virus (HSV, Geller and Breakefield, 1988), and
adenovirus (Stratford-Perricaudet and Perricaudet, 1991) , also have been used as
gene delivery vectors. With these methods, as with microinjected DNA, expression is
variable and mosaic, and the correct interpretation of the results of ectopic gene
expression requires knowing which cells are expressing the gene. While a co-
expression marker such as lacZ, or in situ hybridization for the gene of interest itself,
can indicate the expression pattern of the gene at the time of analysis, sometimes it
can be useful to see the expression before the time point of the final assay. Thus a
reporter gene whose expression could be assessed in real time in the same animal
could be very useful for monitoring the extent and persistence of gene expression.
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Stable mosaic transgenics
While transient transgenics are generally both mosaic and unstable, it is possible
to make stable mosaics - animals in which only some cells are transgenic, but the DNA
is integrated in their chromosomes and thus stable in these cells and their
descendants. This form of transgenesis is very useful for establishing lineage
relationships of cells or investigating the effects of a transgene or genetic alteration in
a subset of cells. It is also a potential vehicle for gene therapy, in which a gene is
introduced into some of the cells of an animal (human animals being the ultimate goal)
to correct a genetic defect. The primary means of achieving stable mosaic
transgenesis are infection with integrating viruses (such as retroviruses or adeno-
associated virus) and cell transplantation.
Retroviruses infect cells and insert a copy of their genome into the chromosome.
Most retroviruses (though not certain lentiviruses) require that the infected cell go
through mitosis before integration can occur. Their natural life cycle then allows them
to replicate and spread from cell to cell, though they can be engineered to be
replication-defective. Replication-defective recombinant retroviruses which express a
visible marker can be used to infect a small number of cells and thus mark clones of
their descendants (Price et al., 1987). Similarly, one can investigate the
consequences of the ectopic expression of a gene of interest in a spatially limited area
of a developing organism by expressing it from either a replication-defective virus
(Ishibashi et al., 1995) or a replication-competent virus, which can increase the target
area (Morgan et al., 1992). Another virus which can be used for gene transfer is
adeno-associated virus (AAV, Muzyczka, 1994) AAV is a non-pathogenic virus whose
genome can persist extrachromosomally but can also integrate into the host cell
genome at some frequency. Unlike retroviruses, AAV does not appear to require cell
division for integration. Recombinant AAV has been used to stably express genes in a
number of primary tissues, such as hematopoietic cells and neurons and glia in the
brain (Zhou et al., 1994; Kaplitt et al., 1994). Both retroviruses and AAV have been
proposed as vehicles for gene therapy, thus the production of GFP might be a good
reporter for effective gene transfer and maintenance of expression.
Alternatively, one can make a chimera by transplanting transgenic cells from a
transgenic to a nontransgenic organism, thus creating clones of transgenic cells.
Such transplantations are easily done in amphibian and fish embryos at many stages
of development. In mice, it is also possible to transplant cells between embryos at
multiple stages of development, though one can also make chimeras by the
transplantation of embryonic stem (ES) cells, which can be genetically altered in
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culture. Thus not only can one make clones of cells which ectopically express a gene
of interest, but one can make clones of cells with directed mutations via homologous
recombination in the ES cells. In order to mark the transplanted cells, they need to
possess some characteristic distinct from the host cells; expression of GFP could be
such a mark.
Stable non-mosaic transgenics
Finally, one can make stable, non-mosaic transgenics in which the transgene is
stably integrated into the same chromosomal location(s) in every cell of the organism.
This can be a better way to study the role of cis-acting sequences on gene expression
and the effects of ectopic gene expression because the lack of mosaicism makes
interpretation easier. Furthermore, it is the best way to analyze the roles of specific
genes through mutagenesis, either by the expression of dominant negative alleles
(Herskowitz 1987; Stacey et al., 1988; Kroll and Amaya, 1996), targeted recessive
mutations by homologous recombination in murine ES cells (Schwartzberg et al.,
1989; Thompson et al., 1989, Zijlstra et al., 1989), or insertional mutagenesis (Meisler,
1992., Gaiano et al., 1996).
In some situations stable non-mosaic transgenesis can be achieved in Go
animals, while in others, only mosaic Go animals can be made. In the latter case,
transmission of an integrated transgene through the germ line is required to make a
stable non-mosaic transgenic; however, even in the former case it is preferable to get
such "germ line transgenics" to be certain that the integrated DNA is non-mosaic. The
use of Go animals is preferred in these cases only if expression of the transgene might
be lethal to the animal, requiring analysis of the consequence of the transgene's
expression before the animals are sexually mature.
In mice, stable non-mosaic transgenics can be made by injection of DNA into the
pronucleus of a fertilized egg; in some proportion of injected eggs the DNA will be
incorporated into the genome. Integration usually occurs at the one cell stage, thus
most of these animals are non-mosaic; however, as stated above, only when
transgenes have been inherited through the germ line can one be sure that the animal
is non-mosaic. One can also make transgenic mice by infecting pre-implantation
embryos with a retrovirus. While the infected animals will be mosaic, if the integrated
provirus is inherited through the germ line, the offspring will inherit the viral sequences
in every cell and thus be non-mosaic. Additionally, one can use chimeras made by the
transplantation of genetically altered ES cells; some of these cells will contribute to
200
the germ line and thus some proportion of the progeny of these chimeras will contain
the genetic alteration.
Stable non-mosaic transgenic fish are made primarily by two methods - DNA
microinjection and retroviral infection (Stuart et al., 1988; Lin et al., 1994). In both
cases the founder fish are mosaic, and thus the transgene must be inherited through
the germ line. DNA microinjection has been used to make transgenics in many fish
species, such as zebrafish, medaka, carp, rainbow trout, and Atlantic salmon
(reviewed in Maclean and Rahman, 1994), and often are capable of expressing genes
of interest (reviewed in lyengar et al., 1996). At this time, retrovirally-induced
transgenesis has only been reported in zebrafish, and transgene expression has
observed only in mosaic Go animals, not after passage through the germ line (N.
Gaiano, M. Allende, K. Kawakami and N.H., unpubl. obs.).
Transgenic frogs have also been made by the inheritance through the germ line of
microinjected DNA. (Etkin and Pearman, 1987), but the generation time of Xenopus is
quite long (8 months) and transgene expression was not observed. Recently, Kroll
and Amaya (1996) reported a novel way to generate transgenic frogs such that the Go
animals were predominantly non-mosaic. Sperm nuclei were isolated, incubated with
plasmid DNA and restriction enzyme, and injected into unfertilized eggs. While some
of the resulting animals appear mosaic, 30-40% appear to be uniformly transgenic and
are capable of expressing the transgene.
ISSUES AFFECTING THE SUCCESSFUL USE OF GFP IN TRANSGENIC
VERTEBRATES
The ability to use GFP for any of the uses described above will require that the
particular application produces enough GFP fluorescence to be detectable. Thus the
real issues for the successful application of GFP in transgenic vertebrates are absolute
expression levels, which mutant versions of GFP are most easily detectable, and
which detection methods to use. Additionally, the animal itself is an issue. Zebrafish
embryos are particularly well suited to GFP expression due to their transparency and
development outside their mother. Xenopus embryos also develop externally and,
while not as transparent as zebrafish, can reveal GFP expression nicely as well (Kroll
and Amaya, 1996). However, the full potential of GFP as a vital marker may not be
fully realized in mice and other mammals. Because these embryos develop inside
their mothers, development of a single animal cannot be watched over time. Instead,
individual embryos are removed from the uterus at discrete time points and analyzed
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only at that developmental stage. Since this prevents further development of the
embryo, this imposes the same limits upon the analysis of gene expression as the use
of a non-vital marker. However, there may be specific applications of GFP that could
be useful in experiments involving transgenic mice, such as those involving explants
which are then manipulated in culture.
Expression levels
Most reports of GFP expression in vertebrates have used very strong regulatory
elements to drive expression, such as the efloa enhancer/promoter in fish (Amsterdam
et al., 1995), CMV in mammals and frogs (Ikawa et al., 1995, Kroll and Amaya, 1996).
The use of tissue specific promoters has mostly been used in transient assays (see
exceptions below), where variability and mosaicism of expression has made it difficult
to assess whether GFP was always detected everywhere that it was expressed. In one
case where GFP expression was subsequently assessed immunohistochemically, it
appeared that a majority of the expressing cells were not visible via fluorescence of
the native protein (Peel et al., 1997). By using transplanted cells from zebrafish
embryos injected with bacterially expressed recombinant GFP, we have estimated that
detection of fluorescence requires nearly ten times more GFP when only expressed in
single cells than when ubiquitously expressed (Amsterdam et al., 1996). Consistent
with this observation, cells transplanted from stable transgenic zebrafish embryos
expressing detectable GFP ubiquitously (see below, under "Successful Applications:
stable non-mosaic transgenics) into non-transgenic embryos could not be detected by
epifluorescence microscopy (Amsterdam and Hopkins, unpubl. obs.). Thus, while a
systematic and truly quantitative analysis of gene expression levels required for
detection of fluorescence has not been done, clearly levels of expression are a
concern. It is noteworthy, however, that toxic effects from high levels of expression of
GFP have not been observed in any of these animals; thus expressing too much GFP
does not appear to be a problem.
GFP variants
The variants of GFP with altered spectral properties and brighter fluorescence (see
chapter by Tsien and Prasher) will be advantageous, but to date there are few reports
of their use in vertebrate animals. The few reports are encouraging. The Ser-65 to Thr
mutant (Heim, et al., 1995) was used in transgenic frogs by Kroll and Amaya (1996),
while Zernicka-Goetz et al. (1996) have observed very strong and long lasting
fluorescence when using another variant, GFP.RN3, for RNA injections into frog
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embryos. This variant incorporates three amino acid substitutions to alter the
absorption characteristics: Phe-64 to Leu, Ser-65 to Thr, and Ile-167 to Thr. This
variant also incorporates two amino acid substitutions thought to improve the folding of
the protein at higher temperatures and a number of silent codon changes. Another
variant selected on the basis of FACS-optimization when expressed in bacteria (GFP
mut2, Cormack et al., 1996) was used for tissue specific expression in both injected
zebrafish embryos and stable transgenic zebrafish (Long et al., 1997; Meng et al.,
1997) This particular variant has three amino acid changes in the chromophore
region: Ser-65 to Ala, Val-68 to Leu, and Ser-72 to Ala. In addition to variants with
amino acid substitutions, altering the codon usage has appeared to improve
expression in mammalian systems. A "humanized" GFP (Zolotukhin et al., 1996), was
used by Peel et al. (1997) for expression in the rat spinal cord. This GFP gene has the
Ser-65 to Thr substitution, and was further modified by altering 88 codons to codons
used more frequently in mammalian cells (see chapter by Tsien and Prasher). Both
this variant and one in which 169 codons were altered (Haas et al., 1996) have also
been used in retroviral vectors to infect mammalian tissue culture cells, and each
additional "humanization" resulted in brighter fluorescence (Levy et al., 1996, Muldoon
et al., 1997).
The GFP variants may be useful not only because they are brighter, but also
because many of them excite maximally in the blue spectrum rather than in the UV.
This alteration of the protein's spectral properties allows for the use of fluorescein filter
sets for observation. This provides less autofluorescence in embryos from some
species and is less likely to cause UV-induced damage to the organism during
observation. Additionally, Zernicka-Goetz et al. (1996) have injected RNA for another
variant which emits in the blue spectrum and observed blue fluorescence. This finding
suggests that two spectrally distinguishable reporters could be expressed in the same
animal.
Visualization methods
Most reports on the use of GFP in vertebrates have used direct observation with
fluorescence microscopes. A systematic comparison of different filter combinations for
viewing in any given organism has not been reported. When using wild-type GFP,
filters which use the UV excitation peak and take advantage of the full emission
spectrum (e.g. 370-420 nm excitation and 455nm long pass emission) have been
used in fish and mice (Amsterdam et. al., 1995; Ikawa et al. 1995), as have filters which
excite primarily in the blue and have a higher wavelength emission barrier (e.g.
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Chroma or Omega's "GFP" filters, Wu et al., 1995; Chiocchetti et al., 1997).
Fluorescein filters have been used as well (Lo et al., 1994), though these are only able
to excite wild-type GFP's minor absorbance peak in the visible spectrum and cut out
much of the emission. Alternatively, for the red-shifted variants, such as the Ser-65 to
Thr mutant (Heim et al., 1995) or mut2 (Cormack et al., 1996), fluorescein filters are
optimal. Our experience with wild-type GFP in zebrafish embryos is relevant here
(Amsterdam and Hopkins, unpubl. obs.). The filter sets which excite at lower
wavelengths (especially in the UV) and use long pass emmission filters at lower
wavelengths (e.g. 455nm) appear to give much stronger signals, but also allow for
much brighter autofluorescence from the yolk. However, this autofluorescence
appears more yellow than green, so it can generally be distinguished from the signal
of interest. The filters which excite at higher wavelengths and have emmision filters
which cut out some of GFPs emmision peak provide somewhat less illumination of the
GFP, though yolk autofluorescence is much less. However, the autofluorescence in
this case is much more similar in color to the actual GFP signal, especially when band-
pass emmision filters were used.
As noted above, many of the GFP variants have different excitation and emission
peaks than the wild-type protein, thus they are more efficiently detected with different
filter sets. For example, the red-shifted variants, such as the Ser-65 to Thr mutant
(Heim et al., 1995) or mut2 (Cormack et al., 1996), are optimally observed using
fluorescein filters.
Most embryos can be observed using either inverted fluorescent microscopes,
such as a Nikon Diaphot, or a non-inverted fluorescence microscope designed for
large working distances (the distance between the lens and the sample) such as a
Nikon microphot-SA. The use of such microscopes with a 4X or 5X objective provides
a large enough field of view to see entire early embryos; however later stage embryos
will not entirely fit in the field of view.
In some instances, fluorescence was enhanced with the use of a cooled CCD
camera. Digital manipulation of the image can suppress the background and highlight
the true signal. Digital image recording also added the ability to quantitate expression
levels. However, it is unclear whether or not this actually allowed detection of GFP that
could not be seen at all without it. Potter et al. (1995) have used two-photon laser-
scanning microscopy to detect fluorescent dyes in cultured neurons. The authors
suggest that GFP could be similarly detected and that this method is far more sensitive
than epifluorescence or confocal microscopy.
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SUCCESSFUL APPLICATIONS OF GFP IN TRANSGENIC VERTEBRATES
Stable transgenics expressing GFP both ubiquitously and tissue-specifically have
been made successfully in zebrafish, mice, and frogs. Tissue-specific expression has
been seen in transiently transgenic zebrafish, transiently and stably transgenic frogs,
and in virally infected rat neurons. GFP has been used to assess alternative gene
delivery systems, including biolistics, several viruses, and direct DNA injection into
muscle tissue (see Table 2)
Stable non-mosaic transgenics.
Stable transgenic lines expressing detectable GFP have been made in zebrafish,
frogs, and mice. The Xenopus efla enhancer/promoter designed for early gene
expression in frogs (Johnson and Krieg, 1994) was used in conjunction with a rabbit 1-
globin intron to express wild-type GFP in transgenic zebrafish generated by DNA
microinjection (Amsterdam et al., 1995). In all five transgenic lines containing this
construct (and in two out of four in which the 13-globin intron was omitted) transgenic
embryos could be unambiguously identified by 24 hours post-fertilization, even while
still in their chorions. Importantly, a single integrated copy of this transgene was
sufficient to produce detectable fluorescence. Fluorescence in most lines appeared
ubiquitous between 20 and 36 hours after fertilization. After this, fluorescence slowly
decreased in most tissues, except the lens of the eye. The absence of detectable
fluorescence until 20 hours post-fertilization is neither due to a lack of transcription
before this point in time or a general inability to detect GFP in early embryos. In
injected (Go) embryos, fluorescence can be detected as early as four hours post-
fertilization, only an hour after the beginning of zygotic transcription. This
demonstrates both that the enhancer/promoter is transcriptionally active at this time,
and that GFP is readily detectable. Furthermore, in situ hybridization on embryos from
the transgenic lines demonstrated the presence of GFP RNA as early as 10 hours
post-fertilization (Y. Grinblat, A.A., H. Sive, and N.H., unpubl obs.). Thus, it appears
that there is a significant delay between the onset of transcription and the appearance
of detectable fluorescence. Presumably it takes this much time to accumulate
sufficient GFP for detection in the transgenic embryos; fluorescence is probably seen
earlier in the injected embryos because, due to the high number of plasmid molecules
per cell, there is much more GFP produced. This delay may may be due to a
requirement for both the accumulation of GFP protein and its correct posttranslational
modification for chromophore formation. Thus the delay might be shorter if a variant
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Table 2: Examples of GFP expression in t ransgenic vert ebrat es
TYPE OF
TRANSGENIC CFGANISMv
AND METHOD OF
TRANSG ENE
DEULIVERY RS-SH FRG MAMMAL
GO  wild type GFP wild type GFP
Transient,mosaic Muscle-specific muscle cell expression
DNA expression wit h when injected into adult
microinject on mouse myosin light muscle driven by (vlVchain enhancer/ enhancer/ promoter or
prom ot er creat ine kinase(Moss et al., 1995) promoter (Bartlett et
al., 1996)
GFPmut2
Independent regulation
of expression in blood
progenit ors,
enveloping layer, and
CNS neurons wit h
deletion analysis of
GATA-2 enhancer/
prom ot er
(Meng et al., 1997)
GO humanized GFP Ser65Thr
Transient ,mosaic adeno-associated virus
Particle-mediat ed vector infection in adult
gene transfer rat spinal cord neuron-
specific expression with
PDGF-1 chain promoter
and neuron-specific
enolase prom ot er
(Peel et al., 1997)
GO wild type GFP
Transient ,mosaict ect al neurons inf ect ed
Viral vector in live animals with
recombinant vaccinia
virus; expression
driven by vaccinia
early/late promoter
(Wu et al., 1995)
Table 2: Examples of GFP expression in transgenic vertebrates (cont.)
TYPE CF
TRANSMNIC ORGANISM
AND METHOD CF
TRANSGEJE
DELIVERY FISH FROG MAMMAL
(3b wild type GFP
Stable,mosaic neurons and glia in rat,
Viral vector ferret and tree shrew
brain slices with CMV
enhancer/promoter
(Lo, et al., 1994)
C wild type GP
Stable, non-mosaic ubiquitous expression
Sperm nuclear with CMV enhancer/
transplantation promoter and muscle-
specific expression
with cardiac actin
enhancer/promoter
(Kroll and Amaya, 1996)
Germline wild type GFP wild type GP
Stable, non-mosaic Ubiquitous expression ubiquitous expression
DNA microinjection with Xenopus efl a from four-cell stage
enhancer/promoter on with CMV
(Amsterdam, et al., enhancer/ B-act in
1995) promoter in
transgenic mice
(lkawa et al.,G FPmut2 1995a,b)
Expression in erythroid
progenitor cells driven Green Lantem GFP
by GATA-1 enhancer/ taste-cell restricted
promoter expression driven by
(Long et al., 1997) gastducin promoter
B. Margolsky, pers.
comm.)
wild type GFP
Expression in the adult
liver driven by the
hemopexin promoter
and expression
throughout embryos
driven by the 3-1
integrin distal
promoter (Chiocchetti
et al., 1997)
such as the Ser-65 to Thr were used, as the kinetics of chromophore formation seem
to be faster in vitro.
Transgenic zebrafish have also been made which express GFP in a tissue-specific
manner. Long et al. (1997) used 5.4 kb of sequence upstream of the GATA-1 gene to
drive the expression of the GFPmut2 variant (Cormack et al., 1996). Fluorescence was
specifically seen in erythroid progenitor cells in the embryo, first in the intermediate
cell mass, then in both the heart endocardium and circulating blood cells. In
transgenic adults, fluorescence could still be observed in circulating blood cells, as
well as in the head kidney, which is thought to be the site of adult hematopoiesis.
Thus fluorescence is observed in a pattern recapitulating the expression of the
endogenous GATA-1 gene, the first demonstration in germ-line transgenic zebrafish of
any reporter gene expressed in the pattern of an endogenous tissue-specific gene.
Transgenic Xenopus expressing GFP were generated by the sperm nuclear
transplantation method (Kroll and Amaya, 1996). Though these transgenes were
analyzed in founder frogs instead of those in which the transgene had been inherited
through the germ line, expression did appear to be non-mosaic in the majority of the
embryos which express the transgene at all. 35% of the embryos produced by this
method expressed the transgene non-mosaically, 20% expressed mosaically, and
45% did not express at all, presumably because the transplanted sperm nuclei had not
incorporated plasmid DNA. Southern analysis of genomic DNA from these frogs
indicated that embryos which expressed the transgene non-mosaically contained
integrated plasmid while those which failed to express it did not.
Both ubiquitous and tissue-specific expression of GFP could be observed in
transgenic frogs made by this method. A transgene in which a nuclear localized red-
shifted Ser-65 to Thr GFP was driven by the CMV enhancer/promoter produced
ubiquitous expression; fluorescence could be seen in all nuclei of the developing
embryo, as confirmed by colocalization of this fluorescence with DAPI staining. In
another plasmid used to make transgenics, the enhancer/promoter of the cardiac actin
gene (Mohun et al., 1986) was used to drive the expression of wild-type GFP. Tissue-
specific non-mosaic fluorescence was observed in somites and cardiac muscle of
developing embryos. This expression was followed over several months, during
which time tadpoles continued to express GFP non-mosaically in myotomes.
Transgenic mice were generated by pronuclear injection and germ-line
transmission of a plasmid containing the CMV enhancer and 1-actin promoter (Ikawa
et al., 1995a) driving wild-type GFP. Transgenic offspring were easily identified
postnatally by the observation of fluorescence in their fingers or tails in all three
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transgenic lines produced. Both microscopic examination of sections and
spectrophotometric analysis of protein extracts from tissues from newborn transgenic
mice revealed that expression was nearly, but not entirely ubiquitous. For example,
while fluorescence was observed in all tissues examined, in the kidney most
fluorescence appeared to be localized to the glomeruli. Muscle tissue appeared to
have the most fluorescence; heart and pancreas had nearly as much, while lung and
kidney had far less.
Preimplantation embryos from these lines could also be identified with 100%
confidence based on observation of fluorescence of morula stage embryos, and
fluorescence could actually be detected as early as the four cell stage (Ikawa et al.,
1995b). The brief exposure to UV light required to observe fluorescence did not
appear to affect the development of the embryos, though it is known that longer
exposures can. The authors postulate that the use of red shifted variants of GFP could
allow detection while exposing the embryos to light in the visible spectrum, thus
making the procedure safer.
Tissue-specific expression of GFP has also been achieved in transgenic mice.
When the gastducin promoter was used to drive the gfp gene, expression of GFP was
restricted to the taste cells of the mice (B. Margolsky, pers. comm.). This study utilized
the Green Lantern GFP (available from Gibco/BRL Life Sciences), which incorporates
the Ser-65 to Thr mutation as well as many silent changes to "humanize" the codon
usage. When detected with antibodies, GFP protein could be seen very clearly in the
taste cells of fixed tissue from young mice. Fluorescence from the GFP itself was much
harder to see; only faint fluorescence could be seen in fixed tissues which were not
antibody-stained, and it was not clear if as many cells could be seen to express GFP
by its own fluorescence as opposed to by antibody detection.
Both tissue-specific expression and ubiquitous expression of GFP in transgenic
mice were demonstrated by Chiocchetti et al. (1997), using wild type gfp fused to the
second intron and final exon of the human beta-globin gene. First, 700 bp of the
hemopexin promoter, which is strongly active in the adult liver and weakly active in
some cells in the brain, was used to drive either gfp or lacZ. Both reporters were
expressed in the correct tissue-specific manner. However, the fluorescent signal in the
gfp transgenics, detected in paraformaledeyde-fixed sections, was much stronger than
the Xgal staining in the lacZ transgenics, and a far greater number of cells were
observed to be fluorescent in the former than X-gal staining in the latter. This was true
even when comparing lines in which an equal concentration of GFP protein and beta-
galactosidase protein were found in liver extracts. Transgenic mice were also made in
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which either wild type gfp or lacZ were driven by 1.5 kb of the beta-1 integrin distal
promoter, which is ubiquitously active in embryogenesis. As with the hemopexin-
driven transgenes, in any given tissue fluorescence in the gfp lines was much stronger
than X-gal staining in lacZ lines. Thus it appears that wild type gfp can give greater
sensitivity as a reporter than lacZ in fixed sections from both embryonic and adult
mouse tissues.
Transient transgenics: DNA microinjection
GFP has also been used in transient expression in zebrafish to demonstrate
tissue-specificity of cis-acting sequences. Moss et al. (1996) demonstrated that a
plasmid containing the wild-type GFP gene driven by the rat myosin light chain
enhancer/promoter was able to produce fluorescence exclusively in muscle cells. The
number of fluorescent somitic muscle fibers varied widely from embryo to embryo, but
fluorescence was never seen in any other tissue. This expression could be observed
as early as 24 hours after fertilization and fluorescent muscle cells could still be
observed in six week old fish.
Another study utilized GFP as a reporter to evaluate the regulatory sequences
upstream of the GATA-2 gene (Meng et al., 1997) Using 7.3 kilobases of upstream
sequence to drive GFPmut2, fluorescence was observed mosaically but exclusively in
ventral mesoderm and ectoderm during gastrulation, and blood progenitors in the ICM,
enveloping layer (EVL) cells and neurons in the central nervous system. This faithfully
reproduces the expression pattern of the endogenous GATA-2 gene (Detrich et al.,
1995), with the possible exception of the EVL expression which was not detected by
whole mount in situ hybridization. Deletions and mutations were then made in this cis-
acting sequence to identify sequences which affected expression in each of these
tissues individually, demonstrating the potential of GFP as a tool for the detailed
analysis of developmentally controlled transcriptional regulatory elements.
As a reporter for alternative DNA delivery techniques
GFP has also been a popular reporter for other DNA delivery techniques,
including experimental studies of gene therapy approaches. For example, two studies
have used GFP to demonstrate the efficacy of gene transfer into neurons for the
purpose of examining the effects of ectopic expression of other genes in these cells.
Lo et al. (1994) demonstrated that particle-mediated gene transfer (bombardment of
tissue with DNA-coated gold particles) into brain slices from developing rats, ferrets,
and tree shrews under conditions in which these tissues can remain healthy and
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continue to differentiate could be used to deliver and express a GFP transgene. Using
the CMV enhancer/promoter to drive the wild-type GFP gene, fluorescence could be
detected in neurons and glia in the brains slices, and expression was sufficiently high
to see dendritic and axonal processes. The authors suggest that this will allow the
identification of live transfected neurons in a physiological setting, opening up the
possibility of investigating the effects of expression of cotransfected genes with
methods such as time-lapse video microscopy and patch-clamp recording.
Towards a similar end, Wu et al. (1995) used GFP-encoding recombinant vaccinia
virus to infect the tectum in developing frogs. The viral genome contained the vaccinia
early/late promoter driving the wild-type GFP gene. By injecting low titers of virus (so
that few cells were infected) they were able to detect fluorescence in individual
neurons for three to four days beginning about one day after infection, allowing
individual infected neurons to be followed in time.
Several studies have utilized GFP as a reporter for long term gene expression in
potential gene therapy vectors. Some of these have involved the infection of tissue
culture cells with retroviruses expressing GFP variants (Cheng et al., 1996; Levy et al.,
1996; Muldoon et al., 1997). Each of these studies utilized red shifted variants, either
the Ser-65 to Thr or RSGFP4 (Phe-64 to Met, Ser-65 to Gly, Gin-69 to Leu; Delagrave
et al., 1995), expressed from a murine retrovirus and was able to show that infected
cells were fluorescent. Furthermore, the use of variants in which more codons were
changed to human codon bias (primarily by the use of either C or G in the third
position) improved the amount of fluorescence and the number of cells which were
fluorescent. While none of these studies infected cells in living animals, the successful
expression and detection of GFP variants in tissue culture cells with retroviral vectors
holds out promise for this goal.
Bartlett et al. (1996) combine the successful uptake, retention, and expression of
plasmid DNA in injected skeletal muscle observed by Wolff et al. (1990) with the fact
that adeno-associated virus (AAV) vectors appear to integrate into the host cell
chromosome at some frequency. Using plasmids in which the AAV integrative
inverted repeats (the sequences necessary to achieve integration) flank a wild-type
GFP gene, they were able to investigate the extent and duration of gene expression
following injection into the skeletal muscle of mice. GFP expression was seen in
nearly 100% of the muscle fibers in the region of the injection by two weeks after
injection, and expression was even higher after six weeks. This study was also able to
demonstrate that such a gene delivery system produces more gene product when the
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muscle-specific creatine kinase promoter is used to drive expression, rather than the
usually strong CMV enhancer/promoter.
In another study using actual AAV vectors to infect target cells, Peel et al. (1997)
were able to demonstrate long-term and cell-type specific gene expression in the
spinal cord of adult rats. Recombinant AAV encoding the "humanized" GFP (the Ser-
65 to Thr GFP variant with the human codon bias) driven by one of two neuron-specific
promoters produced fluorescence in neurons, but not glial cells, for at least fifteen
weeks. Many neurons could be infected and express detectable fluorescence. Often,
enough GFP was produced in these cases to fill the axonal and dendritic processes.
Conversely, the use of an astrocyte-specific promoter driving GFP in a recombinant
virus restricted observed fluorescence to this cell type. This was useful for
demonstrating the efficacy of AAV for gene transfer and tissue-specific and long term
expression in neurons. However, when GFP was stained for immunohistochemically,
it was clear that many more cells contained GFP protein than were observed to be
fluorescent. Thus most of the cells did not contain enough GFP to detect by
fluorescence in spinal cord explants. It is noteworthy that in both of these studies, GFP
was not used as a vital marker; the animals had to be killed for analysis as
fluorescence could not be observed through the skin and fur.
PROSPECTS FOR THE USE OF GFP IN TRANSGENIC EMBRYOS
The successful applications of GFP in transgenic vertebrates so far provide a good
indication of what experiments are possible now and which will require more technical
advances, such as more sensitive detection methods, better expression vectors, and
additional GFP variants. Transient, mosaic expression assays appear to be
particularly effective, probably because the high number of copies of the plasmid per
cell allows for a high level of GFP expression. However, expression in stable
transgenics has also been observed when strong promoters have been used, even
when only a single copy of the transgene was present.
Identifying cis-acting sequences
The examples above suggest that GFP, particularly the brighter variants, will prove
to be a very good reporter for defining cis-acting sequences in both frogs and fish. The
sperm nuclear transplant experiments indicated that GFP expression in transgenic
frogs was as extensive and specific as that of other reporters. Thus it could prove to be
the simplest reporter for delineating sequences required for temporally- and tissue-
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specific gene expression, as fluorescence can be observed repeatedly over time. In
fish one should be able to identify cis-acting sequences by the microinjection of GFP-
containing plasmids into one-cell stage embryos. The results with the GATA-2
upstream sequences suggest that GFP could be very useful in identifying the distinct
sequences responsible for different aspects of a gene's regulation, even though
expression is mosaic.
As a co-expression marker
GFP could also be very useful as a co-expression marker in mosaic transgenics.
Co-expression of GFP with another gene of interest would identify the cells in which
that gene was being expressed. For widespread expression in embryos, one could
inject one-cell stage embryos with a plasmid encoding GFP and the gene of interest,
both driven by a ubiquitously active promoter. Alternatively, one could use tissue
specific regulatory sequences to drive both the gene of interest and GFP so that
expression will be restricted to one cell type but still be widely distributed. In either
case, while expression will be mosaic, the actual cells expressing the gene of interest
should be identifiable by their fluorescence.
To investigate the effects of a gene's overexpression in more discrete areas,
delivery systems like the vaccinia virus, AAV, or muscle injection could be used.
These would be especially appropriate if one wanted to conduct some kind of assay in
living tissue (e.g. electrophysiology) that could be removed from the animal. One
could know which cells in the explant express the gene of interest because of the
coexpression of GFP and conduct and interpret the experiments accordingly.
As a marker for transgenic animals or cells
The ability to use GFP to unambiguously identify stable transgenics will also be of
some use. In the case of the transgenic frogs, if one wants to use the sperm nuclear
transplant method to determine the effects of ectopic gene expression, incorporation of
GFP into the transgene will make it possible to distinguish transgenics from non-
transgenics before analysis. While about half of the embryos generated by this
method can be expected to be transgenic, eliminating those that are not (or are
mosaic) will simplify the analysis of the effects of the transgene. In the case of
establishing transgenic lines of fish or mice, the inclusion of GFP in the transgene to
facilitate the identification of transgenic offspring would save some amount of time and
animal-raising space. However, it is important to note that in both cases, such
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identifiable transgenics have only been made by DNA microinjection. It is not clear yet
whether transgenics made by retroviral infection will produce detectable GFP.
The existence of ubiquitously expressing transgenic lines could prove useful for
transplantation experiments, including both lineage analysis and wild-type/mutant
chimeras. As stated above, the zebrafish lines described by Amsterdam et al. (1995)
do not express strongly enough for this purpose. However, it is possible that the use of
a brighter variant of GFP could make transgenics which produce enough fluorescence
to do this. It is currently unclear if the efla enhancer/promoter will continue to express
ubiquitously in such lines (in the lines with the wild-type GFP, fluorescence did seem
to fade somewhat), but other regulatory regions could also be tried, such as the carp 13-
actin enhancer/promoter in conjunction with boundary elements (Caldovic and
Hackett, 1995).
The feasibility of other applications of GFP is still difficult to assess. For example,
as stated above, it is currently unclear whether the expression of detectable GFP from
retroviruses in transgenic animals will be possible, which may have more to do with
working out aspects of expression from retroviruses in general than with GFP per se.
Similarly, it is unclear whether stable transgenics in which the promoters of specific
genes are used to drive GFP will produce enough fluorescence for detection. It still
needs to be determined whether the level of expression of most endogenous genes
(from their endogenous locus) will provide sufficient expression of GFP. The use of the
bright GFP variants and possibly better fluorescence imaging technology can only
make these possibilities more likely.
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APPENDIX 4
RETROVIRUS-MEDIATED INSERTIONAL MUTAGENESIS IN ZEBRAFISH
(excerpted from: Amsterdam, A., Yoon, C., Allende M., Becker T., Kawakami, K.,
Burgess, S., Gaiano, N., and Hopkins, N. (1997) Cold Spring Harbor Symp. Quant.
Biol. 62: 437-450.)
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Introduction
We are interested in identifying genetic pathways for developmental processes
and simple behaviors in the zebrafish. A particularly powerful approach to the
identification of genes that specify developmental processes has been the application
of large scale Mendelian genetics followed by molecular cloning of mutant genes.
Although long considered impractical in vertebrate animals, some years ago George
Streisinger challenged this notion by proposing that the zebrafish might be a suitable
vertebrate for the "forward genetic" approach (1). Zebrafish possess the two traits
required for the successful application of large scale Mendelian genetics to the study
of early development: zebrafish can be bred, raised and maintained in large numbers
in the laboratory, and second, fish embryos are numerous, transparent, and they
develop outside the mother so that developmental defects can readily be seen. It was
shown some years ago that important developmental mutations could be identified in
the zebrafish, and this year several labs reported the results of large scale
mutagenesis screens aimed at identifying all the embryonic lethal and visible
phenotypes of the fish (2-7). These screens employed ethylnitrosourea (ENU) to
induce mutations (4, 8).
The large scale chemical mutagenesis screens in fish reveal that there are
roughly 2400 genes which when mutated are essential or produce a visible embryonic
phenotype, with most being embryonic lethals (5). The screens did not achieve
saturation, rather it is estimated that mutations in approximately half the embryonic
lethal or visible genes have been seen to date. The mutants display a remarkable
range of phenotypes, with different mutations affecting the development of virtually
every embryonic organ system as well as simple behaviors of the embryo including
motility (7, 9). Small scale chemical mutagenesis screens have shown that mutations
affecting embryonic vision and smell can also be identified (10, 11, Whitlock and
Westerfield, pers. comm.).
While chemical mutagenesis screens in zebrafish are invaluable for displaying
the full range of mutant phenotypes that can be obtained for particular developmental
pathways, at present they suffer from the fact that it is difficult to clone the mutated
genes. Currently this must be done by laborious and costly positional cloning or by the
candidate gene approach. Chemically induced mutants are usually single base
changes, making positional cloning time consuming even in invertebrate organisms
such as flies or worms. The problem is more acute in the fish whose genome is
estimated to be about half to two thirds the size of the mouse genome. In some
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organisms, a powerful complement to chemical mutagenesis screens has been
insertional mutagenesis or gene tagging. Recognizing the special benefit such a
method would have in the zebrafish, we set out to develop insertional mutagenesis for
this organism. This is a significant technical challenge since the number of insertions
needed to induce mutations in a substantial fraction of the genes is expected to be
large. If the fish genome is approximately 1.5x10 9 bp, and if one were to insert
exogenous fragments of DNA into the genome at 10 kb intervals (which might be
sufficient to mutate every gene), one would need 150,000 insertions to hit every gene
once. Since in practice insertions would not be evenly spaced, one would need
several times this number of insertions to achieve saturation.
We have developed a method that will allow us to generate several hundred
thousand insertions of exogenous DNA in the fish germ line with about 6 months of
work (12). We infect blastula-stage embryos with a retroviral vector (12, 13).
Furthermore, we carried out a small pilot screen and determined that proviral
insertions are mutagenic (14, 15). Mutant genes proved even easier to clone than we
had anticipated. In this report, we review the results of our pilot insertional
mutagenesis screen, and discuss plans to perform a large scale insertional
mutagenesis screen.
Results
(i) Mouse retroviral vectors can be used to generate hundreds of thousands of
insertions in the zebrafish germ line
Mouse retroviruses have restricted host ranges, which in many cases are
determined by their envelope glycoproteins. These proteins must interact specifically
with receptors on the cell surface to allow the virus to productively infect the cell. The
host range of mouse retroviruses can be broadened by co-infecting cells with a mouse
retrovirus plus vesicular stomatitis virus (VSV), a lytic virus which belongs to the
Rhabdovirus family and has an extremely broad host range (16). The expanded host
range of mouse retroviruses obtained by co-infection with VSV results from the
incorporation into retrovirus particles of a single VSV-coded gene product, the G
envelope glycoprotein (17, 18). A mouse retrovirus with a VSV-coded envelope
glycoprotein in place of its own glycoprotein is called a pseudotype. While the
potential usefulness of VSV pseudotype viruses was recognized immediately, it took
many years of effort before these viruses could be grown free of contaminating VSV
and could be grown to high titers. Effort in achieving high titers of pure pseudotype
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viruses was driven by the potential usefulness of these viruses for human gene
therapy and was ultimately accomplished by Friedmann's lab at UCSD (19, 20). As
expected, high titer VSV pseudotype viruses can infect cells of virtually all species that
have been tested and they are currently favored retrovirus vectors for use in human
gene therapy.
A critical question in using VSV pseudotypes as mutagens for zebrafish was
whether the virus could be delivered to the fish germ line. Almost nothing was known
about the location of the zebrafish primordial germ cells when we began these
experiments. Because early fish development is so rapid, proceeding from a fertilized
egg to a moving embryo within 24 hours, while mouse retroviral infections were
thought to require at least 5-6 hours before proviral DNA is synthesized and integrated
into the host genome, it was uncertain whether the virus would synthesize and
integrate provirus in time to productively infect a significant fraction of the cells
destined to become the germ line. We found that virus injected into blastula stage
embryos can infect the fish germ line (13). Although this unpredictable result was a
critically important step in developing a methodology, in initial experiments only 15%
of injected eggs grew to be founder fish that transmitted a retrovirus provirus to their
Fl. Furthermore, most founders transmitted only a single insertion to only about 2-4%
of their F1 progeny. At this frequency it would not be feasible to generate a large
numbers of proviral insertions in the fish germ line.
We prepared higher titer stocks of VSV-pseudotyped mouse retroviral vectors
than those used in our initial experiments (12). Using our most recent stocks of virus,
the percent of transgenic founder fish has risen from 15% to 100% (Fig. 1).
Furthermore, each founder fish (of 200 tested) now transmits an average of 12
insertions to it F1 progeny, with each insertion being inherited in a few percent of the
Fls. Most transgenic F1 fish inherit a single provirus, but some inherit 2 to 5 insertions
(see Fig. 1). We attribute the improvement in transgenic frequency to the higher titer of
virus used in the later experiments.
At the frequency shown in Fig. 1, and given the large number of eggs that can be
injected in a day and survive to sexual maturity, we estimate that our lab could
generate founder fish harboring about 250,000 insertions in about 6 months. This
requires an efficient fish facility and a team of 3-4 people who perform injections five
days a week.
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Figure 1. Percent of transgenic Fls obtained from a typical founder fish. Every
blastula-stage embryo injected with high-titer virus grows to be a founder fish that
transmits proviral insertions to its F1 progeny. The percent of transgenic F1 progeny
and the number of insertions inherited in each F1 are shown for a typical founder.
Data is the average for 200 founders whose progeny were analyzed by Southern
blotting of fin clip-DNAs of about 100 F1 progeny.
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(ii) Proviral insertions are mutagenic
Once we had established that we could generate several hundred thousand
insertions in the fish germ line, we needed to determine whether the proviral insertions
were mutagenic, and if so, at what frequency. This question is related to the question
of whether the sites of integration of the provirus are random. Many studies have
addressed the question of whether murine retroviral provirus integration sites are
random. Although the answer remains somewhat controversial, the results indicate
that mouse retroviral proviruses integrate into an extremely large numbers of sites (21,
22). Some experiments suggest that integration is essentially random in most mouse
cell types, while others suggest that mouse proviruses are preferentially integrated into
active genes, possibly with a preference for the 5' ends of the genes.
If the size of the fish genome and the number of embryonic lethal genes were
known with certainty, and if proviral insertions were random, one should be able to
estimate the mutagenic frequency of insertions making an assumption only about the
target size of an average gene. For example, assuming a target size of 10,000
bp/gene, if there are 2400 embryonic lethals and the genome is 1.5x109 bp, then if
insertions were evenly spaced, one would expect a mutagenic frequency of one
insertional mutation per 60 insertions. In practice however, both the numbers and
assumptions are sufficiently inaccurate that such calculations are unreliable. In mice,
retroviral integrations are mutagenic and the frequency has been estimated to be 1
lethal mutation induced for every 20 proviral insertions, a frequency which seems
surprisingly high (23).
To determine the mutagenic frequency of proviral insertions in fish, we performed
a pilot insertional mutagnesis screen. F1 fish inheriting the same single insertion were
crossed to one another, or F1 fish with a single insertion were outcrossed, transgenic
F2 fish identified and these fish mated to one another. Progeny were examined for
embryonic mutant phenotypes in 25% of the embryos. We identified 3 insertional
mutants among 217 insertions screened, for a calculated frequency of 1 mutation per
70 insertions (14, 15). Subsequently, we isolated 3 additional embryonic lethal
mutations and 1 dominant adult phenotype (see below). The frequency has remained
approximately the same. Currently we estimate that about 1/70 to 1/100 insertions
induces an embryonic lethal or visible mutation.
Evidence that the mutants we isolated were induced by insertions is based on
several criteria, but the primary evidence is linkage data (14, 15). Using inverse PCR
we clone a fragment of DNA adjacent to the proviral insertion in each mutant line,
identify a single-copy probe from this fragment, and then determine a restriction
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enzyme digest that allows us to distinguish the chromosome bearing the proviral
insertion from its homologue lacking the insertion. We then mate fish heterozygous for
the insertion in question. DNA extracted from individual mutant and phenotypically
wild type embryos is analyzed by Southern blot. If all mutant embryos are
homozygous for the proviral insertion, while no wild type embryos are homozygous,
the insertion must be linked to the mutation. If enough embryos are analyzed to show
that the insertion and the mutation are very tightly linked, it is highly likely that the
insertion caused the mutation. Additional evidence that our mutations are caused by
proviral insertions has come from cloning genes into which the proviruses have
integrated. Before describing the genes, however, we first consider the phenotypes of
the mutants we obtained.
(iii) Phenotypes of insertional mutants
An important question is whether the phenotypes of insertional mutants display
the same spectrum as that seen in the chemical mutagenesis screens. In chemical
screens, mutants were classified into two broad categories, specific and non-specific,
with the latter being further subdivided into mutations whose most striking defect is
extensive apoptosis or necrosis in the CNS, and mutants with multiple defects and
frequently displaying edemas and retarded growth (4, 5, 6). Nonspecific mutants
comprised 70% of total, with about 20% having extensive cell death in the CNS, 50%
having multiple defects. About 25-30% of the mutants had specific defects, with one or
a few organ systems affected.
As shown in Table 1, our seven insertional mutants can be assigned to the
categories defined by the chemical mutagenesis screens, with four mutants belonging
to the "non-specific phenotype" group, and three to the category of "specific"
phenotypes. One mutant, dead eye (dye), displays extensive cell death in the brain
and neural tube beginning at day one of development (15). Three mutants, no arches
(nar), pescadillo (pes), and 80A, display multiple defects and exhibit edema at day 5
(14). Two of our embryonic lethal insertional mutants have specific developmental
defects. Of the latter, 399 displays a small eye phenotype at day 5 but otherwise
appears normal, although the mutant embryos die at about two weeks of age (Becker,
Burgess, and Hopkins unpublished results). The phenotype of mutant 891 is yolk
degeneration beginning from the yolk extension at day one of development and
proceeding until the entire yolk changes color and recedes, after which the embryo
rapidly declines (Allende and Hopkins, unpublished results). Our seventh insertional
mutant displays a dominant adult phenotype and is homozygous viable (Kawakami
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Retrovirus-Induced Insertional Mutants in Zebrafish
Phenotype Candidate Gene
no arches Embryonic lethal, onset at day 3. Lacks
(nar) branchial arches, other defects.
pescadillo
(pes)
Embryonic lethal, onset at day 3. Defective
in growth of embryonic liver, gut, fins,
arches and brain, but not several other
organs.
dead eye Embryonic lethal, onset at day 2. Extensive
(dye) apoptosis in eyes, brain and neural tube.
80A Embryonic lethal, onset at day 2. Multiple
defects.
SPECIFIC
PHENOTYPES
399
Dl
891
Post-embryonic lethal. Small eyes at day 5.
Dies at about 2 weeks of age. Defective in
the photoreceptor cell layer of the eye.
Homozygous viable. Dominant adult
pigmentation phenotype. Onset at 3 weeks.
Body stripe pattern breaks up into spots.
Embryonic lethal, onset at day 1. Yolk
darkens beginning at the yolk extension,
after which the embryo dies.
Homolog of Drosophila clipper, a ribonuclease (40). No mutants
known in other species. Transcript maternally supplied in flies and
fish, expressed in embryo but low in adult except in ovary.
Homolog of ESTs. No known function. Maternally supplied.
Expressed in embryonic sites that fail to grow in mutants,
expression low in adult except in ovary. May belong to BRCT
superfamily which includes human breast cancer gene BRCA- I
(Altschul and Koonin, pers. comm.)
Homologue described in frog (41) Possible nuclear pore
component, weak homology to yeast NIC96 (Nucleoporin
Interacting Component 96) (42). Yeast loss of function is lethal.
In fish RNA is maternally supplied and gene is expressed in CNS
in embryos.
Not yet cloned.
Transcription factor NRF-1. Unique DNA binding motif. Studied
biochemically in human, rat, chicken and sea urchin (43-45). In
flies a mutant in homologous gene is erect wings (46).
Homolog of ESTs. Protein of unknown function with similarity to
WD-repeat proteins.
Not yet cloned.
Gaiano et al., 1996
(14)
Allende et al., 1996
(15)
Allende et al., 1996
(15)
Gaiano et al., 1996
(14)
Becker, T., Burgess,
S., et al., unpublished
Kawakami et al.,
unpublished
Allende et al.,
unpublished
Mutant
NON-SPECIFIC
PHENOTYPES
Ref.
and Hopkins, unpublished results). In this mutant, the stripes on the body of fish
heterozygous or homozygous for the insertion break up into blobs. Adult phenotypes
affecting pigmentation, body shape, and fins were also seen in the chemical
mutagenesis screens and are assigned to the phenotypically "specific" class of
mutants. Although the number of mutants we have isolated is still very small, the fact
that they are representative of the different types seen in chemical mutagenesis
screens is reassuring.
(iv) Molecular cloning of genes disrupted by proviral insertions
If our putative insertional mutants are indeed caused by a proviral integration, we
would predict that each insertion that is linked to a mutant phenotype should lie in a
gene and disrupt its expression. Furthermore, the disrupted genes should be
expressed in wild type fish at a time and place such that perturbation of gene
expression could explain the mutant phenotype seen in animals homozygous for the
corresponding insertion. To determine if this is the case, we have attempted to clone
genes in the vicinity of the proviral insertions that are linked to mutant phenotypes.
This proved to be easier than we had anticipated, and to date we have identified
candidate genes for 5 of the 7 mutants (14, 15, see below).
To identify a gene in the vicinity of the provirus, we use inverse PCR to clone host
DNA flanking the provirus. The host DNA sequence is then used either for additional
rounds of inverse PCR, or as a probe to clone a larger genomic fragment from a
library. We then sequence host DNA adjacent to the proviral insertion and use the
sequence to search the data base of gene sequences. To date, fish genes have been
identified because of the large number of cDNA and genomic sequences from other
organisms that are in the data base, and because of the high conservation of amino
acid sequences between homologous genes from different organisms. As shown in
Figure 2, in four of five cases, we found the mutagenic provirus to lie within the first
exon or intron of a gene, while in the fifth case, the provirus lies in a large
(approximately 25 kb) intron.
The first four examples in Figure 2 correspond to four recessive embryonic lethal
mutations. In these cases, the gene that has been disrupted by proviral integration
was found to be expressed in phenotypically wild type embryos while mutant embryos
homozygous for the proviral insertions were found to lack detectable gene expression
as determined by Northern blot, RT-PCR, and/or whole mount in situ hybridization.
This result supports the conclusion that disruption of these genes is responsible for the
mutant phenotypes observed. The fifth case represents the proviral insertion linked to
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Figure 2. Genes disrupted by proviral integrations in five insertional mutants.
Diagrams show the position of proviral insertions relative to genes they disrupt. The
first four diagrams represent the positions of proviruses that are genetically linked to
recessive embryonic lethal mutations. The fifth diagram represents the position of a
provirus that is linked to a dominant adult phenotype. The genes are drawn to scale,
the proviruses are not. Note that the fifth diagram is drawn to a different scale than the
first four. In the case of the first four examples, the proviral insertions abolish or alter
detectable transcript from the genes, while in the fifth case alteration in gene
expression has not yet been detected (see text).
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PROVIRAL INSERTIONS IN MUTANT LOCI
recessive mutations 500 bp
dye
ATG >
pes
ATG -
399
ATG >
dominant mutation 5 kb
Dl ATG
ATG >
Figure 2.
4L
ATG -
r>
the dominant, homozygous-viable mutation. In this case the provirus lies in a large
intron and RNA expression from the gene is not abolished.
Further evidence that disruption of the genes we have identified is responsible for
the mutant phenotypes observed comes from the finding that, in cases where whole
mount in situ hybridization has been performed on embryos, we have found that in
wild type embryos the genes are expressed in tissues that are affected in mutant
embryos. This is true of pescadillo, dead eye, and mutant 399.
Definitive proof that the genes we identified are responsible for the mutant
phenotypes we have observed would require rescue of the mutant phenotype or
recreation of the mutant phenotype by knockout technology. However, the latter
technology is not yet available in the fish, and the former is still a demanding
experiment rather than a routine procedure (24, 25). Nevertheless, for the enbryonic
lethal mutations in which gene expression is profoundly affected, the evidence
described above strongly suggests that disruption of the candidate genes we identified
is likely to be responsible for the mutant phenotypes observed. The case of D1, the
dominant adult phenotype, is less certain, however. In this case, expression of the
candidate gene, which is normally expressed in embryos and adult fish, is not
abolished and, as of now, we have not been able to detect aberrant expression of this
gene in heterozygous or homozygous mutant fish. It is possible that proviral
integration results in aberrant expression of the gene at a low level in some tissues,
and this might not have been detected by experiments to date.
So far we have failed to identify a gene in the vicinity of the proviral insertion
linked to mutation 80A, although we have sequenced DNA flanking this provirus. It is
possible that this provirus has integrated in a gene that has no homologue in the data
base yet, or a gene that is sufficiently different in amino acid sequence from its
homologues that we have not recognized it. Alternatively, the provirus may lie at a
considerable distance from the gene it disrupts or from exons of a gene, and we may
not yet have sequenced enough DNA to find the gene. Attempts to clone the gene
presumably mutated by the insertion linked to mutation 891 are underway.
(iv) Feasibility and design of a large scale insertional mutagenesis screen in zebrafish
Our results show that it is relatively easy to generate a large number of insertions
in the fish germ line, that insertions are mutagenic, and that it is easy to clone genes
disrupted by the insertions and presumably responsible for the mutant phenotypes
observed. The results also show, however, that with the viral vector used, the
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frequency of insertional mutagenesis is low, about 1 in 70-100 insertions is mutagenic.
Given these findings, is a large scale insertional mutagenesis screen feasible in the
fish using this technology? Recent findings in our lab suggest that the answer is yes,
and that the number of mutants that can be obtained justifies this arduous undertaking.
In our pilot screen, we identified insertional mutants in most cases by following
the protocol shown in part A of Figure 3. F1 fish with single insertions were identified
by Southern analysis of fin clip DNAs and were then outcrossed. Transgenic F2 fish
were identified among the progeny and crossed to one another, and F3 embryos were
examined to determine if 25% displayed a mutant phenotype. This strategy makes it
easy to immediately clone host DNA flanking a proviral insertion since there is only
one insertion per fish. This strategy means, however, that each fish tank can
accommodate fish harboring just one insertion.
The number of insertions that can be screened in a given number of fish tanks
can be increased substantially using the scheme shown in Figure 3B. In this scheme,
one identifies F1 fish that harbor several insertions, and crosses these to each other to
generate F2 families. Then, just as in a chemical mutagenesis screen, one mates
pairs blindly from the F2 family. Every insertion present in the F1 parents will be
transmitted to 50% of the F2 fish. If one obtains 6 successful pair matings of F2 fish,
every insertion has an 85% chance of coming to homozygosity among the 6 pair
matings. Using the scheme in Fig. 3B rather than A, the number of mutants that can be
obtained from the same size fish facility increases by about five-fold.
We have found that when founder fish are mated to one another, about 20% or
more of their F1 offspring harbor 3-5 insertions per fish (Amsterdam, Allende, and
Hopkins, unpublished results). It is these fish that must be identified to carry out the
protocol shown in figure 3B. This is done by Southern analysis of fin clip DNAs of a
large number of F1 fish. Although laborious, this task is justified by the greater number
of mutants that can be obtained.
Based on the frequencies obtained in our pilot screen, we estimate that we could
generate about 800-1100 insertional embryonic lethal mutations over a period of 3
years. If insertions are random, this should correspond to about 600-800 genes, or 25-
33% of the total number of 2400 embryonic lethals estimated from chemical screens.
233
Figure 3. Two schemes for performing insertional mutagenesis screens. The left hand
figure (A) shows the scheme for breeding single insertions to homozygosity that was
used in a small pilot screen in our lab. The right hand figure (B) shows a scheme for
inbreeding multiple insertions simultaneously. The second scheme makes it possible
to screen a much larger number of proviral insertions with a given number of fish
tanks.
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Discussion
We developed a method of insertional mutagenesis that should allow us to
isolate a significant fraction of the genes essential for the embryonic development of
the zebrafish over the next few years. We estimate that the fraction of embryonic lethal
or visible mutations we could isolate in three years is about 25% of total, assuming
there are roughly 2400 such genes. Is this fraction sufficient to make the screen
valuable, and is it possible that improvements in the methodology could increase the
number of mutants we could isolate?
In invertebrate model organisms it is possible to perform Mendelian genetic
screens on a large enough scale to identify all the genes that are essential for the
process of interest, the so-called "saturation mutagenesis screen", and this has proved
to be an important aspect of the approach. Achieving saturation in a mutagenesis
screen in zebrafish is extraordinarily difficult technically, even using chemical
mutagens, and in fact has not been achieved in screens to date. It is not yet clear
whether the results of achieving saturation will be as profound in fish as they have
been in invertebrate animals because the genetic redundancy seen in vertebrates
may preclude the identification of key genes in pathways even when saturation is
achieved. Despite this possible limitation, it must still be acknowledged that saturation
remains the goal in genetic screens, including in the zebrafish.
Several considerations lead us to conclude that an insertional mutagenesis
screen using our current methodology is a desirable pursuit even though the
frequency of mutagenesis is considerably lower than that of chemical mutagenesis.
First, because the chemical mutagenesis screens have been performed, our
insertional mutants form part of a larger picture. Our ability to interpret the phenotypes
of the tiny group of mutants we have obtained to date is clearly enhanced by the
findings of the chemical mutagenesis screens. Second, although we will obtain a
smaller percent of all the essential genes than was obtained in the chemical screens,
as we have shown, the mutated genes are readily clonable, and this is a tremendous
advantage. As we discovered in our small pilot screen, many of the genes we will find
will be novel in that they will not previously have been associated with phenotypes in
any organism. Many of the genes essential for embryonic development in the fish
could provide a novel entry to studying important developmental processes in
vertebrates. The ease of cloning the genes for insertional mutants means that one
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requires far less certainty that a phenotype is "interesting" before embarking on the
cloning, and this should help to eliminate the bias which is likely to favor mutants that
we can already understand. Insertional mutagenesis may also prove a powerful
stimulus for behavioral screens in zebrafish. In behavioral screens, the desired
phenotypes are usually more difficult to assay than morphological defects, and thus
cloning the mutated genes by positional cloning is even more difficult when the
mutations have been induced by chemicals. The greater ease of tracking mutants and
cloning mutated genes using insertional mutagenesis may make such screens more
manageable, even given the lower frequency of mutagenesis.
Although we plan to apply our current methodology on a large scale, we are also
interested in trying to improve retroviral-mediated insertional mutagenesis. Even small
improvements in the efficiency of some of the steps would lead to a substantial
decrease in the amount of work needed to generate mutants. Some possibilities for
improving the method are the following.
1) Higher titer viruses. Considerable effort is required to generate the F1 fish
with multiple insertions that are needed for the screen (see Figure 3B). These F1 fish
are obtained from crosses of two founder fish, each harboring about 12 insertions in
their germ line (see Figure 1). At present about 20% of the F1 fish from such crosses
have 3-5 insertions and thus are useful for the screen. It is possible that founders
generated from injection of higher titer virus stocks would yield a higher frequency of
multiple-insertion F1 fish.
2) More mutagenic viruses. In mice, about 1 in 20 proviral insertions results
in an embryonic lethal or visible mutation while in our studies the number is only about
1 in 70-100 insertions (14, 15, 23). There are several possible explanations: Mice
might have more embryonic lethal genes than fish, mouse retroviral vectors might
integrate preferentially into genes in mouse cells but not in fish cells, or viruses might
be more mutagenic in mice than fish. We identified one mutant, designated D1, in
which the provirus that is genetically linked to the mutation lies in a large intron of a
gene whose disruption may explain the mutant phenotype. However, in this case, we
have not yet detected an alteration in transcripts from the gene. This observation
suggests that proviral insertion into a gene does not necessarily affect its expression
dramatically, if at all, a result that has been seen in mice as well. It might be possible to
generate a virus that is more mutagenic such that integration into large introns
invariably disrupts transcription. Alteration of the splicing and termination signals
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within the virus might help in this respect. If so, this would increase the target size for
generating mutagenic proviral integrations and hence increase the mutagenic
frequency.
3) Gene traps. If the retroviral vector used for the mutagenesis carried a
reporter gene that was activated upon integration into an active gene, then F1 fish with
integrations into genes could be detected as heterozygotes (21, 26). The ideal
reporter would be GFP, since this would make it possible to isolate live F1 embryos
with proviral insertions in genes expressed during embryogenesis. If one could pre-
select all such F1 fish for inbreeding, one could isolate a much larger number of
embryonic mutants, conceivably even achieving saturation for certain phenotypes,
assuming proviruses can integrate into all possible chromosomal sites.
4) Haploid screens. For phenotypes that can be screened in haploid embryos,
for example morphological defects arising in the first 1-2 days of development, or
possibly, defects detectable at later times by whole mount in situ hybridization,
antibody staining, or other procedures, it might be possible to screen a larger number
of insertions than by performing a diploid screen as shown in Figure 3B (27).
However, the greater effort needed to generate haploid embryos as opposed to simply
letting fish mate must be taken into consideration in making this decision.
Finally, it is possible of course that other insertional elements will become
available for mutagenesis in fish and that these will complement or supplant the
method described here. For example, Tc-1 related elements have been studied
extensively for this purpose by Hackett and his collaborators with promising results
(28).
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